0001213900-22-070278.txt : 20221109 0001213900-22-070278.hdr.sgml : 20221109 20221108203821 ACCESSION NUMBER: 0001213900-22-070278 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221109 DATE AS OF CHANGE: 20221108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Ingredients, Inc. CENTRAL INDEX KEY: 0000778164 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 412170618 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21467 FILM NUMBER: 221370441 BUSINESS ADDRESS: STREET 1: 400 CAPITOL MALL, SUITE 2060 CITY: SACRAMENTO STATE: CA ZIP: 95814 BUSINESS PHONE: 916-403-2123 MAIL ADDRESS: STREET 1: 400 CAPITOL MALL, SUITE 2060 CITY: SACRAMENTO STATE: CA ZIP: 95814 FORMER COMPANY: FORMER CONFORMED NAME: Pacific Ethanol, Inc. DATE OF NAME CHANGE: 20050324 FORMER COMPANY: FORMER CONFORMED NAME: ACCESSITY CORP DATE OF NAME CHANGE: 20030627 FORMER COMPANY: FORMER CONFORMED NAME: DRIVERSSHIELD COM CORP DATE OF NAME CHANGE: 20001115 10-Q 1 f10q0922_altoingred.htm QUARTERLY REPORT

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______ to _______

 

Commission File Number: 000-21467

 

ALTO INGREDIENTS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   41-2170618
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

1300 South Second Street, Pekin, Illinois   61554
(Address of principal executive offices)   (zip code)

 

(916) 403-2123

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of Exchange on Which Registered
Common Stock, $0.001 par value   ALTO  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ☐ Accelerated filer  ☒
Non-accelerated filer  ☐ Smaller reporting company  
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of November 4, 2022, there were 73,956,108 shares of Alto Ingredients, Inc. common stock, $0.001 par value per share, and 896 shares of Alto Ingredients, Inc. non-voting common stock, $0.001 par value per share, outstanding.

 

 

 

 

 

  

      Page
       
  PART I    
  FINANCIAL INFORMATION    
       
ITEM 1. FINANCIAL STATEMENTS   1
       
  Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021   1
       
  Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2022 and 2021 (unaudited)   3
       
  Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2022 and 2021 (unaudited)   4
       
  Consolidated Statements of Stockholders’ Equity for the Three and Nine Months Ended September 30, 2022 and 2021 (unaudited)   5
       
  Notes to Consolidated Financial Statements (unaudited)   6
       
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   17
       
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   31
       
ITEM 4. CONTROLS AND PROCEDURES   32
       
PART II    
OTHER INFORMATION    
       
ITEM 1. LEGAL PROCEEDINGS.   33
     
ITEM 1A. RISK FACTORS   33
       
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS   41
       
ITEM 3. DEFAULTS UPON SENIOR SECURITIES   42
       
ITEM 4. MINE SAFETY DISCLOSURES   42
       
ITEM 5. OTHER INFORMATION   42
       
ITEM 6. EXHIBITS   43
       
SIGNATURES   44

 

i

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)

 

   September 30,   December 31, 
   2022   2021 
   (unaudited)   * 
ASSETS        
Current Assets:        
Cash and cash equivalents  $28,458   $50,612 
Restricted cash   3,955    11,513 
Accounts receivable, net (net of allowance for doubtful accounts of $135 and $378, respectively)   76,455    86,888 
Inventories   61,088    54,373 
Derivative instruments   7,384    15,839 
Notes receivable, current   
    3,125 
Other current assets   8,966    7,176 
Total current assets   186,306    229,526 
Property and equipment, net   233,475    222,550 
Other Assets:          
Right of use operating lease assets, net   12,895    13,413 
Notes receivable, noncurrent   
    11,641 
Intangible assets, net   9,234    2,678 
Goodwill   5,970    
 
Other assets   6,788    5,145 
Total other assets   34,887    32,877 
Total Assets  $454,668   $484,953 

 

 
*Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.

 

See accompanying notes to consolidated financial statements.

 

1

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(in thousands, except par value)

 

   September 30,   December 31, 
   2022   2021 
   (unaudited)   * 
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current Liabilities:        
Accounts payable – trade  $17,493   $23,251 
Accrued liabilities   22,172    21,307 
Current portion – operating leases   3,646    3,909 
Derivative instruments   1,106    13,582 
Other current liabilities   10,096    7,553 
Total current liabilities   54,513    69,602 
           
Long-term debt, net of current portion   45,888    50,361 
Operating leases, net of current portion   9,201    9,382 
Other liabilities   10,068    10,394 
Total Liabilities   119,670    139,739 
Commitments and Contingencies (Note 7)   
 
    
 
 
Stockholders’ Equity:          
Alto Ingredients, Inc. Stockholders’ Equity:          
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2022 and December 31, 2021; liquidation preference of $18,075 as of September 30, 2022   1    1 
Common stock, $0.001 par value; 300,000 shares authorized; 73,956 and 72,778 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively   74    73 
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2022 and December 31, 2021   
    
 
Additional paid-in capital   1,036,459    1,037,205 
Accumulated other comprehensive loss   (284)   (284)
Accumulated deficit   (701,252)   (691,781)
Total Stockholders’ Equity   334,998    345,214 
Total Liabilities and Stockholders’ Equity  $454,668   $484,953 

 

 
*Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.

 

See accompanying notes to consolidated financial statements.

 

2

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands, except per share data)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
                 
Net sales  $336,877   $305,556   $1,007,184   $822,400 
Cost of goods sold   356,716    308,955    1,013,406    796,729 
Gross profit (loss)   (19,839)   (3,399)   (6,222)   25,671 
Selling, general and administrative expenses   (7,403)   (5,533)   (24,028)   (19,777)
Asset impairments   
    
    
    (3,100)
Income (loss) from operations   (27,242)   (8,932)   (30,250)   2,794 
Interest expense, net   (340)   (429)   (859)   (3,359)
Income from cash grant   
    
    22,652    
 
Income from loan forgiveness   
    5,973    
    9,860 
Other income (expense), net   (456)   256    (68)   641 
Income (loss) before provision for income taxes   (28,038)   (3,132)   (8,525)   9,936 
Provision for income taxes   
    
    
    
 
Net income (loss)  $(28,038)  $(3,132)  $(8,525)  $9,936 
Preferred stock dividends  $(319)  $(319)  $(946)  $(946)
Income allocated to participating securities   
    
    
    (120)
Net income (loss) available to common stockholders  $(28,357)  $(3,451)  $(9,471)  $8,870 
Net income (loss) per share, basic  $(0.39)  $(0.05)  $(0.13)  $0.12 
Net income (loss) per share, diluted  $(0.39)  $(0.05)  $(0.13)  $0.12 
Weighted-average shares outstanding, basic   73,011    71,383    71,815    71,002 
Weighted-average shares outstanding, diluted   73,011    71,383    71,815    72,260 

 

See accompanying notes to consolidated financial statements.

 

3

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands)

 

   Nine Months Ended
September 30,
 
   2022   2021 
Operating Activities:        
Net income (loss)  $(8,525)  $9,936 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Depreciation and amortization of intangibles   19,122    17,520 
Inventory valuation   7,963    
 
Asset impairments   
    3,100 
Income from loan forgiveness   
    (9,860)
Non-cash compensation   2,546    2,283 
Amortization of deferred financing fees   29    732 
Bad debt expense (benefit)   (187)   140 
Changes in operating assets and liabilities, net of business acquisition:          
Accounts receivable   16,137    (35,072)
Inventories   (13,290)   (20,192)
Other assets   (7,472)   8,011 
Operating leases   (3,799)   (3,184)
Assets held-for-sale   
    (2,874)
Liabilities held-for-sale   
    1,467 
Accounts payable and accrued expenses   (10,684)   8,482 
Net cash provided by (used in) operating activities   1,840    (19,511)
Investing Activities:          
Proceeds from principal payments on notes receivable   14,766    
 
Proceeds from asset sales   
    19,500 
Additions to property and equipment   (25,233)   (12,240)
Purchase of Eagle Alcohol, net of cash acquired   (14,685)   
 
Net cash provided by (used in) investing activities   (25,152)   7,260 
Financing Activities:          
Net proceeds from (payments on) Kinergy’s line of credit   (4,452)   38,198 
Stock repurchases   (1,002)    
Proceeds from stock option exercises   
    462 
Principal payments on borrowings   
    (37,810)
Preferred stock dividends paid   (946)   
 
Net cash provided by (used in) financing activities   (6,400)   850 
Net change in cash, cash equivalents and restricted cash   (29,712)   (11,401)
Cash, cash equivalents and restricted cash at beginning of period   62,125    48,187 
Cash, cash equivalents and restricted cash at end of period  $32,413   $36,786 
           
Reconciliation of total cash, cash equivalents and restricted cash:          
Cash and cash equivalents  $28,458   $36,029 
Restricted cash   3,955    757 
Total cash, cash equivalents and restricted cash  $32,413   $36,786 

Supplemental Information:

          
Interest paid  $961   $3,194 
Accrued preferred stock dividends  $
   $946 

 

See accompanying notes to consolidated financial statements.

 

4

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(unaudited, in thousands)

 

                 Additional       Accum. Other   Non-      
   Preferred Stock   Common Stock   Paid-In   Accumulated   Comprehensive   Controlling     
   Shares   Amount   Shares   Amount   Capital   Deficit   Loss   Interests   Total 
Balances, January 1, 2022   927   $1    72,778   $73   $1,037,205   $(691,781)  $(284)  $        $345,214 
Restricted stock issued to employees and directors, net of cancellations and tax           684        (9)               (9)
Stock-based compensation                   673                673 
Shares issued for Eagle Alcohol acquisition           949    1                    1 
Preferred stock dividends                       (312)           (312)
Net loss                       (2,602)           (2,602)
Balances, March 31, 2022   927   $1    74,411   $74   $1,037,869   $(694,695)  $(284)  $   $342,965 
Restricted stock issued to employees and directors, net of cancellations and tax           (223)       (2,283)               (2,283)
Stock-based compensation                   1,106                1,106 
Preferred stock dividends                       (315)           (315)
Net income                       22,115            22,115 
Balances, June 30, 2022   927   $1    74,188   $74   $1,036,692   $(672,895)  $(284)  $   $363,588 
Restricted stock issued to employees and directors, net of cancellations and tax           27        2                2 
Stock repurchases           (259)       (1,002)               (1,002)
Stock-based compensation                   767                767 
Preferred stock dividends                       (319)           (319)
Net loss                       (28,038)           (28,038)
Balances, September 30, 2022   927   $1    73,956   $74   $1,036,459   $(701,252)  $(284)  $   $334,998 
Balances, January 1, 2021   927   $1    72,487   $72   $1,036,638   $(736,598)  $(3,878)  $   $296,235 
Restricted stock issued to employees and directors, net of cancellations and tax           550    1    (186)               (185)
Stock-based compensation                   804                804 
Issuances of common stock           124        462                462 
Preferred stock dividends                       (312)           (312)
Net income                       4,678            4,678 
Balances, March 31, 2021   927   $1    73,161   $73   $1,037,718   $(732,232)  $(3,878)  $   $301,682 
Restricted stock issued to employees and directors, net of cancellations and tax           (350)       (2,589)               (2,589)
Stock-based compensation                   851                851 
Preferred stock dividends                       (315)           (315)
Net income                       8,390            8,390 
Balances, June 30, 2021   927   $1    72,811   $73   $1,035,980   $(724,157)  $(3,878)  $   $308,019 
Restricted stock issued to employees and directors, net of cancellations and tax           (11)                        
Stock-based compensation                   628                628 
Preferred stock dividends                       (319)           (319)
Net loss                       (3,132)           (3,132)
Balances, September 30, 2021   927   $1    72,800   $73   $1,036,608   $(727,608)  $(3,878)  $   $305,196 

 

See accompanying notes to consolidated financial statements.

 

5

 

 

ALTO INGREDIENTS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

 

1. ORGANIZATION AND BASIS OF PRESENTATION.

 

Organization and Business – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation (“Alto Op Co.”), Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.

 

On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022.

 

The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing.

 

The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties.

 

The Company focuses on four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Essential Ingredients markets include dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Renewable Fuels includes fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

 

As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility.

 

6

 

 

Basis of PresentationInterim Financial Statements – The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Results for interim periods should not be considered indicative of results for a full year. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The accounting policies used in preparing these consolidated financial statements are the same as those described in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Accounts Receivable and Allowance for Doubtful Accounts – Trade accounts receivable are presented at face value, net of the allowance for doubtful accounts. The Company sells specialty alcohols to large consumer products companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and biodiesel customers generally without requiring collateral.

 

The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required.

 

Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.

 

Financial Instruments – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, derivative assets, accounts payable, accrued liabilities and derivative liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value because the interest rates on these instruments are variable.

 

Business Combinations – Business acquisitions are accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations”. FASB ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).

 

7

 

 

Income from Cash Grant – The Company applied for and received $22,652,000 in cash from the USDA’s Biofuel Producer Program. The program was created as part of the CARES Act in 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The cash grant is not required to be repaid. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.

 

Share Repurchase Program – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50 million of its common stock with an initial purchase authorization of $10 million. Amounts in excess of the initial purchase authorization of $10 million will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the three and nine months ended September 30, 2022, the Company repurchased an aggregate of 259,000 shares for $1,002,000 in cash.

 

Estimates and Assumptions – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for doubtful accounts, net realizable value of inventory, estimated lives of property and equipment, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.

 

2. ACQUISITION OF EAGLE ALCOHOL.

 

On January 14, 2022, the Company purchased 100% of the membership interests of Eagle Alcohol. The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol are eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the next three years and an aggregate of $5.0 million in the Company’s common stock on the fourth and fifth year anniversaries of the closing date, subject to the satisfaction of certain conditions, including continued employment with the Company. With respect to these payments, the Company has recognized an estimated $0.9 million and $2.6 million for the three and nine months ended September 30, 2022, respectively, in selling, general and administrative expenses in the accompanying consolidated statements of operations.

 

Eagle Alcohol specializes in break bulk distribution of specialty alcohols. Eagle Alcohol purchases bulk alcohol from suppliers and then stores, denatures, packages, and resells alcohol products in smaller sizes, including tank trucks, totes, and drums, that garner a premium to bulk alcohols. Eagle Alcohol delivers products to customers in the beverage, food, and related-process industries via its own dedicated trucking fleet and common carrier. The acquisition has provided the Company further vertical integration and access to new markets in the specialty alcohol industry.

 

8

 

 

Eagle Alcohol’s unaudited results for the three months ended September 30, 2022 and 2021 generated $4.2 million and $9.9 million in net sales and $0.0 million and $1.0 million in net income, respectively. Eagle Alcohol’s unaudited results for the nine months ended September 30, 2022 and 2021 generated $12.1 million and $27.5 million in net sales and $0.1 million and $3.0 million in net income, respectively. The following table presents unaudited pro forma combined financial information assuming the acquisition occurred on January 1, 2021 (dollars in thousands except per share amounts): 

 

  

Three Months Ended

September 30,

 
   2022   2021 
Revenues – pro forma  $336,877   $311,821 
Net loss available to common stockholders – pro forma  $(28,357)  $(3,424)
Diluted net loss per share – pro forma  $(0.38)  $(0.05)
Diluted shares   73,960    72,332 

 

   Nine Months Ended
September 30,
 
   2022   2021 
Revenues – pro forma  $1,007,711   $840,947 
Net income (loss) available to common stockholders – pro forma  $(9,538)  $8,474 
Diluted net income (loss) per share – pro forma  $(0.13)  $0.12 
Diluted shares   72,764    73,209 

  

The following preliminary allocation of the estimated purchase price assumes, with the exception of property and equipment and intangibles, carrying values approximate fair value. Estimates of uncollectible accounts receivable are not considered material due to the short-term nature and customer collection history. The preliminary estimate of working capital is under review by management and is subject to change. Based upon these assumptions, the preliminary purchase price allocation is as follows (in thousands):

 

Cash and equivalents  $705 
Accounts receivable   5,517 
Inventories   1,388 
Other assets   29 
Total current assets   7,639 
      
Property and equipment   1,067 
Right of use assets   2,749 
Total tangible assets  $11,455 
      
Current liabilities  $6,262 
Right of use liability   2,749 
Total liabilities  $9,011 
      
Net tangible assets acquired  $2,444 
Customer relationships   6,556 
Tradename   420 
Goodwill   5,970 
Total Purchase Price  $15,390 

 

Goodwill represents the value of the downstream integration that the operations of Eagle Alcohol will add to the Company. The Company expects the amortization of goodwill to be deductible for tax purposes. For the identifiable intangible assets, the Company has estimated 12 years for useful lives for customer relationships and 10 years for tradename. For the three months ended September 30, 2022, the Company recorded amortization expense of $137,000 and $10,000 for customer relationships and tradename, respectively. For the nine months ended September 30, 2022, the Company recorded amortization expense of $390,000 and $30,000 for customer relationships and tradename, respectively. Any changes to the initial estimates of the fair value of the acquired assets and assumed liabilities will be recorded as adjustments to those assets and liabilities and residual amounts will be allocated to goodwill if net assets acquired are less than the purchase price. The Company did not incur any material acquisition costs.

 

9

 

 

3. SEGMENTS.

 

The Company reports its financial and operating performance in three segments: (1) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis and third-party fuel-grade ethanol sales (2) Pekin production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus (“Pekin Campus”), and (3) Other production, which includes the production and sale of renewable fuel and essential ingredients produced at all of the Company’s other production facilities on an aggregated basis (“Other production”), none of which are individually so significant as to be considered a reportable segment.

 

The following tables set forth certain financial data for the Company’s operating segments (in thousands):

  

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Net Sales                
Pekin Campus, recorded as gross:                    
Alcohol sales  $133,680   $114,587   $393,498   $341,967 
Essential ingredient sales   54,537    46,016    169,670    140,670 
Intersegment sales   332    293    857    919 
Total Pekin Campus sales   188,549    160,896    564,025    483,556 
Marketing and distribution:                    
Alcohol sales, gross  $55,262   $112,391   $172,746   $255,702 
Alcohol sales, net   308    505    975    1,489 
Intersegment sales   3,121    2,415    9,360    7,277 
Total marketing and distribution sales   58,691    115,311    183,081    264,468 
Other production, recorded as gross:                    
Alcohol sales  $64,492   $25,190   $191,483   $63,311 
Essential ingredient sales   24,439    6,867    66,748    19,261 
Intersegment sales   3    259    14    896 
Total Other production sales   88,934    32,316    258,245    83,468 
Corporate and other   4,159    
    12,064    
 
Intersegment eliminations   (3,456)   (2,967)   (10,231)   (9,092)
Net sales as reported  $336,877   $305,556   $1,007,184   $822,400 
Cost of goods sold:                
Pekin Campus  $207,939   $169,721   $572,512   $468,972 
Marketing and distribution   55,159    105,902    173,670    245,606 
Other production   91,663    35,613    261,514    87,055 
Corporate and other   2,925    
    8,995    
 
Intersegment eliminations   (970)   (2,281)   (3,285)   (4,904)
Cost of goods sold as reported  $356,716   $308,955   $1,013,406   $796,729 
Gross profit (loss):                    
Pekin Campus  $(19,390)  $(8,825)  $(8,487)  $14,584 
Marketing and distribution   3,532    9,409    9,411    18,862 
Other production   (2,729)   (3,297)   (3,269)   (3,587)
Corporate and other   1,234    
    3,069    
 
Intersegment eliminations   (2,486)   (686)   (6,946)   (4,188)
Gross profit (loss) as reported  $(19,839)  $(3,399)  $(6,222)  $25,671 
Income (loss) before provision for income taxes:                
Pekin Campus  $(22,664)  $(11,830)  $(6,252)  $8,907 
Marketing and distribution   1,622    7,517    3,444    12,929 
Other production   (4,958)   (4,856)   1,404    (12,467)
Corporate and other   (2,038)   6,037    (7,121)   567 
   $(28,038)  $(3,132)  $(8,525)  $9,936 
Depreciation and amortization of intangibles:                    
Pekin Campus  $4,758   $4,372   $14,381   $13,043 
Other production   1,273    1,468    4,095    4,433 
Corporate and other   229    11    646    44 
   $6,260   $5,851   $19,122   $17,520 
Interest expense, net of capitalized interest:                
Pekin Campus  $(48)  $176   $(81)  $767 
Marketing and distribution   487    295    1,060    721 
Other production   (74)   
    (128)   182 
Corporate and other   (25)   (42)   8    1,689 
   $340   $429   $859   $3,359 

 

10

 

 

The following table sets forth the Company’s total assets by operating segment (in thousands): 

 

   September 30,
2022
   December 31,
2021
 
Total assets:        
Pekin Campus  $247,449   $266,197 
Marketing and distribution   111,900    130,302 
Other production   63,904    57,046 
Corporate and other   31,415    31,408 
   $454,668   $484,953 

 

4. INVENTORIES.

 

Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of a valuation adjustment of $7,963,000 and $0 as of September 30, 2022 and December 31, 2021, respectively. Inventory balances consisted of the following (in thousands):

 

   September 30,
2022
   December 31,
2021
 
Finished goods  $40,630   $35,509 
Work in progress   8,084    6,909 
Raw materials   11,321    10,837 
Other   1,053    1,118 
Total  $61,088   $54,373 

 

11

 

 

5. DERIVATIVES.

 

The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results.

 

Commodity RiskCash Flow Hedges – The Company uses derivative instruments to protect cash flows from fluctuations caused by volatility in commodity prices for periods of up to twelve months in order to protect gross profit margins from potentially adverse effects of market and price volatility on alcohol sales and purchase commitments where the prices are set at a future date and/or if the contracts specify a floating or index-based price. In addition, the Company hedges anticipated sales of alcohol to minimize its exposure to the potentially adverse effects of price volatility. These derivatives may be designated and documented as cash flow hedges and effectiveness is evaluated by assessing the probability of the anticipated transactions and regressing commodity futures prices against the Company’s purchase and sales prices. Ineffectiveness, which is defined as the degree to which the derivative does not offset the underlying exposure, is recognized immediately in cost of goods sold. For the three and nine months ended September 30, 2022 and 2021, the Company did not designate any of its derivatives as cash flow hedges.

 

Commodity Risk – Non-Designated Hedges – The Company uses derivative instruments to lock in prices for certain amounts of corn and alcohols by entering into exchange-traded forward contracts or options for those commodities. These derivatives are not designated for hedge accounting treatment. The changes in fair value of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. The Company recognized net losses of $1,772,000 and $976,000 as the change in the fair value of these contracts for the three months ended September 30, 2022 and 2021, respectively. The Company recognized net gains of $20,164,000 and $18,435,000 as the change in the fair value of these contracts for the nine months ended September 30, 2022 and 2021, respectively.

 

Non Designated Derivative Instruments – The classification and amounts of the Company’s derivatives not designated as hedging instruments, and related cash collateral balances, are as follows (in thousands):

 

   As of September 30, 2022 
   Assets   Liabilities 
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
Cash collateral balance  Restricted cash  $3,955  
 
   
 
 
Commodity contracts  Derivative assets  $7,384   Derivative liabilities  $1,106 

 

   As of December 31, 2021 
   Assets   Liabilities 
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
Cash collateral balance  Restricted cash  $11,513  
 
   
 
 
Commodity contracts  Derivative assets  $15,839   Derivative liabilities  $13,582 

 

The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but its intent is to close out positions individually, therefore, they are reported at gross.

 

The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands):

 

      Realized Losses 
      For the Three Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
Commodity contracts  Cost of goods sold  $(13,332)  $(2,894)
      $(13,332)  $(2,894)

 

12

 

 

      Realized Gains 
Type of Instrument  Statements of Operations Location  For the Nine Months Ended September 30, 
      2022   2021 
Commodity contracts  Cost of goods sold  $16,143   $21,449 
      $16,143   $21,449 

 

      Unrealized Gains 
      For the Three Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
            
Commodity contracts  Cost of goods sold  $11,560   $1,918 
      $11,560   $1,918 

 

 

      Unrealized Gains (Losses) 
      For the Nine Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
            
Commodity contracts  Cost of goods sold  $4,021   $(3,014)
      $4,021   $(3,014)

  

6.DEBT.

 

Long-term borrowings are summarized as follows (in thousands):

 

   September 30,
2022
   December 31,
2021
 
Kinergy line of credit  $45,949   $50,401 
Less unamortized debt financing costs   (61)   (40)
Less short-term portion   
    
 
Long-term debt  $45,888   $50,361 

 

As of September 30, 2022, Kinergy had $30.7 million in unused borrowing availability under its line of credit. The Company believes it was in compliance with its covenants under the line of credit as of September 30, 2022.

  

13

 

 

7. COMMITMENTS AND CONTINGENCIES.

 

Sales Commitments – At September 30, 2022, the Company had entered into sales contracts with its major customers to sell certain quantities of alcohol and essential ingredients. The Company had open alcohol indexed-price contracts for 92,771,000 gallons as of September 30, 2022 and open fixed-price alcohol sales contracts totaling $101,427,000 as of September 30, 2022. The Company had open fixed-price sales contracts for essential ingredients totaling $17,274,000 as of September 30, 2022. These sales contracts are scheduled to be completed throughout 2022 and 2023.

 

Purchase Commitments – At September 30, 2022, the Company had indexed-price purchase contracts to purchase 13,988,000 gallons of alcohol and fixed-price purchase contracts to purchase $45,599,000 of alcohol from its suppliers. The Company had fixed-price purchase contracts to purchase $38,769,000 of corn from its suppliers as of September 30, 2022. The Company had fixed-price purchase contracts for natural gas totaling $1,947,000 and indexed-price purchase contracts for natural gas totaling 4,463,000 MMBTU. The Company also had future commitments for certain capital projects totaling $46,796,000. These purchase commitments are scheduled to be satisfied throughout 2022 and 2023.

 

Litigation – General The Company is subject to various claims and contingencies in the ordinary course of its business, including those related to litigation, business transactions, employee-related matters, environmental regulations, and others. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible and the amount involved could be material. While there can be no assurances, the Company does not expect that any of its pending legal proceedings will have a material impact on the Company’s financial condition or results of operations.

 

8. PENSION AND RETIREMENT BENEFIT PLANS.

 

The Company sponsors a defined benefit pension plan (the “Retirement Plan”) and a healthcare and life insurance plan (the “Postretirement Plan”).

 

The Retirement Plan is noncontributory, and covers only “grandfathered” unionized employees at the Company’s Pekin, Illinois facility who fulfill minimum age and service requirements. Benefits are based on a prescribed formula based upon the employee’s years of service. The Retirement Plan, which is part of a collective bargaining agreement, covers only union employees hired prior to November 1, 2010.

 

The Company uses a December 31 measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. As of December 31, 2021, the Retirement Plan’s accumulated projected benefit obligation was $23.8 million, with a fair value of plan assets of $20.0 million. The underfunded amount of $3.8 million is recorded on the Company’s consolidated balance sheet in other liabilities.

 

For the three months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $8,000, comprised of $273,000 of expected return on plan assets, partially offset by $164,000 in interest cost and $101,000 in service cost. For the three months ended September 30, 2021, the Retirement Plan’s net periodic expense was $22,000, comprised of $151,000 in interest cost and $109,000 in service cost, partially offset by $238,000 of expected return on plan assets. For the nine months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $24,000, comprised of $819,000 of expected return on plan assets, partially offset by $492,000 in interest cost and $303,000 in service cost. For the nine months ended September 30, 2021, the Retirement Plan’s net periodic expense was $66,000, comprised of $453,000 in interest cost and $327,000 in service cost, partially offset by $714,000 of expected return on plan assets.

 

The Postretirement Plan provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees. Employees hired after December 31, 2000 are not eligible to participate in the Postretirement Plan. The Postretirement Plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan declines at age 65 from a defined benefit to a defined dollar cap based upon years of service. As of December 31, 2021, the Postretirement Plan’s accumulated projected benefit obligation was $4.3 million and is recorded on the Company’s consolidated balance sheet in other liabilities. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations.

 

For the three months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $32,000, comprised of $6,000 of interest cost and $26,000 of service cost. For the three months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $42,000, comprised of $10,000 of interest cost, $26,000 of service cost and $6,000 of amortization expense.

 

For the nine months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $96,000, comprised of $18,000 of interest cost and $78,000 of service cost. For the nine months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $126,000, comprised of $30,000 of interest cost, $78,000 of service cost and $18,000 of amortization expense.

 

14

 

 

9. FAIR VALUE MEASUREMENTS.

 

The fair value hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows:

 

Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities;

 

Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and

 

Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period.

 

Pooled separate accounts – Pooled separate accounts invest primarily in domestic and international stocks, commercial paper or single mutual funds. The net asset value is used as a practical expedient to determine fair value for these accounts. Each pooled separate account provides for redemptions by the Retirement Plan at reported net asset values per share, with little to no advance notice requirement, therefore these funds are classified within Level 2 of the valuation hierarchy.

 

Long-Lived Assets Held-for-Sale – The Company recorded its long-lived assets associated with its property and equipment held-for-sale at fair value at December 31, 2021 of $1,000,000. These assets were sold during the three months ended September 30, 2022. The fair values of these assets are based on observable values for the assets through corroboration with market data and are designated as Level 3 inputs.

 

Other Derivative Instruments – The Company’s other derivative instruments consist of commodity positions. The fair values of the commodity positions are based on quoted prices on the commodity exchanges and are designated as Level 1 inputs.

  

The following table summarizes recurring and nonrecurring fair value measurements by level at September 30, 2022 (in thousands):

 

   Fair             
   Value   Level 1   Level 2   Level 3 
Assets:                
Derivative financial instruments  $7,384   $7,384   $
     —
   $
     —
 
Liabilities:                    
Derivative financial instruments  $(1,106)  $(1,106)  $
   $
 

 

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2021 (in thousands):

 

                   Benefit Plan 
   Fair               Percentage 
   Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $15,839   $15,839   $
   $
      
Long-lived assets held-for-sale   1,000    
    
    1,000      
Defined benefit plan assets (1) (pooled separate accounts):                         
Large U.S. Equity(2)   5,612    
    5,612    
    28%
Small/Mid U.S. Equity(3)   3,684    
    3,684    
    18%
International Equity(4)   2,909    
    2,909    
    15%
Fixed Income(5)   7,782    
    7,782    
    39%
   $36,826   $15,839   $19,987   $1,000      
Liabilities:                         
Derivative financial instruments  $(13,582)  $(13,582)  $
   $
      

 

 

(1)Included in other assets in the consolidated balance sheets.

(2)This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(3)This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(4)This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(5)This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

 

15

 

 

10. EARNINGS (LOSS) PER SHARE.

 

The following tables compute basic and diluted earnings (loss) per share (in thousands, except per share data):

 

   Three Months Ended September 30, 2022 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(28,038)          
Less: Preferred stock dividends   (319)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(28,357)   73,011   $(0.39)

 

   Three Months Ended September 30, 2021 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(3,132)          
Less: Preferred stock dividends   (319)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(3,451)   71,383   $(0.05)

 

   Nine Months Ended September 30, 2022 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(8,525)          
Less: Preferred stock dividends   (946)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(9,471)   71,815   $(0.13)

 

   Nine Months Ended September 30, 2021 
   Income
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net income  $9,936           
Less: Preferred stock dividends   (946)          
Less: Income allocated to participating securities   (120)          
Basic income per share:               
Income available to common stockholders  $8,870    71,002   $0.12 
Add: Dilutive instruments   
    1,258      
Diluted income per share:               
Income available to common stockholders  $8,870    72,260   $0.12 

 

There were an additional aggregate potentially dilutive weighted-average shares of 964,000 from convertible securities outstanding for the three and nine months ended September 30, 2022 and 2021. These securities were not considered in calculating diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021, as their effect would have been anti-dilutive. At December 31, 2021, the Company had outstanding unexercised warrants to purchase 8.9 million shares of its common stock at an exercise price of $9.76 per share. These warrants expired unexercised on April 28, 2022.

 

11. SUBSEQUENT EVENTS.

 

New Term Loan FacilityOn November 7, 2022, the Company closed on a senior secured term loan credit facility with certain funds managed by Orion Infrastructure Capital for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. The Company’s obligations under the term loan are secured by all of the Company’s tangible and intangible assets.

 

In connection with the term loan facility, the Company will issue to the lenders an aggregate of up to 1,602,564 shares of the Company’s common stock.

 

Kinergy Operating Line of Credit Extension – On November 7, 2022, the Company amended Kinergy’s operating line of credit to extend the maturity to 2027.

 

16

 

  

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion and analysis should be read in conjunction with our consolidated financial statements and notes to consolidated financial statements included elsewhere in this report. This report and our consolidated financial statements and notes to consolidated financial statements contain forward-looking statements, which generally include the plans and objectives of management for future operations, including plans and objectives relating to our future economic performance and our current beliefs regarding revenues we might generate and profits we might earn if we are successful in implementing our business and growth strategies. The forward-looking statements and associated risks may include, relate to or be qualified by other important factors, including:

 

fluctuations in the market prices of our products;

 

fluctuations  in the costs of key production input commodities such as corn and natural gas;

 

the projected growth or contraction in the markets in which we operate;

 

our strategies for expanding, maintaining or contracting our presence in these markets;

 

anticipated trends in our financial condition and results of operations;

 

the timing, cost and results of our capital improvement projects; and

 

our ability to distinguish ourselves from our current and future competitors.

 

You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this report, or in the case of a document incorporated by reference, as of the date of that document. We do not undertake to update, revise or correct any forward-looking statements, except as required by law.

 

Any of the factors described immediately above, or referenced from time to time in our filings with the Securities and Exchange Commission or in the “Risk Factors” section below could cause our financial results, including our net income or loss or growth in net income or loss to differ materially from prior results, which in turn could, among other things, cause the price of our common stock to fluctuate substantially.

 

Overview

 

We are a leading producer and distributor of specialty alcohols and essential ingredients, and the largest producer of specialty alcohols in the United States.

 

We operate five alcohol production facilities. Three of our production facilities are located in Illinois, one is located in Oregon and another is located in Idaho. We have an annual alcohol production capacity of 350 million gallons, comprised of 210 million gallons of fuel-grade ethanol and up to 140 million gallons of specialty alcohols. We market and distribute all of the alcohols produced at our facilities as well as fuel-grade ethanol produced by third parties. In 2021, we marketed and distributed approximately 480 million gallons combined of our own alcohols as well as fuel-grade ethanol produced by third parties, and over 1.2 million tons of essential ingredients.

 

We report our financial and operating performance in three segments: (1) marketing and distribution, which includes marketing and merchant trading for company-produced alcohols and essential ingredients on an aggregated basis and third party fuel-grade ethanol sales, (2) Pekin production, which includes the production and sale of alcohols and essential ingredients produced at our Pekin, Illinois campus, or Pekin Campus, and (3) Other production, which includes the production and sale of renewable fuel and essential ingredients produced at all of our other production facilities on an aggregated basis, none of which are individually so significant as to be considered a reportable segment.

 

Our mission is to expand our business as a leading producer and distributor of specialty alcohols and essential ingredients. We intend to accomplish this goal in part by investing in our specialized and higher value specialty alcohol production and distribution infrastructure, expanding production in high-demand essential ingredients, expanding and extending the sale of our products into new regional and international markets, building efficiencies and economies of scale and by capturing a greater portion of the value stream.

 

Our wholly-owned subsidiary, Eagle Alcohol Company, LLC, or Eagle Alcohol, specializes in break bulk distribution of specialty alcohols. Eagle Alcohol purchases bulk alcohol from suppliers and then stores, denatures, packages, and resells alcohol products in smaller sizes, including tank trucks, totes, and drums, that garner a premium to bulk alcohols. Eagle Alcohol delivers products to customers in the beverage, food, and related-process industries via its own dedicated trucking fleet and common carrier.

 

17

 

 

Production Segments

 

We produce specialty alcohols, fuel-grade ethanol and essential ingredients, focusing on four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Essential Ingredients markets include dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Our Renewable Fuels products include fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

 

We produce our alcohols and essential ingredients at our production facilities described below. Our production facilities located in Illinois are in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and enjoy logistical advantages that enable us to provide our products to both domestic and international markets via truck, rail or barge. Our production facilities located in Oregon and Idaho are near their respective fuel and feed customers, offering significant timing, transportation cost and logistical advantages.

 

All of our production facilities are currently operating and have been operating through all of 2022. As market conditions change, we may increase, decrease or idle production at one or more operating facilities or resume operations at any idled facility.

 

      Annual Alcohol Production Capacity
(estimated, in gallons)
Production Facility  Location  Fuel-Grade
Ethanol
  Specialty
Alcohol
 
Pekin Campus  Pekin, IL  110,000,000   140,000,000 
Magic Valley  Burley, ID  60,000,000    
Columbia  Boardman, OR  40,000,000    

 

Marketing and Distribution Segment

 

We market and distribute all of the alcohols and essential ingredients we produce at our facilities. We also market and distribute alcohol produced by third parties.

 

We have extensive and long-standing customer relationships, both domestic and international, for our specialty alcohols and essential ingredients. These customers include producers and distributors of ingredients for cosmetics, sanitizers and related products, distilled spirits producers, food products manufacturers, producers of personal health/consumer health and personal care hygiene products, and global trading firms.

 

Our renewable fuel customers are located throughout the Western and Midwestern United States and consist of integrated oil companies and gasoline marketers who blend fuel-grade ethanol into gasoline. Our customers depend on us to provide a reliable supply of fuel-grade ethanol and manage the logistics and timing of delivery with very little effort on their part. Our customers collectively require fuel-grade ethanol volumes in excess of the supplies we produce at our facilities. We secure additional fuel-grade ethanol supplies from third-party producers. We arrange for transportation, storage and delivery of fuel-grade ethanol purchased by our customers through our agreements with third-party service providers in the Western United States as well as in the Midwest from a variety of sources.

 

We market our essential ingredient feed products to dairies and feedlots, in many cases located near our production facilities. These customers use our feed products for livestock as a substitute for corn and other sources of starch and protein. We sell our corn oil to poultry and biodiesel customers. We do not market essential ingredients from other producers.

 

See “Note 3 – Segments” to our Notes to Consolidated Financial Statements included elsewhere in this report for financial information about our business segments.

 

18

 

 

Current Initiatives and Outlook

 

During the third quarter, we continued our efforts to lay the groundwork for long-term success by upgrading equipment and operating systems to increase plant efficiency, reliability and redundancy, and corn storage capacity. We also have plans for larger capital-intensive growth projects. In November, we secured debt financing for up to $125 million to accelerate and fund our diversification growth strategies, including carbon capture sequestration, additional corn oil production, expansion of our protein and yeast products, and renewable natural gas and natural gas pipeline installations. This financing will facilitate, without the need to rely solely on our cash flow from operations, the simultaneous undertaking and timely completion of larger capital projects with a greater cost-benefit return to all stakeholders through a more stable business. We expect these projects when completed to contribute significantly to our revenues and net income and to help insulate our results of operations from commodity price and margin volatility.

 

We rescheduled many of our fall repair and maintenance activities to August to reduce our use of corn and minimize the impact of short-term higher commodity prices. However, our third quarter results were negatively affected by logistical constraints and rail interruptions resulting in plant outages in excess of six days that contributed to negative margins at our Western plants. We also experienced overall higher transportation costs and lower commodity margins. Our personnel nevertheless skillfully managed through supply chain and logistical challenges to prevent disruption with our customer base.

 

Through the third quarter, we invested and capitalized over $25 million in infrastructure improvements and spent an additional $3 million in related costs, negatively affecting our cost of goods sold, operating margins and our net income for the quarter. We spent $15 million during the third quarter on capital improvement projects in anticipation of our debt financing transaction.

 

As previously reported, we launched our first project to produce enhanced protein at our dry mill in Magic Valley, Idaho by installing Harvesting Technology’s patented CoPromaxTM system. The project consists of two phases. The first phase – corn oil extraction – is complete and yields have grown significantly, meeting our initial expectations. Based on these positive results, we intend to install corn oil extraction technologies at our three other dry mills. The second phase – separating and producing enhanced protein – is on schedule for completion in the first quarter of 2023. Once the system is fully operational and tested, we will evaluate additional deployments at our other plants.

 

We are doubling our corn storage capacity at our Pekin Campus to increase our corn-buying flexibility and reduce the need to purchase product at premium prices when farmers and elevators are less inclined to ship corn, including during holidays, unfavorable weather conditions, or due to supply chain and logistical constraints. We expect this increased storage capacity to reduce the volatility of our production input costs. We are well into construction of the new storage facilities and expect completion before year-end.

 

We prioritized upgrades to specialty alcohol equipment at our Pekin wet mill to align with higher quality standards for our beverage customers. We installed additional equipment, including a demethylizer column, which we expect will be fully operational in the first quarter of 2023. With these upgrades and our process and quality certifications, our equipment will be best-in-class and enable us to meet the highest quality requirements for specialty alcohols and service additional beverage customers from both our ICP distillery and our Pekin wet mill. This production redundancy, which will also provide surety of supply to our customers, will enable us to improve our product mix and capture higher premiums in the alcohol value chain.

 

We also continue to replace or upgrade older equipment at our Pekin Campus. For example, we recently purchased two new state-of-the-art boilers to enhance our steam capabilities and increase interconnectivity among our Pekin Campus facilities. This increased capacity will allow us to replace three older boiler units. Our new boiler system will be more reliable and efficient, resulting in lower energy use and costs. Additional redundancy from the new boilers will also increase our control of process steam across our Pekin Campus.

 

19

 

 

Consistent with our sustainability improvement program, we intend to add new renewable natural gas and natural gas pipelines at our Pekin Campus with direct access to nearby major hubs. These pipelines will increase our access to more competitively priced natural gas, better address our future energy needs, including our support for carbon capture sequestration, and facilitate the monetization and sale of the renewable natural gas we produce and currently flare. When completed, these efforts will further reduce our carbon footprint and enhance the value of our products. This capital improvement project is in the design and permitting phase with an expected completion date in 2024.

 

After 24 years operating as a valued and reliable supplier to the pet food industry, we intend to commercially develop primary yeast through an aerobic fermentation process at our wet mill. Extending our brand along the value chain is a natural progression to other markets that demand higher product quality and offer increased margins, including for flavors, nutraceuticals, and baking and meat substitutes. Although primary yeast production requires a different process and serves a different market, many existing as well as prospective customers have for years expressed interest in a primary yeast product.

 

We are highly motivated to further reduce the impact of commodity exposure. Our efforts are improving our position to capture a variety of new opportunities and drive profitable growth.

 

Looking ahead to the fourth quarter, while fuel demand typically slows in the late fall and winter periods, we are encouraged by the recent improvement in crush margins compared to the September lows, much of which is related to the late corn harvest and improving corn basis. We expect these factors to translate into much improved results in the fourth quarter. We also expect to exceed by up to 10 million gallons by year-end our contracted volume of 90 million gallons for 2022. We anticipate maintaining or growing our market share with our existing customer base for annual contracted specialty alcohols for 2023 while adding new accounts in the beverage category once system improvements to our grain neutral spirits production at our Pekin Campus are brought online in 2023.

 

Based on our progress in upgrading equipment and operating systems, we expect to see modest improvement in profits in early 2023, with a baseline earnings before interest, taxes, depreciation and amortization, or EBITDA, of $40.0 million for 2023 at historical average crush margins and before accounting for EBITDA contributions from our pending capital improvement projects. With funding from our new term loan accelerating our investments in the further diversification of our specialty alcohol and essential ingredients products, we expect to add over $20 million in recurring annual EBITDA by the end of 2023 and an additional $30 million in recurring annual EBITDA by 2025, resulting in total additional recurring annual EBITDA of $50 million by 2025. These amounts do not yet include our anticipated results for projects in the early stages of development, including primary yeast expansion and carbon capture sequestration.

 

20

 

 

Use of Non-GAAP Financial Measures

 

Management believes that certain financial measures not in accordance with generally accepted accounting principles, or GAAP, are useful measures of operations. Management provides EBITDA and Adjusted EBITDA as non-GAAP financial measures so that investors will have the same financial information that management uses, which may assist investors in properly assessing our performance on a period-over-period basis. We define Adjusted EBITDA as unaudited net income (loss) before interest expense, interest income, provision for income taxes, asset impairments, loss on extinguishment of debt, acquisition-related expense, fair value adjustments, and depreciation and amortization expense. A table is provided below to reconcile Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). EBITDA and Adjusted EBITDA are not measures of financial performance under GAAP and should not be considered as alternatives to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. EBITDA and Adjusted EBITDA have limitations as analytical tools and you should not consider these measures in isolation or as a substitute for analysis of our results as reported under GAAP.

 

Information reconciling forward-looking EBITDA to forward-looking net income (loss) would require a forward-looking statement of net income (loss) prepared in accordance with GAAP, which is unavailable to us without unreasonable effort. We are not able to provide a quantitative reconciliation of forward-looking EBITDA to forward-looking net income (loss) because certain items required for reconciliation are uncertain, outside of our control and/or cannot reasonably be predicted, such as net sales, cost of goods sold, provision (benefit) for income taxes and asset impairments, which we view as the most material components of net income (loss) that are not presently estimable.

 

Reconciliation of Adjusted EBITDA to Net Income (Loss)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
(in thousands) (unaudited)  2022   2021   2022   2021 
Net income (loss)  $(28,038)  $(3,132)  $(8,525)  $9,936 
Adjustments:                    
Interest expense   340    429    859    3,359 
Interest income   (38)   (183)   (341)   (553)
Asset impairments               3,100 
Acquisition-related expense   875        2,625     
Provision for income taxes                
Depreciation and amortization expense   6,260    5,851    19,122    17,520 
Total adjustments   7,437    6,097    22,265    23,426 
Adjusted EBITDA  $(20,601)  $2,965   $13,740   $33,362 

 

21

 

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of net sales and expenses for each period. We believe that of our significant accounting policies, the following critical accounting policies and estimates are those policies that we believe are the most important to the portrayal of our financial condition and results of operations and that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain: revenue recognition; accounting for business combinations; impairment of long-lived assets and held-for-sale classification; valuation allowance for deferred taxes and derivative instruments. Except as noted below, these significant accounting principles are more fully described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2021.

 

Accounting for Business Combinations

 

Determining the fair value of assets acquired and liabilities assumed in a business combination is considered a critical accounting estimate because the allocation of the purchase price to assets acquired and liabilities assumed based upon fair values requires significant management judgment and the use of subjective measurements. Variability in industry conditions and changes in assumptions or subjective measurements used to allocate fair value are reasonably possible and may have a material impact on our financial position, liquidity or results of operations.

 

Results of Operations

 

The following selected financial information should be read in conjunction with our consolidated financial statements and notes to our consolidated financial statements included elsewhere in this report, and the other sections of “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report.

 

Certain performance metrics that we believe are important indicators of our results of operations include:

 

   Three Months Ended
September 30,
   Percentage   Nine Months Ended
September 30,
   Percentage 
   2022   2021   Variance   2022   2021   Variance 
Renewable fuel production gallons sold (in millions)   53.0    38.3    38.4%   153.4    118.6    29.3%
Specialty alcohol production gallons sold (in millions)   23.3    19.7    18.3%   72.4    63.1    14.7%
Third party renewable fuel gallons sold (in millions)   27.6    67.2    (58.9)%   88.4    180.5    (51.0)%
Total gallons sold (in millions)   103.9    125.2    (17.0)%   314.2    362.2    (13.3)%
                               
Total gallons produced (in millions)   74.7    60.6    23.3%   226.0    182.2    24.0%
                               
Production capacity utilization   85%   59%   44.1%   86%   57%   50.9%
                               
Average sales price per gallon  $2.70   $2.47    9.3%  $2.66   $2.27    17.2%
                               
Corn cost per bushel – CBOT equivalent  $7.27   $6.09    19.4%  $6.98   $5.71    22.2%
Average basis (1)  $1.08   $0.89    21.3%  $0.80   $0.53    50.9%
Delivered cost of corn  $8.35   $6.98    19.6%  $7.78   $6.24    24.7%
                               
Total essential ingredients tons sold (in thousands)   422.0    305.6    38.1%   1,234.9    886.5    39.3%
Essential ingredients revenues as % of delivered cost of corn(2)   30.4%   29.5%   3.1%   33.2%   33.8%   (1.8)%
Average CBOT ethanol price per gallon  $2.16   $2.25    (4.0)%  $2.16   $2.08    3.8%
Average CBOT corn price per bushel  $6.58   $5.59    17.7%  $7.03   $5.87    19.8%

 

 

(1)Corn basis represents the difference between the immediate cash price of delivered corn and the future price of corn for Chicago delivery.

 

(2)Essential ingredients revenues as a percentage of delivered cost of corn shows our yield based on sales of essential ingredients, including wet distillers grains and corn oil, generated from alcohol we produced.

 

22

 

 

Net Sales, Cost of Goods Sold and Gross Profit (Loss)

 

The following table presents our net sales, cost of goods sold and gross profit (loss) in dollars and gross profit as a percentage of net sales (in thousands, except percentages):

 

   Three Months Ended
September 30,
   Variance in   Nine Months Ended
September 30,
   Variance in 
   2022   2021   Dollars   Percent   2022   2021   Dollars   Percent 
Net sales  $336,877   $305,556   $31,321    10.3%  $1,007,184   $822,400   $184,784    22.5%
Cost of goods sold   356,716    308,955    47,761    15.5%   1,013,406    796,729    216,677    27.2%
Gross profit (loss)  $(19,839)  $(3,399)  $(16,440)   483.7%  $(6,222)  $25,671   $(31,893)   

NM 

 
Percentage of net sales   (5.9)%   (1.1)%             (0.6)%   3.1%          

 

The increase in our consolidated net sales for the three and nine months ended September 30, 2022 as compared to the same period in 2021 was primarily due to an increase in our average sales price per gallon and substantial increases in sales prices and volume of essential ingredients, partially offset by a decrease in our third-party gallons sold.

 

Our production gallons sold and our volume of essential ingredients sold increased for both the three and nine months ended September 30, 2022 as compared to the same periods in 2021 primarily due to production from our Magic Valley facility operating in all of 2022, whereas the facility was idled during the same period of 2021. Specialty alcohols contributed 23.3 million gallons and 72.4 million gallons for the three and nine months ended September 30, 2022, respectively, on pace with our contracted volume of 90 million gallons for all of 2022. Our third-party gallons sold declined as compared to the same periods in 2021, reflecting our strategy to focus our marketing and sales efforts around our own core production assets.

 

Three Months Ended September 30, 2022 and 2021

 

On a consolidated basis, our average sales price per gallon increased by 9% to $2.70 for the three months ended September 30, 2022 as compared to $2.47 for the same period in 2021. The average Chicago Board of Trade, or CBOT, fuel-grade ethanol price per gallon, however, decreased 4% to $2.16 for the three months ended September 30, 2022 as compared to $2.25 for the same period in 2021.

 

Pekin Campus Production Segment

 

Net sales of alcohol from our Pekin Campus production segment increased by $19.1 million, or 17%, to $133.7 million for the three months ended September 30, 2022 as compared to $114.6 million for the same period in 2021. Our total volume of production gallons sold increased by 3.6 million gallons, or 7%, to 52.8 million gallons for the three months ended September 30, 2022 as compared to 49.2 million gallons for the same period in 2021. The increase of $0.20, or 9%, in our Pekin Campus production segment’s average sales price per gallon in the three months ended September 30, 2022 as compared to the same period in 2021 improved our net sales from our Pekin Campus production segment by $10.0 million. At our Pekin Campus production segment’s average sales price per gallon of $2.53 for the three months ended September 30, 2022, we generated $9.1 million in additional net sales from our Pekin Campus production segment from the 3.6 million additional gallons of alcohol sold in the three months ended September 30, 2022 as compared to the same period in 2021.

 

Net sales of essential ingredients increased by $8.5 million, or 18%, to $54.5 million for the three months ended September 30, 2022 as compared to $46.0 million for the same period in 2021. Our total volume of essential ingredients sold decreased by 9,200 tons, or 4%, to 218,100 tons for the three months ended September 30, 2022 from 227,300 tons for the same period in 2021. The increase of $47.61, or 24%, in our average sales price per ton for the three months ended September 30, 2022 as compared to the same period in 2021 increased our net sales from our Pekin Campus production segment by $10.8 million. At our average sales price per ton of $250.06 for the three months ended September 30, 2022, we generated $2.3 million less in net sales from the 9,200 fewer tons of essential ingredients sold in the three months ended September 30, 2022 as compared to the same period in 2021.

 

23

 

 

Marketing and Distribution Segment

 

Net sales of fuel-grade ethanol from our marketing and distribution segment reported gross, excluding intersegment sales, decreased by $57.1 million, or 51%, to $55.3 million for the three months ended September 30, 2022 as compared to $112.4 million for the same period in 2021.

 

Our volume of third party fuel-grade ethanol gallons sold reported gross by our marketing and distribution segment declined by 24.0 million gallons, or 56%, to 19.0 million gallons for the three months ended September 30, 2022 as compared to 43.0 million gallons for the same period in 2021. At our marketing and distribution segment’s average sales price per gallon of $2.91 for the three months ended September 30, 2022, we generated $69.8 million less in net sales from our marketing and distribution segment from the 24.0 million fewer gallons of third-party fuel-grade ethanol sold gross in the three months ended September 30, 2022 as compared to the same period in 2021.

 

The $0.29 per gallon, or 11%, increase in our marketing and distribution segment’s average sales price per gallon for the three months ended September 30, 2022 as compared to the same period in 2021 resulted in a $12.7 million increase in our net sales from third-party fuel-grade ethanol sold reported gross by our marketing segment.

 

Our volume of third party fuel-grade ethanol gallons sold reported net by our marketing and distribution segment decreased by 15.6 million gallons, or 64%, to 8.6 million gallons for the three months ended September 30, 2022 as compared to 24.2 million gallons for the same period in 2021. The decrease in third-party fuel-grade ethanol gallons sold reported net reduced our net sales by less than $0.1 million for the period.

 

Other Production Segment

 

Net sales of alcohol from our other production segment increased by $39.3 million, or 156%, to $64.5 million for the three months ended September 30, 2022 as compared to $25.2 million for the same period in 2021. Our total volume of gallons sold increased by 14.7 million gallons, or 167%, to 23.5 million gallons for the three months ended September 30, 2022 as compared to 8.8 million gallons for the same period in 2021. At our other production segment’s average sales price per gallon of $2.74 for the three months ended September 30, 2022, we generated an additional $40.4 million in net sales from our other production segment from the 14.7 million additional gallons of alcohol sold in the three months ended September 30, 2022 as compared to the same period in 2021. The decrease of $0.12, or 5%, in our other production segment’s average sales price per gallon for the three months ended September 30, 2022 as compared to the same period in 2021 reduced our net sales from our other production segment by $1.1 million.

 

Net sales of essential ingredients increased by $17.6 million, or 259%, to $24.4 million for the three months ended September 30, 2022 as compared to $6.8 million for the same period in 2021. Our total volume of essential ingredients sold increased by 125,600 tons, or 160%, to 203,900 tons for the three months ended September 30, 2022 from 78,300 tons for the same period in 2021. At our average sales price per ton of $119.86 for the three months ended September 30, 2022, we generated an additional $15.0 million in net sales from the 125,600 additional tons of essential ingredients sold in the three months ended September 30, 2022 as compared to the same period in 2021. The increase of $32.16, or 37%, in our average sales price per ton for the three months ended September 30, 2022 as compared to the same period in 2021 increased our net sales from our other production segment by $2.6 million.

 

Corporate and other

 

Net sales of alcohol from corporate and other represented $4.2 million associated with our sales from Eagle Alcohol for the three months ended September 30, 2022.

 

Nine Months Ended September 30, 2022 and 2021 

 

On a consolidated basis, our average sales price per gallon increased by 17% to $2.66 for the nine months ended September 30, 2022 as compared to $2.27 for the same period in 2021. The average CBOT fuel-grade ethanol price per gallon, increased by 4% to $2.16 for the nine months ended September 30, 2022 as compared to $2.08 for the same period in 2021.

 

24

 

 

Pekin Campus Production Segment

 

Net sales of alcohol from our Pekin Campus production segment increased by $51.5 million, or 15%, to $393.5 million for the nine months ended September 30, 2022 as compared to $342.0 million for the same period in 2021. Our total volume of production gallons sold declined by 0.8 million gallons, or less than 1%, to 156.6 million gallons for the nine months ended September 30, 2022 as compared to 157.4 million gallons for the same period in 2021. The increase of $0.34, or 16%, in our Pekin Campus production segment’s average sales price per gallon in the nine months ended September 30, 2022 as compared to the same period in 2021 improved our net sales from our Pekin Campus production segment by $53.4 million. At our Pekin Campus production segment’s average sales price per gallon of $2.51 for the nine months ended September 30, 2022, we generated $1.9 million less in net sales from our Pekin Campus production segment from the 0.8 million fewer gallons of alcohol sold in the nine months ended September 30, 2022 as compared to the same period in 2021.

 

Net sales of essential ingredients increased by $29.0 million, or 21%, to $169.7 million for the nine months ended September 30, 2022 as compared to $140.7 million for the same period in 2021. Our total volume of essential ingredients sold declined by 16,000 tons, or 2%, to 644,900 tons for the nine months ended September 30, 2022 from 660,900 tons for the same period in 2021. The increase of $50.25, or 24%, in our average sales price per ton for the nine months ended September 30, 2022 as compared to the same period in 2021 increased our net sales from our Pekin Campus production segment by $33.2 million. At our average sales price per ton of $263.10 for the nine months ended September 30, 2022, we generated $4.2 million less in net sales from the 16,000 fewer tons of essential ingredients sold in the nine months ended September 30, 2022 as compared to the same period in 2021.

 

Marketing and Distribution Segment

 

Net sales of fuel-grade ethanol from our marketing and distribution segment, excluding intersegment sales, decreased by $83.5 million, or 32%, to $173.7 million for the nine months ended September 30, 2022 as compared to $257.2 million for the same period in 2021.

 

Our volume of third party fuel-grade ethanol gallons sold reported gross by our marketing and distribution segment declined by 43.5 million gallons, or 42%, to 59.7 million gallons for the nine months ended September 30, 2022 as compared to 103.2 million gallons for the same period in 2021. At our marketing segment’s average sales price per gallon of $2.89 for the nine months ended September 30, 2022, we generated $125.9 million less in net sales from our marketing and distribution segment from the 43.5 million fewer gallons of third-party fuel-grade ethanol sold gross in the nine months ended September 30, 2022 as compared to the same period in 2021.

 

The $0.42 per gallon, or 17%, increase in our marketing segment’s average sales price per gallon for the nine months ended September 30, 2022 as compared to the same period in 2021 resulted in a $42.9 million increase in our net sales from third-party fuel-grade ethanol sold reported gross by our marketing and distribution segment.

 

Our volume of third party fuel-grade ethanol gallons sold reported net by our marketing and distribution segment decreased by 48.6 million gallons, or 63%, to 28.7 million gallons for the nine months ended September 30, 2022 as compared to 77.3 million gallons for the same period in 2021. The decrease in third-party fuel-grade ethanol gallons sold reported net reduced net sales by $0.5 million.

 

Other Production Segment

 

Net sales of alcohol from our other production segment increased $128.2 million, or 203%, to $191.5 million for the nine months ended September 30, 2022 as compared to $63.3 million for the same period in 2021. Our total volume of gallons sold increased by 44.9 million gallons, or 185%, to 69.2 million gallons for the nine months ended September 30, 2022 as compared to 24.3 million gallons for the same period in 2021. At our other production segment’s average sales price per gallon of $2.77 for the nine months ended September 30, 2022, we generated $124.2 million in additional net sales from the 44.9 million additional gallons of alcohol sold in the nine months ended September 30, 2022 as compared to the same period in 2021. The increase of $0.16, or 6%, in our other production segment’s average sales price per gallon for the nine months ended September 30, 2022 as compared to the same period in 2021 improved our net sales from our other production segment by $4.0 million.

 

Net sales of essential ingredients increased by $47.5 million, or 247%, to $66.7 million for the nine months ended September 30, 2022 as compared to $19.2 million for the same period in 2021. Our total volume of essential ingredients sold increased by 364,400 tons, or 162%, to 590,000 tons for the nine months ended September 30, 2022 from 225,600 tons for the same period in 2021. At our average sales price per ton of $113.13 for the nine months ended September 30, 2022, we generated an additional $41.2 million in net sales from the 364,400 additional tons of essential ingredients sold in the nine months ended September 30, 2022 as compared to the same period in 2021. The increase of $27.76, or 32.5%, in our average sales price per ton for the nine months ended September 30, 2022 as compared to the same period in 2021 increased our net sales from our other production segment by $6.3 million.

 

25

 

 

Corporate and other

 

Net sales of alcohol from corporate and other represented $12.1 million associated with our sales from Eagle Alcohol for the nine months ended September 30, 2022.

 

Cost of Goods Sold and Gross Profit (Loss)

 

Our consolidated gross profit (loss) declined to a loss of $19.8 million, representing a gross profit margin of negative 5.9%, for the three months ended September 30, 2022 compared to a loss of $3.4 million, representing a gross profit margin of negative 1.1%, for the same period in 2021. Our consolidated gross profit (loss) declined to a loss of $6.2 million, representing a gross profit margin of negative 0.6%, for the nine months ended September 30, 2022 compared to gross profit of $25.7 million, representing a gross profit margin of 3.1%, for the same period in 2021.

 

Our consolidated gross profit (loss) for both the three and nine month periods declined due to higher overall commodity prices and extreme commodity price volatility due to inflationary pressures, including drawn-out supply chains and higher delivery costs, and logistical and service disruptions, some of which caused plant outages for over six days in the third quarter of 2022 contributing to negative margins at our Western plants. Corn basis costs increased significantly in the third quarter of 2022 by approximately $11.0 million. We also accelerated much of our fall repair and maintenance activities to August to reduce our use of corn and minimize the impact of short-term higher commodity prices, resulting in higher costs and lower production than we otherwise would have achieved. For all of 2022, our corn basis costs increased significantly year-over-year.

 

Our cost of goods sold and gross loss for the current periods also include $3.0 million in charges associated with the uncapitalized portion of our infrastructure upgrades. We also recorded an additional $3.0 million of losses on our forward derivative positions in the third quarter.

 

Three Months Ended September 30, 2022 and 2021

 

Pekin Campus Production Segment

 

Our Pekin Campus production segment’s gross profit declined by $11.9 million to a gross loss of $19.0 million for the three months ended September 30, 2022 as compared to a gross loss of $7.1 million for the same period in 2021. Of this decline, $10.6 million is attributable to lower margins from our specialty alcohols and $1.3 million is attributable to decreased sales volumes of essential ingredients in the three months ended September 30, 2022 as compared to the same period in 2021.

 

Marketing and Distribution Segment

 

Our marketing and distribution segment’s gross profit declined by $6.8 million to $0.5 million for the three months ended September 30, 2022 as compared to $7.3 million for the same period in 2021. Of this reduction, $0.6 million is attributable to lower marketing volumes of third-party fuel-grade ethanol and nearly $6.2 million is attributable to lower margins from sales of third-party fuel-grade ethanol due to high volatility in fuel prices for the three months ended September 30, 2022 as compared to the same period in 2021.

 

Other Production Segment

 

Our other production segment’s gross profit (loss) improved by $1.0 million to a gross loss of $2.5 million for the three months ended September 30, 2022 as compared to a gross loss of $3.5 million for the same period in 2021. Of this improvement, $2.5 million is attributable to better, but still negative, margins for fuel-grade ethanol, partially offset by $1.5 million attributable to increased volumes at negative margins of fuel-grade ethanol for the three months ended September 30, 2022 as compared to the same period in 2021.

 

Corporate and other

 

Gross profit from corporate and other represented $1.2 million associated with our sales from Eagle Alcohol for the three months ended September 30, 2022.

 

Nine Months Ended September 30, 2022 and 2021

 

Pekin Campus Production Segment

 

Our Pekin Campus production segment’s gross profit (loss) declined by $24.2 million to a gross loss of $6.8 million for the nine months ended September 30, 2022 as compared to a gross profit of $17.4 million for the same period in 2021. Of this decline, $0.4 million is attributable to lower sales volumes and $23.8 million is attributable to lower margins from our specialty alcohols in the nine months ended September 30, 2022 as compared to the same period in 2021.

 

Marketing and Distribution Segment

 

Our marketing segment’s gross profit declined by $12.4 million to a gross profit of $0.1 million for the nine months ended September 30, 2022 as compared to a gross profit of $12.5 million for the same period in 2021. Of this decline, $12.2 million is attributable to lower margins from sales of third-party fuel-grade ethanol and $0.2 million is attributable to lower marketing volumes of third-party fuel-grade ethanol for the nine months ended September 30, 2022 as compared to the same period in 2021.

 

26

 

 

Other Production Segment

 

Our other production segment’s gross loss improved by $1.6 million to a gross loss of $2.6 million for the nine months ended September 30, 2022 as compared to a gross loss of $4.2 million for the same period in 2021. Of this improvement, $3.2 million is attributable to better margins, although negative, partially offset by $1.6 million attributable to lower sales volumes at negative margins for the nine months ended September 30, 2022 as compared to the same period in 2021.

 

Corporate and other

 

Gross profit from corporate and other represented $3.0 million associated with our sales from Eagle Alcohol for the nine months ended September 30, 2022.

 

Selling, General and Administrative Expenses

 

The following table presents our selling, general and administrative, or SG&A, expenses in dollars and as a percentage of net sales (in thousands, except percentages):

 

   Three Months Ended
September 30,
   Variance in   Nine Months Ended
September 30,
   Variance in 
   2022   2021   Dollars   Percent   2022   2021   Dollars   Percent 
Selling, general and administrative expenses  $7,403   $5,533   $1,870    33.8%  $24,028   $19,777   $4,251    21.5%
Percentage of net sales   2.2%   1.8%             2.4%   2.4%          

 

Our SG&A expenses increased for the three and nine months ended September 30, 2022 as compared to the same period in 2021. The period over period increases in SG&A expenses are primarily due to increased stock compensation expenses and an acquisition-related accrual for future cash payments attributable to our acquisition of Eagle Alcohol of $0.9 million and $2.6 million for the three and nine months ended September 30, 2022, respectively.

 

Income from Cash Grant

 

We applied for and received $22.7 million in cash from the USDA’s Biofuel Producer Program. The program was created as part of the CARES Act in 2020, which allocated $700 million to support biofuel producers who experienced market losses due to the pandemic. The cash grant is not required to be repaid nor will it recur in the future.

 

Net Income (Loss) Available to Common Stockholders

 

The following table presents our net income (loss) available to common stockholders in dollars and as a percentage of net sales (in thousands, except percentages):

 

   Three Months Ended
September 30,
   Variance in   Nine Months Ended
September 30,
   Variance in 
   2022   2021   Dollars   Percent   2022   2021   Dollars   Percent 
Net income (loss) available to common stockholders  $(28,357)  $(3,451)  $(24,906)   (721.7)%  $(9,471)  $8,870   $(18,341)   

NM 

 
Percentage of net sales   (8.4)%   (1.1)%             (0.9)%   1.1%          

 

The decline in our net income available to common stockholders for the three and nine months ended September 30, 2022 as compared to the same periods in 2021 is primarily due to substantially higher production input costs resulting in negative gross margins as well as higher SG&A expenses.

 

27

 

 

Liquidity and Capital Resources

 

During the nine months ended September 30, 2022, we funded our operations primarily from cash generated by our operations, income from a cash grant under the CARES Act, collection of notes receivable, proceeds from our line of credit, asset sales and cash on hand. A portion of these funds were also used to acquire Eagle Alcohol and for capital expenditures. As of September 30, 2022, we had $32.4 million in cash, cash equivalents and restricted cash and $30.7 million available for borrowing under Kinergy’s operating line of credit. In addition to Kinergy’s operating line of credit, we have a senior secured term loan facility to fund large capital-intensive projects. We believe we have sufficient liquidity to meet our anticipated working capital, debt service, capital expenditure and other liquidity needs for the next twelve months from the filing of this report.

 

Quantitative Period-End Liquidity Status

 

We believe that the following amounts provide insight into our liquidity and capital resources. The following selected financial information should be read in conjunction with our consolidated financial statements and notes to consolidated financial statements included elsewhere in this report, and the other sections of “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report (dollars in thousands).

 

  

September 30,
2022
 

  

December 31,
2021
 

  

Change 

 
Cash, cash equivalents and restricted cash  $32,413   $62,125    (47.8)%
Current assets  $186,306   $229,526    (18.8)%
Property and equipment, net  $233,475   $222,550    4.9%
Current liabilities  $54,513   $69,602    (21.7)%
Long-term debt  $45,888   $50,361    (8.9)%
Working capital  $131,793   $159,924    (17.6)%
Working capital ratio   3.42    3.30    3.6%

 

Changes in Working Capital and Cash Flows

 

Working capital declined to $131.8 million at September 30, 2022 from $159.9 million at December 31, 2021 as a result of a decrease of $43.2 million in current assets, partially offset by a decrease of $15.1 million in current liabilities.

 

Current assets decreased primarily due to a decrease in cash, restricted cash, accounts receivable and derivative assets due to the timing of sales and increased capital expenditures for the nine months ended September 30, 2022.

 

Our current liabilities decreased primarily due to a decrease in derivative instruments due to the end of period change in commodity prices for open contracts and a decrease in accounts payable due to the timing of payments.

 

Our cash, cash equivalents and restricted cash decreased by $29.7 million primarily due to $25.2 million in cash used in our investing activities and $6.4 million in cash used in our financing activities, partially offset by $1.8 million in cash provided by our operating activities.

 

28

 

 

Cash provided by our Operating Activities

 

We generated $1.8 million in cash from our operating activities during the nine months ended September 30, 2022, as compared to cash used in our operating activities of $19.5 million for the same period in 2021. Specific factors that contributed to the change in cash from our operating activities include:

 

An increase of $51.2 million related to higher accounts receivable balances due to the timing of payments and higher commodity prices and sales volumes;

 

an increase of $6.9 million related to higher inventories due to increased commodity prices;

 

a decrease in income from loan forgiveness of $9.9 million due to a CARES Act loan forgiven in the prior period; and

 

an increase in inventory valuation of $8.0 million due to increased commodity prices.

 

These amounts were partially offset by:

 

A decrease of $19.2 million related to accounts payable due to the timing of payments;

 

a decrease of $18.5 million in our consolidated net income (loss) due to lower margins driven by higher corn costs;

 

a decrease in other assets of $15.4 million due to changes in derivative assets related to commodity price changes; and

 

a reduction of asset impairments of $3.1 million due to plants recorded as held-for-sale in the prior period.

 

Cash used in our Investing Activities

 

We used $25.2 million of cash for additions to property and equipment and $14.7 million of cash to acquire Eagle Alcohol, net of cash acquired, partially offset by collections of $14.8 million from notes receivable held in connection with the sale in 2020 of our ethanol production facilities in Aurora, Nebraska for the nine months ended September 30, 2022. Our additions to property and equipment increased by $13.0 million for the nine months ended September 30, 2022 as compared to the same period in 2021 due to higher capital expenditures associated with our plant improvement initiatives in 2022.

 

Cash used in our Financing Activities

 

Cash used in our financing activities was $6.4 million for the nine months ended September 30, 2022, which reflects net payments of $4.5 million on Kinergy’s operating line of credit, $1.0 million of share repurchases and $0.9 million paid in cash dividends on our preferred stock.

 

Term Loan

 

On November 7, 2022, we entered into a senior secured term loan for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. Our obligations under the term loan are secured by all of our tangible and intangible assets. In connection with the term loan facility, we will issue to the lenders an aggregate of up to 1.6 million shares of our common stock.

 

Kinergy’s Operating Line of Credit

 

Kinergy maintains an operating line of credit for an aggregate amount of up to $100.0 million. The credit facility matures in 2027. Interest accrues under the credit facility at a rate equal to (i) the daily Secured Overnight Financing Rate, plus (ii) a specified applicable margin ranging from 1.75% to 2.25%. The credit facility’s monthly unused line fee is 0.25% to 0.375% of the amount by which the maximum credit under the facility exceeds the average daily principal balance during the immediately preceding month. Payments that may be made by Kinergy to Alto Ingredients, Inc. as reimbursement for management and other services provided by Alto Ingredients, Inc. to Kinergy are limited under the terms of the credit facility to $1.5 million per fiscal quarter. The credit facility also includes the accounts receivable of our indirect wholly-owned subsidiary, Alto Nutrients, LLC, or Alto Nutrients, as additional collateral. Payments that may be made by Alto Nutrients to Alto Ingredients, Inc. as reimbursement for management and other services provided by Alto Ingredients, Inc. to Alto Nutrients are limited under the terms of the credit facility to $0.5 million per fiscal quarter. Alto Nutrients markets our essential ingredients and also provides raw material procurement services to our subsidiaries.

 

29

 

 

For all monthly periods in which excess borrowing availability falls below a specified level, Kinergy and Alto Nutrients must collectively maintain a fixed-charge coverage ratio (calculated as a twelve-month rolling earnings before interest, taxes, depreciation and amortization divided by the sum of interest expense, capital expenditures, principal payments of indebtedness, indebtedness from capital leases and taxes paid during such twelve-month rolling period) of at least 2.0 and are prohibited from incurring certain additional indebtedness (other than specific intercompany indebtedness). The obligations of Kinergy and Alto Nutrients under the credit facility are secured by all of our tangible and intangible assets.

 

We believe Kinergy and Alto Nutrients are in compliance with the fixed-charge coverage ratio covenant as of the filing of this report. The following table sets forth the fixed-charge coverage ratio financial covenant and the actual results for the periods presented:

 

   Three Months Ended
September 30,
   Years Ended
December 31,
 
   2022   2021   2021   2020 
Fixed-Charge Coverage Ratio Requirement   2.00    2.00    2.00    2.00 
Actual   3.13    16.11    13.32    5.35 
Excess   1.13    14.11    11.32    3.35 

 

Alto Ingredients, Inc. has guaranteed all of Kinergy’s obligations under the credit facility. As of September 30, 2022, Kinergy had an outstanding balance of $45.9 million and $30.7 million of unused borrowing availability under the credit facility.

 

Share Repurchase Program

 

For the three months ended September 30, 2022, we repurchased 259,000 shares of our common stock as part of our publicly announced share repurchase program at an average price per share of $3.86 for an aggregate expenditure of $1,002,000 during the period. See “Unregistered Sales of Equity Securities and Use of Proceeds – Purchases of Equity Securities by the Issuer and Affiliated Purchasers.”

 

30

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are exposed to various market risks, including changes in commodity prices as discussed below. Market risk is the potential loss arising from adverse changes in market rates and prices. In the ordinary course of business, we may enter into various types of transactions involving financial instruments to manage and reduce the impact of changes in commodity prices. We do not have material exposure to interest rate risk. We do not expect to have any exposure to foreign currency risk as we conduct all of our transactions in U.S. dollars.

 

We produce alcohol and essential ingredients. Our business is sensitive, in particular, to changes in the prices of ethanol and corn. In the ordinary course of business, we may enter into various types of transactions involving financial instruments to manage and reduce the impact of changes in ethanol and corn prices. We do not enter into derivatives or other financial instruments for trading or speculative purposes.

 

We are subject to market risk with respect to ethanol and corn pricing. Ethanol prices are sensitive to global and domestic ethanol supply; crude-oil supply and demand; crude-oil refining capacity; carbon intensity; government regulation, including governmental mandates for renewable fuel use; and consumer demand for alternative fuels. Our ethanol sales are priced using contracts that are either based on a fixed price or an indexed price tied to a specific market, such as the CBOT or the Oil Price Information Service. Under these fixed-priced arrangements, we are exposed to the risk of a decrease in the market price of ethanol between the time the price is fixed and the time the ethanol is sold.

 

We satisfy our physical corn needs, the principal raw material used to produce alcohol and essential ingredients, based on purchases from our corn vendors. Generally, we determine the purchase price of our corn at or near the time we begin to grind. Additionally, we also enter into volume contracts with our vendors to fix the purchase price. As such, we are also subject to market risk with respect to the price of corn. The price of corn is subject to wide fluctuations due to unpredictable factors such as weather conditions, farmer planting decisions, governmental policies with respect to agriculture and international trade, including trade and other sanctions that may be levied against grain producing countries, and global supply and demand. Under the fixed price arrangements, we assume the risk of a decrease in the market price of corn between the time the price is fixed and the time the corn is utilized.

 

Essential ingredients are sensitive to various demand factors such as numbers of livestock on feed, prices for feed alternatives, and supply factors, primarily the production of alcohol co-products by plants and other sources.

  

As noted above, we may attempt to reduce the market risk associated with fluctuations in the price of ethanol or corn by employing a variety of risk management and hedging strategies. Strategies include the use of derivative financial instruments such as futures and options executed on the CBOT and/or the New York Mercantile Exchange, as well as the daily management of physical corn supplies.

  

These derivatives are not designated for special hedge accounting treatment, and as such, the changes in the fair values of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. We recognized net gains of $21.2 million and $18.4 million related to the changes in the fair values of these contracts for the nine months ended September 30, 2022 and 2021, respectively.

  

At September 30, 2022, we prepared a sensitivity analysis to estimate our exposure to ethanol and corn costs. Market risk related to these factors was estimated as the potential change in pre-tax income resulting from a hypothetical 10% adverse change in the prices of our expected ethanol and corn volumes. The analysis uses average CBOT prices for the year and does not factor in future contracted volumes. The results of this analysis for the nine months ended September 30, 2022, which may differ materially from actual results, are as follows (in millions):

  

Commodity  Volume   Unit of Measure  Approximate
Adverse
Change to
Pre-Tax
Income
 
Ethanol   314.24   Gallons  $(48.9)
Corn   80.7   Bushels  $(56.7)

 

31

 

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

We conducted an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded as of September 30, 2022 that our disclosure controls and procedures were effective at a reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on the Effectiveness of Controls

 

Management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control systems are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in a cost-effective control system, no evaluation of internal control over financial reporting can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been or will be detected.

 

These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of a simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 

32

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We are subject to legal proceedings, claims and litigation arising in the ordinary course of business. While the amounts claimed may be substantial, the ultimate liability cannot presently be determined because of considerable uncertainties that exist. Therefore, it is possible that the outcome of those legal proceedings, claims and litigation could adversely affect our quarterly or annual operating results or cash flows when resolved in a future period. However, based on facts currently available, management believes such matters will not adversely affect in any material respect our financial position, results of operations or cash flows.

 

ITEM 1A. RISK FACTORS.

 

Before deciding to purchase, hold or sell our common stock, you should carefully consider the risks described below in addition to the other information contained in this Report and in our other filings with the Securities and Exchange Commission, including subsequent reports on Forms 10-Q and 8-K. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. If any of these known or unknown risks or uncertainties actually occurs with material adverse effects on Alto Ingredients, our business, financial condition, results of operations and/or liquidity could be seriously harmed. In that event, the market price for our common stock will likely decline, and you may lose all or part of your investment.

 

Risks Related to our Business

 

Our results of operations and our ability to operate at a profit are largely dependent on our ability to manage the costs of corn, natural gas and other production inputs, with the prices of our alcohols and essential ingredients, all of which are subject to volatility and uncertainty.

 

Our results of operations are highly impacted by commodity prices, including the cost of corn, natural gas and other production inputs that we must purchase, and the prices of alcohols and essential ingredients that we sell. Prices and supplies are subject to and determined by market and other forces over which we have no control, such as weather, domestic and global demand, supply shortages, export prices, inflationary conditions, global geopolitical tensions and various governmental policies in the United States and throughout the world.

 

Price volatility of corn, natural gas and other production inputs, and alcohols and essential ingredients, may cause our results of operations to fluctuate substantially. We may fail to generate expected levels of net sales and profits even under fixed-price and other contracts for the sale of specialty alcohols used in consumer products. Our customers may not pay us timely or at all, even under longer-term, fixed-price contracts for our specialty alcohols, and may seek to renegotiate prices under those contracts during periods of falling prices or high price volatility.

 

Over the past several years, for example, the spread between corn and fuel-grade ethanol prices has fluctuated significantly. Fluctuations are likely to continue to occur. A sustained negative or narrow spread, whether as a result of sustained high or increased corn prices or sustained low or decreased alcohol or essential ingredient prices, would adversely affect our results of operations and financial condition. Revenues from sales of alcohols, particularly fuel-grade ethanol, and essential ingredients could decline below the marginal cost of production, which may force us to suspend production, particularly fuel-grade ethanol production, at some or all of our facilities.

 

In addition, some of our fuel-grade ethanol marketing and distribution activities will likely be unprofitable in a market of generally declining prices due to the nature of our business. For example, to satisfy customer demands, we maintain certain quantities of fuel-grade ethanol inventory for subsequent resale. Moreover, we procure much of our fuel-grade ethanol inventory outside of contracted third-party marketing and distribution arrangements and therefore must buy fuel-grade ethanol at a price established at the time of purchase and sell fuel-grade ethanol at an index price established later at the time of sale that is generally reflective of movements in the market price of fuel-grade ethanol. As a result, our margins for fuel-grade ethanol sold in these transactions generally decline and may turn negative as the market price of fuel-grade ethanol declines.

 

We can provide no assurance that corn, natural gas or other production inputs can be purchased at or near current or any particular prices, or that our alcohols or essential ingredients will sell at or near current or any particular prices. Consequently, our results of operations and financial condition may be adversely affected by increases in the prices of corn, natural gas and other production inputs or decreases in the prices of our alcohols and essential ingredients.

 

33

 

 

Inflation, including as a result of commodity price inflation or supply chain constraints due to the war in Ukraine, and higher prices in general may adversely impact our results of operations.

 

We have experienced inflationary impacts on key production inputs, wages and other costs of labor, equipment, services, and other business expenses. Commodity prices in particular have risen significantly over the past year. Inflation and its negative impacts could escalate in future periods.

 

Ukraine is the third largest exporter of grain in the world. Russia is one of the largest producers of natural gas and oil and is the largest exporter of fertilizers. The commodity price impact of the war in Ukraine has been a sharp and sustained rise in grain and energy prices, including corn and natural gas, two of our primary production input commodities. In addition, the war in Ukraine has adversely affected and may continue to adversely affect global supply chains resulting in further commodity price inflation for our production inputs. Lower fertilizer supplies may also impact future growing seasons, further impacting grain supplies and prices. Also, given high global grain prices, U.S. farmers may prefer to lock in prices and export additional volumes, reducing domestic grain supplies and resulting in further inflationary pressures on key production inputs.

 

Even if inflation stabilizes or abates, the prices of key production inputs, wages and other costs of labor, equipment, services, and other business expenses may remain at elevated levels. We may not be able to include these additional costs in the prices of the products we sell. As a result, inflation and higher prices in general may have a material adverse effect on our results of operations and financial condition.

 

Increased alcohol or essential ingredient production or higher inventory levels may cause a decline in prices for those products, and may have other negative effects, adversely impacting our results of operations, cash flows and financial condition.

 

The prices of our alcohols and essential ingredients are impacted by competing third-party supplies of those products. For example, we believe that the most significant factor influencing the price of fuel-grade ethanol has been the substantial increase in production. According to the Renewable Fuels Association, domestic fuel-grade ethanol production capacity increased from an annualized rate of 1.5 billion gallons per year in January 1999 to a record 16.1 billion gallons in 2018. In addition, if fuel-grade ethanol production margins improve, we anticipate that owners of production facilities operating at below capacity, or owners of idled production facilities, will increase production levels, thereby resulting in more abundant fuel-grade ethanol supplies and inventories. Increases in the supply of alcohols and essential ingredients may not be commensurate with increases in demand for alcohols and essential ingredients, thus leading to lower prices. Any of these outcomes could have a material adverse effect on our results of operations, cash flows and financial condition.

 

The prices of our products are volatile and subject to large fluctuations, which may cause our results of operations to fluctuate significantly.

 

The prices of our products are volatile and subject to large fluctuations. For example, the market price of fuel-grade ethanol is dependent upon many factors, including the supply of ethanol and the price of gasoline, which is in turn dependent upon the price of petroleum which itself is highly volatile, difficult to forecast and influenced by a wide variety of geopolitical and global economic conditions, including decisions concerning petroleum output by the Organization of Petroleum Exporting Countries (OPEC) and their allies, an intergovernmental organization that seeks to manage the price and supply of oil on the global energy market. Our fuel-grade ethanol sales are tied to prevailing spot market prices rather than long-term, fixed-price contracts. Fuel-grade ethanol prices, as reported by the CBOT, ranged from $2.00 to $2.88 per gallon in the nine months ended September 30, 2022, from $1.48 to $3.75 per gallon in 2021 and from $0.81 to $1.62 per gallon in 2020. In addition, even under longer-term, fixed-price contracts for our specialty alcohols, our customers may seek to renegotiate prices under those contracts during periods of falling prices or high price volatility. Fluctuations in the prices of our products may cause our results of operations to fluctuate significantly.

 

Disruptions in our production or distribution may adversely affect our business, results of operations and financial condition.

 

Our business depends on the continuing availability of rail, road, port, storage and distribution infrastructure. In particular, due to limited storage capacity at some of our production facilities and other considerations related to production efficiencies, certain facilities depend on just-in-time delivery of corn. The production of alcohols also requires a significant and uninterrupted supply of other raw materials and energy, primarily water, electricity and natural gas. Local water, electricity and gas utilities may fail to reliably supply the water, electricity and natural gas that our production facilities need or may fail to supply those resources on acceptable terms. In the past, poor weather has caused disruptions in rail transportation, which slowed the delivery of fuel-grade ethanol by rail, the principal manner by which fuel-grade ethanol from our facilities located in the Midwest is transported to market.

 

For example, in 2022, a lightning strike at the utility servicing our Pekin Campus disrupted our operations, cutting power to our facilities and materially affecting our production, resulting in unexpected repair and maintenance costs, lost production and degradation in the quality of work-in-progress inventories. In addition, in 2020, we experienced closure of the Illinois River for lock repairs which required greater use of less cost-effective modes of product transport such as via rail and truck, which resulted in higher costs and negatively affected our results of operations.

 

34

 

 

Disruptions in production or distribution, whether caused by labor difficulties, unscheduled downtimes and other operational hazards inherent in the alcohol production industry, including equipment failures, fires, explosions, abnormal pressures, blowouts, pipeline ruptures, transportation accidents and natural disasters such as earthquakes, floods and storms, or human error or malfeasance or other reasons, could prevent timely deliveries of corn or other raw materials and energy, and could delay transport of our products to market, and may require us to halt production at one or more production facilities, any of which could have a material adverse effect on our business, results of operations and financial condition.

 

Some of these operational hazards may also cause personal injury or loss of life, severe damage to or destruction of property and equipment or environmental damage, and may result in suspension of operations and the imposition of civil or criminal penalties. Our insurance may not fully cover the potential hazards described above or we may be unable to renew our insurance on commercially reasonable terms or at all.

 

The effects of the coronavirus pandemic may materially and adversely affect our business, results of operations and liquidity.

 

The coronavirus pandemic resulted in businesses suspending or substantially curtailing operations and travel, quarantines, and an overall substantial slowdown of economic activity. Federal, state and foreign governments implemented measures to contain the virus, including social distancing requirements, travel restrictions, border closures, limitations on public gatherings, work-from-home orders, and closure of non-essential businesses. Some of these measures remain or have been curtailed only partially. Transportation fuels in particular, including fuel-grade ethanol, experienced significant price declines and reduced demand. A renewed downturn in global economic activity, including travel, or recessionary conditions in general, would likely lead to poor demand for, and negatively affect the prices of, our products, materially and adversely affecting our business, results of operations and liquidity.

 

We may engage in hedging transactions and other risk mitigation strategies that could harm our results of operations and financial condition.

 

In an attempt to partially offset the effects of volatility of our production input and product prices, in particular, corn and natural gas costs and fuel-grade ethanol prices, we may enter into contracts to purchase a portion of our corn or natural gas requirements on a forward basis or fix the sale price of portions of our alcohol production. In addition, we may engage in other hedging transactions involving exchange-traded futures contracts for corn, natural gas and unleaded gasoline from time to time. The financial statement impact of these activities is dependent upon, among other things, the prices involved and our ability to sell sufficient products to use all of the corn and natural gas for which forward commitments have been made. Hedging arrangements also expose us to the risk of financial loss in situations where our counterparty to the hedging contract defaults on its contract or, in the case of exchange-traded contracts, where there is a change in the expected differential between the underlying price in the hedging agreement and the actual prices paid or received by us. In addition, our open contract positions may require cash deposits to cover margin calls, negatively impacting our liquidity. As a result, our hedging activities and fluctuations in the price of corn, natural gas, fuel-grade ethanol and unleaded gasoline may adversely affect our results of operations, financial condition and liquidity.

 

Risks Related to our Finances

 

We have incurred significant losses and negative operating cash flow in the past and we may incur losses and negative operating cash flow in the future, which may hamper our operations and impede us from expanding our business.

 

We have incurred significant losses and negative operating cash flow in the past. For example, for the three and nine months ended September 30, 2022 and for the year ended December 31, 2020, we incurred consolidated net losses of approximately $28.0 million, $8.5 million and $17.3 million, respectively. We may incur losses and negative operating cash flow in the future. We expect to rely on cash on hand, cash, if any, generated from our operations, borrowing availability under our lines of credit and proceeds from our future financing activities, if any, to fund all of the cash requirements of our business. Additional losses and negative operating cash flow may hamper our operations and impede us from expanding our business.

 

We incur significant expenses to maintain and upgrade our production facilities and operating equipment, and any interruption in our operations would harm our operating performance.

 

We regularly incur significant expenses to maintain and upgrade our production facilities and operating equipment. The machines and equipment we use to produce our alcohols and essential ingredients are complex, have many parts, and some operate on a continuous basis. We must perform routine equipment maintenance and must periodically replace a variety of parts such as motors, pumps, pipes and electrical parts. In addition, our production facilities require periodic shutdowns to perform major maintenance and upgrades. These scheduled shutdowns result in lower sales and increased costs in the periods during which a shutdown occurs and could result in unexpected operational issues in future periods as a result of changes to equipment and operational and mechanical processes made during shutdown.

 

35

 

 

Our indebtedness may expose us to risks that could negatively impact our business, prospects, liquidity, cash flows and results of operations.

 

We anticipate incurring substantial indebtedness to engage in capital improvement projects. We expect that these projects, when completed, will generate financial returns sufficient to service and ultimately repay or refinance our indebtedness. However, the timing, cost and results of our capital improvement projects may not meet our projections. In addition, our indebtedness could:

 

make it more difficult to pay or refinance our indebtedness as it becomes due during adverse economic and industry conditions;

 

limit our flexibility to pursue strategic opportunities or react to changes in our business and the industries in which we operate and, consequently, place us at a competitive disadvantage to our competitors who have less debt;

 

require a substantial portion of our cash flows from operations for debt service payments, thereby reducing the availability of our cash flows to fund working capital, additional capital expenditures, acquisitions, dividend payments and for other general corporate purposes; or

 

Limit our ability to procure additional financing for working capital or other purposes.

 

Our ability to generate sufficient cash to make all interest payments when due depends on our performance, which is subject to a variety of factors beyond our control, including the cost of key production inputs, the supply of and demand for specialty alcohols and essential ingredients, and many other factors incident to the industries in which we operate. We cannot provide any assurance that we will be able to timely service or satisfy our debt obligations. Our failure to timely service or satisfy our debt obligations would have a material adverse effect on our business, business prospects, liquidity, cash flows and results of operations.

 

Our ability to utilize net operating loss carryforwards and certain other tax attributes may be limited.

 

Federal and state income tax laws impose restrictions on our use of net operating loss, or NOL, and tax credit carryforwards in the event that an “ownership change” occurs for tax purposes, as defined by Section 382 of the Internal Revenue Code, or Code. In general, an ownership change occurs when stockholders owning 5% or more of a corporation entitled to use NOL or other loss carryforwards have increased their ownership by more than 50 percentage points during any three-year period. The annual base limitation under Section 382 of the Code is calculated by multiplying the corporation’s value at the time of the ownership change by the greater of the long-term tax-exempt rate determined by the Internal Revenue Service in the month of the ownership change or the two preceding months. Our ability to utilize our NOL and other loss carryforwards may be substantially limited. These limitations could result in increased future tax obligations, which could have a material adverse effect on our financial condition and results of operations.

 

Risks Related to Legal and Regulatory Matters

 

We may be adversely affected by environmental, health and safety laws, regulations and liabilities, and which may not be adequately covered by insurance.

 

We are subject to various federal, state and local environmental laws and regulations, including those relating to the discharge of materials into the air, water and ground; the generation, storage, handling, use, transportation and disposal of hazardous materials and wastes; and the health and safety of our employees. In addition, some of these laws and regulations require us to operate under permits that are subject to renewal or modification. These laws, regulations and permits often require expensive pollution control equipment or operational changes to limit actual or potential impacts to the environment. A violation of these laws and regulations or permit conditions may result in substantial fines, natural resource damages, criminal sanctions, permit revocations and/or production facility shutdowns. In addition, we have made, and expect to make, significant capital expenditures on an ongoing basis to comply with increasingly stringent environmental laws, regulations and permits.

 

36

 

 

We may be liable for the investigation and cleanup of environmental contamination at each of our production facilities and at off-site locations where we arrange for the disposal of hazardous substances or wastes. If these substances or wastes have been or are disposed of or released at sites that undergo investigation and/or remediation by regulatory agencies, we may be responsible under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, or other environmental laws for all or part of the costs of investigation and/or remediation, and for damages to natural resources. We may also be subject to related claims by private parties alleging property damage and personal injury due to exposure to hazardous or other materials at or from those properties. Some of these matters may require us to expend significant amounts for investigation, cleanup or other costs.

 

In addition, new laws, new interpretations of existing laws, increased governmental enforcement of environmental laws or other developments could require us to make significant additional expenditures. Continued government and public emphasis on environmental issues will likely result in increased future investments for environmental controls at our production facilities. Present and future environmental laws and regulations, and interpretations of those laws and regulations, applicable to our operations, more vigorous enforcement policies and discovery of currently unknown conditions may require substantial expenditures that could have a material adverse effect on our results of operations and financial condition.

 

The hazards and risks associated with producing and transporting our products (including fires, natural disasters, explosions and abnormal pressures and blowouts) may also result in personal injury claims or damage to property and third parties. As protection against operating hazards, we maintain insurance coverage against some, but not all, potential losses. However, we could sustain losses for uninsurable or uninsured risks, or in amounts in excess of existing insurance coverages. Events that result in significant personal injury or damage to our property or third parties or other losses that are not fully covered by insurance could have a material adverse effect on our results of operations and financial condition.

 

Future demand for fuel-grade ethanol is uncertain and may be affected by changes to federal mandates, public perception, consumer acceptance and overall consumer demand for transportation fuel, any of which could negatively affect demand for fuel-grade ethanol and our results of operations.

 

Although many trade groups, academics and governmental agencies have supported fuel-grade ethanol as a fuel additive that promotes a cleaner environment, others have criticized fuel-grade ethanol production as consuming considerably more energy and emitting more greenhouse gases than other biofuels and potentially depleting water resources. Some studies have suggested that corn-based ethanol is less efficient than ethanol produced from other feedstock and that it negatively impacts consumers by causing increased prices for dairy, meat and other food generated from livestock that consume corn. Additionally, critics of fuel-grade ethanol contend that corn supplies are redirected from international food markets to domestic fuel markets. If negative views of corn-based ethanol production gain acceptance, support for existing measures promoting use and domestic production of corn-based ethanol as a fuel additive could decline, leading to a reduction or repeal of federal ethanol usage mandates, which would materially and adversely affect the demand for fuel-grade ethanol. These views could also negatively impact public perception of the fuel-grade ethanol industry and acceptance of ethanol as an alternative fuel.

 

There are limited markets for fuel-grade ethanol beyond those established by federal mandates. Discretionary blending and E85 blending (i.e., gasoline blended with up to 85% fuel-grade ethanol by volume) are important secondary markets. Discretionary blending is often determined by the price of fuel-grade ethanol relative to the price of gasoline. In periods when discretionary blending is financially unattractive, the demand for fuel-grade ethanol may decline. Also, the demand for fuel-grade ethanol is affected by the overall demand for transportation fuel. Demand for transportation fuel is affected by the number of miles traveled by consumers and vehicle fuel economy. Lower demand for fuel-grade ethanol and co-products would reduce the value of our ethanol and related products, erode our overall margins and diminish our ability to generate revenue or to operate profitably. In addition, we believe that consumer acceptance of E15 and E85 fuels is necessary before fuel-grade ethanol can achieve any significant growth in market share relative to other transportation fuels.

 

37

 

 

The United States fuel-grade ethanol industry is highly dependent upon various federal and state laws and any changes in those laws could have a material adverse effect on our results of operations, cash flows and financial condition.

 

The Environmental Protection Agency, or EPA, has implemented the Renewable Fuel Standard, or RFS, under the Energy Policy Act of 2005 and the Energy Independence and Security Act of 2007. The RFS program sets annual quotas for the quantity of renewable fuels (such as fuel-grade ethanol) that must be blended into motor fuels consumed in the United States through 2022. After 2022, the EPA is to determine volume requirements in coordination with the Secretary of Energy and the Secretary of Agriculture. The EPA has stated its intention to propose post-2022 mandatory volumes by mid-November 2022 for finalization by mid-June 2023 in compliance with a consent decree by the United States District Court for the District of Columbia.

 

Under the provisions of the Clean Air Act, as amended by the Energy Independence and Security Act of 2007, the EPA has limited authority to waive or reduce the mandated RFS requirements, which authority is subject to consultation with the Secretaries of Agriculture and Energy, and based on a determination that there is inadequate domestic renewable fuel supply or implementation of the applicable requirements would severely harm the economy or environment of a state, region or the United States in general. In particular, the EPA may issue small refinery waivers, in full or in part, to reduce or eliminate annual renewable fuel volume requirements for small refineries that process fewer than 75,000 barrels of petroleum daily. Our results of operations, cash flows and financial condition could be adversely impacted if the EPA reduces the RFS requirements from the statutory levels specified in the RFS or issues significant small refinery waivers.

 

The domestic market for fuel-grade ethanol is significantly impacted by federal mandates under the RFS program for volumes of renewable fuels (such as ethanol) required to be blended with gasoline. Future demand for fuel-grade ethanol will largely depend on incentives to blend ethanol into motor fuels, including the price of ethanol relative to the price of gasoline, the relative octane value of ethanol, constraints in the ability of vehicles to use higher ethanol blends, the RFS and the EPA’s established volumes from time to time, small refinery waivers, and other applicable environmental requirements.

 

Various bills in Congress introduced from time to time are also directed at altering existing renewable fuels energy legislation, but none has passed in recent years. Some legislative bills are directed at halting or reversing expansion of, or even eliminating, the renewable fuel program, while other bills are directed at bolstering the program or enacting further mandates or grants that would support the renewable fuels industry. Our results of operations, cash flows and financial condition could be adversely impacted if any legislation is enacted that reduces the RFS volume requirements.

 

Risks Related to Ownership of our Common Stock

 

Our stock price is highly volatile, which could result in substantial losses for investors purchasing shares of our common stock and in litigation against us.

 

The market price of our common stock has fluctuated significantly in the past and may continue to fluctuate significantly in the future. The market price of our common stock may continue to fluctuate in response to one or more of the following factors, many of which are beyond our control:

 

fluctuations in the market prices of our products;

 

fluctuations in the costs of key production input commodities such as corn and natural gas;

 

the volume and timing of the receipt of orders for our products from major customers;

 

the coronavirus pandemic, including governmental and public responses to the pandemic;

 

competitive pricing pressures;

 

anticipated trends in our financial condition and results of operations;

 

38

 

 

changes in market valuations of companies similar to us;

 

stock market price and volume fluctuations generally;

 

regulatory developments or increased enforcement;

 

fluctuations in our quarterly or annual operating results;

 

additions or departures of key personnel;

 

our ability to obtain any necessary financing;

 

the timing, cost and results of our capital improvement projects;

 

our financing activities and future sales of our common stock or other securities; and

 

our ability to maintain contracts that are critical to our operations.

 

The price at which you purchase shares of our common stock may not be indicative of the price that will prevail in the trading market. You may be unable to sell your shares of common stock at or above your purchase price, which may result in substantial losses to you and which may include the complete loss of your investment. In the past, securities class action litigation has often been brought against a company following periods of high stock price volatility. We may be the target of similar litigation in the future. Securities litigation could result in substantial costs and divert management’s attention and our resources away from our business.

 

Any of the risks described above could have a material adverse effect on our results of operations, the price of our common stock, or both.

 

Because we do not intend to pay any cash dividends on our shares of common stock in the near future, our stockholders will not be able to receive a return on their shares unless and until they sell them.

 

We intend to retain a significant portion of any future earnings to finance the development, operation and expansion of our business. We do not anticipate paying any cash dividends on our common stock in the near future. The declaration, payment, and amount of any future dividends will be made at the discretion of our board of directors, and will depend upon, among other things, our results of operations, cash flows, and financial condition, operating and capital requirements, compliance with any applicable debt covenants, and other factors as our board of directors considers relevant. There is no assurance that future dividends will be paid, and, if dividends are paid, there is no assurance with respect to the amount of any such dividend. Unless our board of directors determines to pay dividends, our stockholders will be required to look solely to appreciation in the value of our common stock to realize any gain on their investment. There can be no assurance that any such appreciation will occur.

 

Our bylaws contain an exclusive forum provision, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.

 

Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Delaware Court of Chancery shall be the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf, (b) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of us to us or our stockholders, (c) any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law, or (d) any action asserting a claim governed by the internal affairs doctrine.

 

For the avoidance of doubt, the exclusive forum provision described above does not apply to any claims arising under the Securities Act of 1933, as amended, or the Securities Act, or the Exchange Act. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.

 

The choice of forum provision in our bylaws may limit our stockholders’ ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers, employees or agents, which may discourage such lawsuits against us and our directors, officers, employees and agents even though an action, if successful, might benefit our stockholders. The applicable courts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. With respect to the provision making the Delaware Court of Chancery the sole and exclusive forum for certain types of actions, stockholders who do bring a claim in the Delaware Court of Chancery could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near Delaware. Finally, if a court were to find this provision of our bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could have a material adverse effect on us.

 

39

 

 

General Risk Factors

 

Cyberattacks through security vulnerabilities could lead to disruption of our business, reduced revenue, increased costs, liability claims, or harm to our reputation or competitive position.

 

Security vulnerabilities may arise from our hardware, software, employees, contractors or policies we have deployed, which may result in external parties gaining access to our networks, data centers, cloud data centers, corporate computers, manufacturing systems, and/or access to accounts we have at our suppliers, vendors or customers. External parties may gain access to our data or our customers’ data, or attack the networks causing denial of service or attempt to hold our data or systems in ransom. The vulnerability could be caused by inadequate account security practices such as failure to timely remove employee access when terminated. To mitigate these security issues, we have implemented measures throughout our organization, including firewalls, backups, encryption, employee information technology policies and user account policies. However, there can be no assurance that these measures will be sufficient to avoid cyberattacks. If any of these types of security breaches were to occur and we were unable to protect sensitive data, our relationships with our business partners and customers could be materially damaged, our reputation could be materially harmed, and we could be exposed to a risk of litigation and possible significant liability.

 

Further, if we fail to adequately maintain our information technology infrastructure, we may have outages and data loss. Excessive outages may affect our ability to timely and efficiently deliver products to customers or develop new products. Such disruptions and data loss may adversely impact our ability to fulfill orders and interrupt other processes. Delayed sales or lost customers resulting from these disruptions could adversely affect our financial results, stock price and reputation.

 

Our and our business partners’ or contractors’ failure to fully comply with applicable data privacy or similar laws could lead to significant fines and require onerous corrective action. In addition, data security breaches experienced by us or our business partners or contractors could result in the loss of trade secrets or other intellectual property, public disclosure of sensitive commercial data, and the exposure of personally identifiable information (including sensitive personal information) of our employees, customers, suppliers, contractors and others.

 

Unauthorized use or disclosure of, or access to, any personal information maintained by us or on our behalf, whether through breach of our systems, breach of the systems of our suppliers or vendors by an unauthorized party, or through employee or contractor error, theft or misuse, or otherwise, could harm our business. If any such unauthorized use or disclosure of, or access to, such personal information was to occur, our operations could be seriously disrupted, and we could be subject to demands, claims and litigation by private parties, and investigations, related actions, and penalties by regulatory authorities. In addition, we could incur significant costs in notifying affected persons and entities and otherwise complying with the multitude of foreign, federal, state and local laws and regulations relating to the unauthorized access to, or use or disclosure of, personal information. Finally, any perceived or actual unauthorized access to, or use or disclosure of, such information could harm our reputation, substantially impair our ability to attract and retain customers and have an adverse impact on our business, financial condition and results of operations.

 

40

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Unregistered Sales of Equity Securities

 

None.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

The following table sets forth information about repurchases of our common stock for the three months ended September 30, 2022:

 

 

Period

  Total number
of shares
purchased (1)
   Average price
paid per share
   Total number of
shares purchased
as part of publicly
announced plans or programs (2)
   Approximate
dollar value of
shares that may
yet be purchased
under plans or
programs (2)(3)
 
July 1 to July 31, 2022      $       $ 
August 1 to August 31, 2022      $       $ 
September 1 to September 30, 2022   259,000   $3.86    259,000   $49,000,000 
Three months ended September 30, 2022   259,000   $3.86    259,000   $49,000,000 

 

 

(1)We repurchased 259,000 shares as part of our publicly announced share repurchase program during the three months ended September 30, 2022 and received no shares transferred from employees in satisfaction of minimum statutory tax withholding obligations upon the vesting of restricted stock during the period.

 

(2)On September 12, 2022, we announced a share repurchase program under which we may repurchase up to $50 million of our common stock with an initial purchase authorization of $10 million. Amounts in excess of the initial purchase authorization of $10 million will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. For additional information, see "Note 1 - Organization and Business — Share Repurchase Program" to our Notes to Consolidated Financial Statements included in this Quarterly Report on Form 10-Q.

 

(3)Amount represents the share repurchase program size of $50 million less approximately $1 million in aggregate share repurchases, but is subject to additional board and preferred stockholder authorization for purchases in excess of the initial purchase authorization of $10 million.

 

41

 

 

Dividends

 

Our current and future debt financing arrangements may limit or prevent cash distributions from our subsidiaries to us, depending upon the achievement of specified financial and other operating conditions and our ability to properly service our debt, thereby limiting or preventing us from paying cash dividends.

 

For the three and nine months ended September 30, 2022 and 2021, we accrued and paid in cash an aggregate of $0.3 million and $0.9 million, respectively, in dividends on our Series B Cumulative Convertible Preferred Stock, or Series B Preferred Stock.

 

We have never declared or paid cash dividends on our common stock and do not currently intend to pay cash dividends on our common stock in the foreseeable future. We currently anticipate that we will retain any earnings for use in the continued development of our business.

 

The holders of our outstanding Series B Preferred Stock are entitled to dividends of 7% per annum, payable quarterly. Accrued and unpaid dividends in respect of our Series B Preferred Stock must be paid prior to the payment of any dividends in respect of shares of our common stock.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

Not applicable.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

Not applicable.

 

42

 

 

ITEM 6. EXHIBITS.

 

Exhibit
Number
  Description
31.1   Certifications Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (*)
31.2   Certifications Required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (*)
32.1   Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (*)
101.INS   Inline XBRL Instance Document (*)
101.SCH   Inline XBRL Taxonomy Extension Schema Document (*)
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document (*)
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document (*)
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document (*)
101.PRE  

Inline XBRL Taxonomy Extension Presentation Linkbase Document (*)

104   Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101) (*)

 

 

(*)Filed herewith.

 

43

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ALTO INGREDIENTS, INC.
       
Dated: November 8, 2022   By: /S/ BRYON T. MCGREGOR
      Bryon T. McGregor
      Chief Financial Officer
      (Principal Financial and Accounting Officer)

 

 

44

 

 

 

false --12-31 Q3 0000778164 0000778164 2022-01-01 2022-09-30 0000778164 2022-11-04 0000778164 2022-09-30 0000778164 2021-12-31 0000778164 us-gaap:SeriesAPreferredStockMember 2022-09-30 0000778164 us-gaap:SeriesAPreferredStockMember 2021-12-31 0000778164 us-gaap:SeriesBPreferredStockMember 2022-09-30 0000778164 us-gaap:SeriesBPreferredStockMember 2021-12-31 0000778164 us-gaap:NonvotingCommonStockMember 2022-09-30 0000778164 us-gaap:NonvotingCommonStockMember 2021-12-31 0000778164 2022-07-01 2022-09-30 0000778164 2021-07-01 2021-09-30 0000778164 2021-01-01 2021-09-30 0000778164 2020-12-31 0000778164 2021-09-30 0000778164 us-gaap:PreferredStockMember 2021-12-31 0000778164 us-gaap:CommonStockMember 2021-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000778164 us-gaap:RetainedEarningsMember 2021-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000778164 us-gaap:NoncontrollingInterestMember 2021-12-31 0000778164 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000778164 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000778164 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000778164 2022-01-01 2022-03-31 0000778164 us-gaap:PreferredStockMember 2022-03-31 0000778164 us-gaap:CommonStockMember 2022-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000778164 us-gaap:RetainedEarningsMember 2022-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2022-03-31 0000778164 2022-03-31 0000778164 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0000778164 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000778164 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0000778164 2022-04-01 2022-06-30 0000778164 us-gaap:PreferredStockMember 2022-06-30 0000778164 us-gaap:CommonStockMember 2022-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000778164 us-gaap:RetainedEarningsMember 2022-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-06-30 0000778164 2022-06-30 0000778164 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0000778164 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000778164 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0000778164 us-gaap:PreferredStockMember 2022-09-30 0000778164 us-gaap:CommonStockMember 2022-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000778164 us-gaap:RetainedEarningsMember 2022-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-09-30 0000778164 us-gaap:PreferredStockMember 2020-12-31 0000778164 us-gaap:CommonStockMember 2020-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000778164 us-gaap:RetainedEarningsMember 2020-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000778164 us-gaap:NoncontrollingInterestMember 2020-12-31 0000778164 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000778164 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000778164 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000778164 2021-01-01 2021-03-31 0000778164 us-gaap:PreferredStockMember 2021-03-31 0000778164 us-gaap:CommonStockMember 2021-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000778164 us-gaap:RetainedEarningsMember 2021-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2021-03-31 0000778164 2021-03-31 0000778164 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000778164 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000778164 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0000778164 2021-04-01 2021-06-30 0000778164 us-gaap:PreferredStockMember 2021-06-30 0000778164 us-gaap:CommonStockMember 2021-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000778164 us-gaap:RetainedEarningsMember 2021-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-06-30 0000778164 2021-06-30 0000778164 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000778164 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000778164 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0000778164 us-gaap:PreferredStockMember 2021-09-30 0000778164 us-gaap:CommonStockMember 2021-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000778164 us-gaap:RetainedEarningsMember 2021-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-09-30 0000778164 alto:OwnershipMember 2022-01-14 0000778164 2021-01-01 2021-12-31 0000778164 2022-09-02 2022-09-12 0000778164 2022-01-01 2022-01-14 0000778164 2022-01-14 0000778164 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0000778164 alto:AcquisitionOfEagleAlcoholMember 2022-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2021-01-01 2021-09-30 0000778164 us-gaap:CorporateAndOtherMember 2022-07-01 2022-09-30 0000778164 us-gaap:CorporateAndOtherMember 2021-07-01 2021-09-30 0000778164 us-gaap:CorporateAndOtherMember 2022-01-01 2022-09-30 0000778164 us-gaap:CorporateAndOtherMember 2021-01-01 2021-09-30 0000778164 alto:IntersegmentEliminationsMember 2022-07-01 2022-09-30 0000778164 alto:IntersegmentEliminationsMember 2021-07-01 2021-09-30 0000778164 alto:IntersegmentEliminationsMember 2022-01-01 2022-09-30 0000778164 alto:IntersegmentEliminationsMember 2021-01-01 2021-09-30 0000778164 alto:NetSalesMember 2022-07-01 2022-09-30 0000778164 alto:NetSalesMember 2021-07-01 2021-09-30 0000778164 alto:NetSalesMember 2022-01-01 2022-09-30 0000778164 alto:NetSalesMember 2021-01-01 2021-09-30 0000778164 alto:PekinCampusMember 2022-07-01 2022-09-30 0000778164 alto:PekinCampusMember 2021-07-01 2021-09-30 0000778164 alto:PekinCampusMember 2022-01-01 2022-09-30 0000778164 alto:PekinCampusMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2021-01-01 2021-09-30 0000778164 alto:CorporateActivitiesMember 2022-07-01 2022-09-30 0000778164 alto:CorporateActivitiesMember 2021-07-01 2021-09-30 0000778164 alto:CorporateActivitiesMember 2022-01-01 2022-09-30 0000778164 alto:CorporateActivitiesMember 2021-01-01 2021-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2022-07-01 2022-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2021-07-01 2021-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2022-01-01 2022-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2021-01-01 2021-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2022-07-01 2022-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2021-07-01 2021-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2022-01-01 2022-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember 2021-01-01 2021-09-30 0000778164 us-gaap:AssetsTotalMember 2022-07-01 2022-09-30 0000778164 us-gaap:AssetsTotalMember 2021-07-01 2021-09-30 0000778164 us-gaap:AssetsTotalMember 2022-01-01 2022-09-30 0000778164 us-gaap:AssetsTotalMember 2021-01-01 2021-09-30 0000778164 alto:PekinCampusMember 2022-09-30 0000778164 alto:PekinCampusMember 2021-12-31 0000778164 alto:MarketingAndDistributionsMember 2022-09-30 0000778164 alto:MarketingAndDistributionsMember 2021-12-31 0000778164 alto:OtherProductionIncomeTaxMember 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2021-12-31 0000778164 us-gaap:CorporateAndOtherMember 2022-09-30 0000778164 us-gaap:CorporateAndOtherMember 2021-12-31 0000778164 alto:RealizedLossesMember 2022-07-01 2022-09-30 0000778164 alto:RealizedLossesMember 2021-07-01 2021-09-30 0000778164 alto:RealizedGainsMember 2022-01-01 2022-09-30 0000778164 alto:RealizedGainsMember 2021-01-01 2021-09-30 0000778164 alto:UnrealizedGainsMember 2022-07-01 2022-09-30 0000778164 alto:UnrealizedGainsMember 2021-07-01 2021-09-30 0000778164 alto:UnrealizedGainsLossesMember 2022-01-01 2022-09-30 0000778164 alto:UnrealizedGainsLossesMember 2021-01-01 2021-09-30 0000778164 alto:AlcoholSalesContractsMember 2022-09-30 0000778164 alto:AlcoholFromItsSuppliersMember alto:EthanolPurchaseContractsMember 2022-01-01 2022-09-30 0000778164 alto:AlcoholFromItsSuppliersMember alto:EthanolPurchaseContractsMember 2022-09-30 0000778164 alto:CornFromSuppliersMember alto:EthanolPurchaseContractsMember 2022-09-30 0000778164 us-gaap:NaturalGasProductionMember alto:EthanolPurchaseContractsMember 2022-09-30 0000778164 us-gaap:NaturalGasProductionMember alto:EthanolPurchaseContractsMember 2022-01-01 2022-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2022-07-01 2022-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2021-12-31 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2022-07-01 2022-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2021-07-01 2021-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2022-01-01 2022-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2021-01-01 2021-09-30 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 alto:LargeUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:LargeUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:LargeUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:LargeUSEquityMember 2021-12-31 0000778164 alto:SmallMidUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:SmallMidUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:SmallMidUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:SmallMidUSEquityMember 2021-12-31 0000778164 alto:InternationalEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:InternationalEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:InternationalEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:InternationalEquityMember 2021-12-31 0000778164 alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member 2021-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 2021-12-01 2021-12-31 0000778164 us-gaap:SubsequentEventMember 2022-11-02 2022-11-07 0000778164 us-gaap:SubsequentEventMember 2022-11-07 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 f10q0922ex31-1_altoingred.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Michael D. Kandris, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Alto Ingredients, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: November 8, 2022   /S/ MICHAEL D. KANDRIS
    Michael D. Kandris
   

President and Chief Executive Officer

    (Principal Executive Officer)

 

 

 

EX-31.2 3 f10q0922ex31-2_altoingred.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Bryon T. McGregor, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Alto Ingredients, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 8, 2022

 

/S/ BRYON T. MCGREGOR

    Bryon T. McGregor
   

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 f10q0922ex32-1_altoingred.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION OF
CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Alto Ingredients, Inc. (the “Company”) for the period ended September 30, 2022 (the “Report”), the undersigned hereby certify in their capacities as Chief Executive Officer and Chief Financial Officer of the Company, respectively, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 8, 2022   By: /S/ MICHAEL D. KANDRIS
      Michael D. Kandris
      President and Chief Executive Officer
      (Principal Executive Officer)

 

Dated: November 8, 2022   By: /S/ BRYON T. MCGREGOR
      Bryon T. McGregor
      Chief Financial Officer
      (Principal Financial Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.SCH 5 alto-20220930.xsd XBRL SCHEMA FILE 001 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Organization and Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Acquisition of Eagle Alcohol link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Segments link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Derivatives link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Pension and Retirement Benefit Plans link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Acquisition of Eagle Alcohol (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Segments (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Derivatives (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Organization and Basis of Presentation (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Acquisition of Eagle Alcohol (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Segments (Details) - Schedule of financial data for operating segments link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Segments (Details) - Schedule of assets by operating segments link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Inventories (Details) - Schedule of inventories link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Derivatives (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Derivatives (Details) - Schedule of derivatives not designated as hedging instruments link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Derivatives (Details) - Schedule of recognized gains for its derivatives link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Debt (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Debt (Details) - Schedule of long-term borrowings link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Pension and Retirement Benefit Plans (Details) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Earnings (Loss) Per Share (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 alto-20220930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 alto-20220930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 alto-20220930_lab.xml XBRL LABEL FILE EX-101.PRE 9 alto-20220930_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 04, 2022
Document Information Line Items    
Entity Registrant Name ALTO INGREDIENTS, INC.  
Trading Symbol ALTO  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   73,956,108
Amendment Flag false  
Entity Central Index Key 0000778164  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-21467  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 41-2170618  
Entity Address, Address Line One 1300 South Second Street  
Entity Address, City or Town Pekin  
Entity Address, State or Province IL  
Entity Address, Postal Zip Code 61554  
City Area Code (916)  
Local Phone Number 403-2123  
Title of 12(b) Security Common Stock, $0.001 par value  
Security Exchange Name NASDAQ  
Entity Interactive Data Current Yes  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
[1]
Current Assets:    
Cash and cash equivalents $ 28,458 $ 50,612
Restricted cash 3,955 11,513
Accounts receivable, net (net of allowance for doubtful accounts of $135 and $378, respectively) 76,455 86,888
Inventories 61,088 54,373
Derivative instruments 7,384 15,839
Notes receivable, current 3,125
Other current assets 8,966 7,176
Total current assets 186,306 229,526
Property and equipment, net 233,475 222,550
Other Assets:    
Right of use operating lease assets, net 12,895 13,413
Notes receivable, noncurrent 11,641
Intangible assets, net 9,234 2,678
Goodwill 5,970
Other assets 6,788 5,145
Total other assets 34,887 32,877
Total Assets 454,668 484,953
Current Liabilities:    
Accounts payable – trade 17,493 23,251
Accrued liabilities 22,172 21,307
Current portion – operating leases 3,646 3,909
Derivative instruments 1,106 13,582
Other current liabilities 10,096 7,553
Total current liabilities 54,513 69,602
Long-term debt, net of current portion 45,888 50,361
Operating leases, net of current portion 9,201 9,382
Other liabilities 10,068 10,394
Total Liabilities 119,670 139,739
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2022 and December 31, 2021; liquidation preference of $18,075 as of September 30, 2022 1 1
Common stock, $0.001 par value; 300,000 shares authorized; 73,956 and 72,778 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 74 73
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2022 and December 31, 2021, respectively
Additional paid-in capital 1,036,459 1,037,205
Accumulated other comprehensive loss (284) (284)
Accumulated deficit (701,252) (691,781)
Total Stockholders’ Equity 334,998 345,214
Total Liabilities and Stockholders’ Equity $ 454,668 $ 484,953
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets (Parentheticals) - USD ($)
shares in Thousands, $ in Thousands
Sep. 30, 2022
Dec. 31, 2021
[1]
Net of allowance for doubtful accounts (in Dollars) $ 135 $ 378
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000 10,000
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 300,000 300,000
Common stock, shares issued 73,956 72,778
Common stock, shares outstanding 73,956 72,778
Series A Preferred Stock    
Preferred stock, shares authorized 1,684 1,684
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock    
Preferred stock, shares authorized 1,581 1,581
Preferred stock, shares issued 927 927
Preferred stock, shares outstanding 927 927
Preferred stock, liquidation preference (in Dollars) $ 18,075  
Non-Voting Common Stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 3,553 3,553
Common stock, shares issued 1 1
Common stock, shares outstanding 1 1
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Net sales $ 336,877 $ 305,556 $ 1,007,184 $ 822,400
Cost of goods sold 356,716 308,955 1,013,406 796,729
Gross profit (loss) (19,839) (3,399) (6,222) 25,671
Selling, general and administrative expenses (7,403) (5,533) (24,028) (19,777)
Asset impairments (3,100)
Income (loss) from operations (27,242) (8,932) (30,250) 2,794
Interest expense, net (340) (429) (859) (3,359)
Income from cash grant 22,652
Income from loan forgiveness 5,973 9,860
Other income (expense), net (456) 256 (68) 641
Income (loss) before provision for income taxes (28,038) (3,132) (8,525) 9,936
Provision for income taxes
Net income (loss) (28,038) (3,132) (8,525) 9,936
Preferred stock dividends (319) (319) (946) (946)
Income allocated to participating securities (120)
Net income (loss) available to common stockholders $ (28,357) $ (3,451) $ (9,471) $ 8,870
Net income (loss) per share, basic (in Dollars per share) $ (0.39) $ (0.05) $ (0.13) $ 0.12
Net income (loss) per share, diluted (in Dollars per share) $ (0.39) $ (0.05) $ (0.13) $ 0.12
Weighted-average shares outstanding, basic (in Shares) 73,011 71,383 71,815 71,002
Weighted-average shares outstanding, diluted (in Shares) 73,011 71,383 71,815 72,260
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities:    
Net income (loss) $ (8,525) $ 9,936
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization of intangibles 19,122 17,520
Inventory valuation 7,963
Asset impairments 3,100
Income from loan forgiveness (9,860)
Non-cash compensation 2,546 2,283
Amortization of deferred financing fees 29 732
Bad debt expense (benefit) (187) 140
Changes in operating assets and liabilities, net of business acquisition:    
Accounts receivable 16,137 (35,072)
Inventories (13,290) (20,192)
Other assets (7,472) 8,011
Operating leases (3,799) (3,184)
Assets held-for-sale (2,874)
Liabilities held-for-sale 1,467
Accounts payable and accrued expenses (10,684) 8,482
Net cash provided by (used in) operating activities 1,840 (19,511)
Investing Activities:    
Proceeds from principal payments on notes receivable 14,766
Proceeds from asset sales 19,500
Additions to property and equipment (25,233) (12,240)
Purchase of Eagle Alcohol, net of cash acquired (14,685)
Net cash provided by (used in) investing activities (25,152) 7,260
Financing Activities:    
Net proceeds from (payments on) Kinergy’s line of credit (4,452) 38,198
Stock repurchases (1,002)  
Proceeds from stock option exercises 462
Principal payments on borrowings (37,810)
Preferred stock dividends paid (946)
Net cash provided by (used in) financing activities (6,400) 850
Net change in cash, cash equivalents and restricted cash (29,712) (11,401)
Cash, cash equivalents and restricted cash at beginning of period 62,125 48,187
Cash, cash equivalents and restricted cash at end of period 32,413 36,786
Reconciliation of total cash, cash equivalents and restricted cash:    
Cash and cash equivalents 28,458 36,029
Restricted cash 3,955 757
Total cash, cash equivalents and restricted cash 32,413 36,786
Supplemental Information:    
Interest paid 961 3,194
Accrued preferred stock dividends $ 946
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accum. Other Comprehensive Loss
Non- Controlling Interests
Total
Balances at Dec. 31, 2020 $ 1 $ 72 $ 1,036,638 $ (736,598) $ (3,878) $ 296,235
Balances (in Shares) at Dec. 31, 2020 927 72,487          
Restricted stock issued to employees and directors, net of cancellations and tax $ 1 (186) (185)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   550          
Stock-based compensation 804 804
Issuances of common stock 462 462
Issuances of common stock (in Shares)   124          
Preferred stock dividends (312) (312)
Net income (loss) 4,678 4,678
Balances at Mar. 31, 2021 $ 1 $ 73 1,037,718 (732,232) (3,878) 301,682
Balances (in Shares) at Mar. 31, 2021 927 73,161          
Balances at Dec. 31, 2020 $ 1 $ 72 1,036,638 (736,598) (3,878) 296,235
Balances (in Shares) at Dec. 31, 2020 927 72,487          
Net income (loss)             9,936
Balances at Sep. 30, 2021 $ 1 $ 73 1,036,608 (727,608) (3,878) 305,196
Balances (in Shares) at Sep. 30, 2021 927 72,800          
Balances at Mar. 31, 2021 $ 1 $ 73 1,037,718 (732,232) (3,878) 301,682
Balances (in Shares) at Mar. 31, 2021 927 73,161          
Restricted stock issued to employees and directors, net of cancellations and tax (2,589) (2,589)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   (350)          
Stock-based compensation 851 851
Preferred stock dividends (315) (315)
Net income (loss) 8,390 8,390
Balances at Jun. 30, 2021 $ 1 $ 73 1,035,980 (724,157) (3,878) 308,019
Balances (in Shares) at Jun. 30, 2021 927 72,811          
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   (11)          
Stock-based compensation 628 628
Preferred stock dividends (319) (319)
Net income (loss) (3,132) (3,132)
Balances at Sep. 30, 2021 $ 1 $ 73 1,036,608 (727,608) (3,878) 305,196
Balances (in Shares) at Sep. 30, 2021 927 72,800          
Balances at Dec. 31, 2021 $ 1 $ 73 1,037,205 (691,781) (284) 345,214
Balances (in Shares) at Dec. 31, 2021 927 72,778          
Restricted stock issued to employees and directors, net of cancellations and tax (9) (9)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares) 684          
Stock-based compensation 673 673
Shares issued for Eagle Alcohol acquisition $ 1 1
Shares issued for Eagle Alcohol acquisition (in Shares)   949          
Preferred stock dividends (312) (312)
Net income (loss) (2,602) (2,602)
Balances at Mar. 31, 2022 $ 1 $ 74 1,037,869 (694,695) (284) 342,965
Balances (in Shares) at Mar. 31, 2022 927 74,411          
Balances at Dec. 31, 2021 $ 1 $ 73 1,037,205 (691,781) (284) 345,214
Balances (in Shares) at Dec. 31, 2021 927 72,778          
Net income (loss)             (8,525)
Balances at Sep. 30, 2022 $ 1 $ 74 1,036,459 (701,252) (284) 334,998
Balances (in Shares) at Sep. 30, 2022 927 73,956          
Balances at Mar. 31, 2022 $ 1 $ 74 1,037,869 (694,695) (284) 342,965
Balances (in Shares) at Mar. 31, 2022 927 74,411          
Restricted stock issued to employees and directors, net of cancellations and tax (2,283) (2,283)
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares) (223)          
Stock-based compensation 1,106 1,106
Preferred stock dividends (315) (315)
Net income (loss) 22,115 22,115
Balances at Jun. 30, 2022 $ 1 $ 74 1,036,692 (672,895) (284) 363,588
Balances (in Shares) at Jun. 30, 2022 927 74,188          
Restricted stock issued to employees and directors, net of cancellations and tax 2 2
Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)   27          
Stock repurchases (1,002) (1,002)
Stock repurchases (in Shares)   (259)          
Stock-based compensation 767 767
Preferred stock dividends (319) (319)
Net income (loss) (28,038) (28,038)
Balances at Sep. 30, 2022 $ 1 $ 74 $ 1,036,459 $ (701,252) $ (284) $ 334,998
Balances (in Shares) at Sep. 30, 2022 927 73,956          
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Basis of Presentation
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION

1. ORGANIZATION AND BASIS OF PRESENTATION.

 

Organization and Business – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation (“Alto Op Co.”), Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.

 

On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022.

 

The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing.

 

The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties.

 

The Company focuses on four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Essential Ingredients markets include dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Renewable Fuels includes fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

 

As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility.

 

Basis of PresentationInterim Financial Statements – The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Results for interim periods should not be considered indicative of results for a full year. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The accounting policies used in preparing these consolidated financial statements are the same as those described in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Accounts Receivable and Allowance for Doubtful Accounts – Trade accounts receivable are presented at face value, net of the allowance for doubtful accounts. The Company sells specialty alcohols to large consumer products companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and biodiesel customers generally without requiring collateral.

 

The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required.

 

Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.

 

Financial Instruments – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, derivative assets, accounts payable, accrued liabilities and derivative liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value because the interest rates on these instruments are variable.

 

Business Combinations – Business acquisitions are accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations”. FASB ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).

 

Income from Cash Grant – The Company applied for and received $22,652,000 in cash from the USDA’s Biofuel Producer Program. The program was created as part of the CARES Act in 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The cash grant is not required to be repaid. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.

 

Share Repurchase Program – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50 million of its common stock with an initial purchase authorization of $10 million. Amounts in excess of the initial purchase authorization of $10 million will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the three and nine months ended September 30, 2022, the Company repurchased an aggregate of 259,000 shares for $1,002,000 in cash.

 

Estimates and Assumptions – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for doubtful accounts, net realizable value of inventory, estimated lives of property and equipment, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisition of Eagle Alcohol
9 Months Ended
Sep. 30, 2022
Acquisition of Eagle Alcohol [Abstract]  
ACQUISITION OF EAGLE ALCOHOL

2. ACQUISITION OF EAGLE ALCOHOL.

 

On January 14, 2022, the Company purchased 100% of the membership interests of Eagle Alcohol. The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol are eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the next three years and an aggregate of $5.0 million in the Company’s common stock on the fourth and fifth year anniversaries of the closing date, subject to the satisfaction of certain conditions, including continued employment with the Company. With respect to these payments, the Company has recognized an estimated $0.9 million and $2.6 million for the three and nine months ended September 30, 2022, respectively, in selling, general and administrative expenses in the accompanying consolidated statements of operations.

 

Eagle Alcohol specializes in break bulk distribution of specialty alcohols. Eagle Alcohol purchases bulk alcohol from suppliers and then stores, denatures, packages, and resells alcohol products in smaller sizes, including tank trucks, totes, and drums, that garner a premium to bulk alcohols. Eagle Alcohol delivers products to customers in the beverage, food, and related-process industries via its own dedicated trucking fleet and common carrier. The acquisition has provided the Company further vertical integration and access to new markets in the specialty alcohol industry.

 

Eagle Alcohol’s unaudited results for the three months ended September 30, 2022 and 2021 generated $4.2 million and $9.9 million in net sales and $0.0 million and $1.0 million in net income, respectively. Eagle Alcohol’s unaudited results for the nine months ended September 30, 2022 and 2021 generated $12.1 million and $27.5 million in net sales and $0.1 million and $3.0 million in net income, respectively. The following table presents unaudited pro forma combined financial information assuming the acquisition occurred on January 1, 2021 (dollars in thousands except per share amounts): 

 

  

Three Months Ended

September 30,

 
   2022   2021 
Revenues – pro forma  $336,877   $311,821 
Net loss available to common stockholders – pro forma  $(28,357)  $(3,424)
Diluted net loss per share – pro forma  $(0.38)  $(0.05)
Diluted shares   73,960    72,332 

 

   Nine Months Ended
September 30,
 
   2022   2021 
Revenues – pro forma  $1,007,711   $840,947 
Net income (loss) available to common stockholders – pro forma  $(9,538)  $8,474 
Diluted net income (loss) per share – pro forma  $(0.13)  $0.12 
Diluted shares   72,764    73,209 

  

The following preliminary allocation of the estimated purchase price assumes, with the exception of property and equipment and intangibles, carrying values approximate fair value. Estimates of uncollectible accounts receivable are not considered material due to the short-term nature and customer collection history. The preliminary estimate of working capital is under review by management and is subject to change. Based upon these assumptions, the preliminary purchase price allocation is as follows (in thousands):

 

Cash and equivalents  $705 
Accounts receivable   5,517 
Inventories   1,388 
Other assets   29 
Total current assets   7,639 
      
Property and equipment   1,067 
Right of use assets   2,749 
Total tangible assets  $11,455 
      
Current liabilities  $6,262 
Right of use liability   2,749 
Total liabilities  $9,011 
      
Net tangible assets acquired  $2,444 
Customer relationships   6,556 
Tradename   420 
Goodwill   5,970 
Total Purchase Price  $15,390 

 

Goodwill represents the value of the downstream integration that the operations of Eagle Alcohol will add to the Company. The Company expects the amortization of goodwill to be deductible for tax purposes. For the identifiable intangible assets, the Company has estimated 12 years for useful lives for customer relationships and 10 years for tradename. For the three months ended September 30, 2022, the Company recorded amortization expense of $137,000 and $10,000 for customer relationships and tradename, respectively. For the nine months ended September 30, 2022, the Company recorded amortization expense of $390,000 and $30,000 for customer relationships and tradename, respectively. Any changes to the initial estimates of the fair value of the acquired assets and assumed liabilities will be recorded as adjustments to those assets and liabilities and residual amounts will be allocated to goodwill if net assets acquired are less than the purchase price. The Company did not incur any material acquisition costs.

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segments
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
SEGMENTS

3. SEGMENTS.

 

The Company reports its financial and operating performance in three segments: (1) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis and third-party fuel-grade ethanol sales (2) Pekin production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus (“Pekin Campus”), and (3) Other production, which includes the production and sale of renewable fuel and essential ingredients produced at all of the Company’s other production facilities on an aggregated basis (“Other production”), none of which are individually so significant as to be considered a reportable segment.

 

The following tables set forth certain financial data for the Company’s operating segments (in thousands):

  

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Net Sales                
Pekin Campus, recorded as gross:                    
Alcohol sales  $133,680   $114,587   $393,498   $341,967 
Essential ingredient sales   54,537    46,016    169,670    140,670 
Intersegment sales   332    293    857    919 
Total Pekin Campus sales   188,549    160,896    564,025    483,556 
Marketing and distribution:                    
Alcohol sales, gross  $55,262   $112,391   $172,746   $255,702 
Alcohol sales, net   308    505    975    1,489 
Intersegment sales   3,121    2,415    9,360    7,277 
Total marketing and distribution sales   58,691    115,311    183,081    264,468 
Other production, recorded as gross:                    
Alcohol sales  $64,492   $25,190   $191,483   $63,311 
Essential ingredient sales   24,439    6,867    66,748    19,261 
Intersegment sales   3    259    14    896 
Total Other production sales   88,934    32,316    258,245    83,468 
Corporate and other   4,159    
    12,064    
 
Intersegment eliminations   (3,456)   (2,967)   (10,231)   (9,092)
Net sales as reported  $336,877   $305,556   $1,007,184   $822,400 
Cost of goods sold:                
Pekin Campus  $207,939   $169,721   $572,512   $468,972 
Marketing and distribution   55,159    105,902    173,670    245,606 
Other production   91,663    35,613    261,514    87,055 
Corporate and other   2,925    
    8,995    
 
Intersegment eliminations   (970)   (2,281)   (3,285)   (4,904)
Cost of goods sold as reported  $356,716   $308,955   $1,013,406   $796,729 
Gross profit (loss):                    
Pekin Campus  $(19,390)  $(8,825)  $(8,487)  $14,584 
Marketing and distribution   3,532    9,409    9,411    18,862 
Other production   (2,729)   (3,297)   (3,269)   (3,587)
Corporate and other   1,234    
    3,069    
 
Intersegment eliminations   (2,486)   (686)   (6,946)   (4,188)
Gross profit (loss) as reported  $(19,839)  $(3,399)  $(6,222)  $25,671 
Income (loss) before provision for income taxes:                
Pekin Campus  $(22,664)  $(11,830)  $(6,252)  $8,907 
Marketing and distribution   1,622    7,517    3,444    12,929 
Other production   (4,958)   (4,856)   1,404    (12,467)
Corporate and other   (2,038)   6,037    (7,121)   567 
   $(28,038)  $(3,132)  $(8,525)  $9,936 
Depreciation and amortization of intangibles:                    
Pekin Campus  $4,758   $4,372   $14,381   $13,043 
Other production   1,273    1,468    4,095    4,433 
Corporate and other   229    11    646    44 
   $6,260   $5,851   $19,122   $17,520 
Interest expense, net of capitalized interest:                
Pekin Campus  $(48)  $176   $(81)  $767 
Marketing and distribution   487    295    1,060    721 
Other production   (74)   
    (128)   182 
Corporate and other   (25)   (42)   8    1,689 
   $340   $429   $859   $3,359 

 

The following table sets forth the Company’s total assets by operating segment (in thousands): 

 

   September 30,
2022
   December 31,
2021
 
Total assets:        
Pekin Campus  $247,449   $266,197 
Marketing and distribution   111,900    130,302 
Other production   63,904    57,046 
Corporate and other   31,415    31,408 
   $454,668   $484,953 
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories
9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
INVENTORIES

4. INVENTORIES.

 

Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of a valuation adjustment of $7,963,000 and $0 as of September 30, 2022 and December 31, 2021, respectively. Inventory balances consisted of the following (in thousands):

 

   September 30,
2022
   December 31,
2021
 
Finished goods  $40,630   $35,509 
Work in progress   8,084    6,909 
Raw materials   11,321    10,837 
Other   1,053    1,118 
Total  $61,088   $54,373 
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivatives
9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVES

5. DERIVATIVES.

 

The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results.

 

Commodity RiskCash Flow Hedges – The Company uses derivative instruments to protect cash flows from fluctuations caused by volatility in commodity prices for periods of up to twelve months in order to protect gross profit margins from potentially adverse effects of market and price volatility on alcohol sales and purchase commitments where the prices are set at a future date and/or if the contracts specify a floating or index-based price. In addition, the Company hedges anticipated sales of alcohol to minimize its exposure to the potentially adverse effects of price volatility. These derivatives may be designated and documented as cash flow hedges and effectiveness is evaluated by assessing the probability of the anticipated transactions and regressing commodity futures prices against the Company’s purchase and sales prices. Ineffectiveness, which is defined as the degree to which the derivative does not offset the underlying exposure, is recognized immediately in cost of goods sold. For the three and nine months ended September 30, 2022 and 2021, the Company did not designate any of its derivatives as cash flow hedges.

 

Commodity Risk – Non-Designated Hedges – The Company uses derivative instruments to lock in prices for certain amounts of corn and alcohols by entering into exchange-traded forward contracts or options for those commodities. These derivatives are not designated for hedge accounting treatment. The changes in fair value of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. The Company recognized net losses of $1,772,000 and $976,000 as the change in the fair value of these contracts for the three months ended September 30, 2022 and 2021, respectively. The Company recognized net gains of $20,164,000 and $18,435,000 as the change in the fair value of these contracts for the nine months ended September 30, 2022 and 2021, respectively.

 

Non Designated Derivative Instruments – The classification and amounts of the Company’s derivatives not designated as hedging instruments, and related cash collateral balances, are as follows (in thousands):

 

   As of September 30, 2022 
   Assets   Liabilities 
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
Cash collateral balance  Restricted cash  $3,955  
 
   
 
 
Commodity contracts  Derivative assets  $7,384   Derivative liabilities  $1,106 

   As of December 31, 2021 
   Assets   Liabilities 
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
Cash collateral balance  Restricted cash  $11,513  
 
   
 
 
Commodity contracts  Derivative assets  $15,839   Derivative liabilities  $13,582 

 

The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but its intent is to close out positions individually, therefore, they are reported at gross.

 

The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands):

 

      Realized Losses 
      For the Three Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
Commodity contracts  Cost of goods sold  $(13,332)  $(2,894)
      $(13,332)  $(2,894)

 

      Realized Gains 
Type of Instrument  Statements of Operations Location  For the Nine Months Ended September 30, 
      2022   2021 
Commodity contracts  Cost of goods sold  $16,143   $21,449 
      $16,143   $21,449 

 

      Unrealized Gains 
      For the Three Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
            
Commodity contracts  Cost of goods sold  $11,560   $1,918 
      $11,560   $1,918 

 

      Unrealized Gains (Losses) 
      For the Nine Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
            
Commodity contracts  Cost of goods sold  $4,021   $(3,014)
      $4,021   $(3,014)
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt
9 Months Ended
Sep. 30, 2022
Debt [Abstract]  
DEBT
6.DEBT.

 

Long-term borrowings are summarized as follows (in thousands):

 

   September 30,
2022
   December 31,
2021
 
Kinergy line of credit  $45,949   $50,401 
Less unamortized debt financing costs   (61)   (40)
Less short-term portion   
    
 
Long-term debt  $45,888   $50,361 

 

As of September 30, 2022, Kinergy had $30.7 million in unused borrowing availability under its line of credit. The Company believes it was in compliance with its covenants under the line of credit as of September 30, 2022.

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

7. COMMITMENTS AND CONTINGENCIES.

 

Sales Commitments – At September 30, 2022, the Company had entered into sales contracts with its major customers to sell certain quantities of alcohol and essential ingredients. The Company had open alcohol indexed-price contracts for 92,771,000 gallons as of September 30, 2022 and open fixed-price alcohol sales contracts totaling $101,427,000 as of September 30, 2022. The Company had open fixed-price sales contracts for essential ingredients totaling $17,274,000 as of September 30, 2022. These sales contracts are scheduled to be completed throughout 2022 and 2023.

 

Purchase Commitments – At September 30, 2022, the Company had indexed-price purchase contracts to purchase 13,988,000 gallons of alcohol and fixed-price purchase contracts to purchase $45,599,000 of alcohol from its suppliers. The Company had fixed-price purchase contracts to purchase $38,769,000 of corn from its suppliers as of September 30, 2022. The Company had fixed-price purchase contracts for natural gas totaling $1,947,000 and indexed-price purchase contracts for natural gas totaling 4,463,000 MMBTU. The Company also had future commitments for certain capital projects totaling $46,796,000. These purchase commitments are scheduled to be satisfied throughout 2022 and 2023.

 

Litigation – General The Company is subject to various claims and contingencies in the ordinary course of its business, including those related to litigation, business transactions, employee-related matters, environmental regulations, and others. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible and the amount involved could be material. While there can be no assurances, the Company does not expect that any of its pending legal proceedings will have a material impact on the Company’s financial condition or results of operations.

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Pension and Retirement Benefit Plans
9 Months Ended
Sep. 30, 2022
Retirement Benefits [Abstract]  
PENSION AND RETIREMENT BENEFIT PLANS

8. PENSION AND RETIREMENT BENEFIT PLANS.

 

The Company sponsors a defined benefit pension plan (the “Retirement Plan”) and a healthcare and life insurance plan (the “Postretirement Plan”).

 

The Retirement Plan is noncontributory, and covers only “grandfathered” unionized employees at the Company’s Pekin, Illinois facility who fulfill minimum age and service requirements. Benefits are based on a prescribed formula based upon the employee’s years of service. The Retirement Plan, which is part of a collective bargaining agreement, covers only union employees hired prior to November 1, 2010.

 

The Company uses a December 31 measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. As of December 31, 2021, the Retirement Plan’s accumulated projected benefit obligation was $23.8 million, with a fair value of plan assets of $20.0 million. The underfunded amount of $3.8 million is recorded on the Company’s consolidated balance sheet in other liabilities.

 

For the three months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $8,000, comprised of $273,000 of expected return on plan assets, partially offset by $164,000 in interest cost and $101,000 in service cost. For the three months ended September 30, 2021, the Retirement Plan’s net periodic expense was $22,000, comprised of $151,000 in interest cost and $109,000 in service cost, partially offset by $238,000 of expected return on plan assets. For the nine months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $24,000, comprised of $819,000 of expected return on plan assets, partially offset by $492,000 in interest cost and $303,000 in service cost. For the nine months ended September 30, 2021, the Retirement Plan’s net periodic expense was $66,000, comprised of $453,000 in interest cost and $327,000 in service cost, partially offset by $714,000 of expected return on plan assets.

 

The Postretirement Plan provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees. Employees hired after December 31, 2000 are not eligible to participate in the Postretirement Plan. The Postretirement Plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan declines at age 65 from a defined benefit to a defined dollar cap based upon years of service. As of December 31, 2021, the Postretirement Plan’s accumulated projected benefit obligation was $4.3 million and is recorded on the Company’s consolidated balance sheet in other liabilities. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations.

 

For the three months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $32,000, comprised of $6,000 of interest cost and $26,000 of service cost. For the three months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $42,000, comprised of $10,000 of interest cost, $26,000 of service cost and $6,000 of amortization expense.

 

For the nine months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $96,000, comprised of $18,000 of interest cost and $78,000 of service cost. For the nine months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $126,000, comprised of $30,000 of interest cost, $78,000 of service cost and $18,000 of amortization expense.

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

9. FAIR VALUE MEASUREMENTS.

 

The fair value hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows:

 

Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities;

 

Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and

 

Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period.

 

Pooled separate accounts – Pooled separate accounts invest primarily in domestic and international stocks, commercial paper or single mutual funds. The net asset value is used as a practical expedient to determine fair value for these accounts. Each pooled separate account provides for redemptions by the Retirement Plan at reported net asset values per share, with little to no advance notice requirement, therefore these funds are classified within Level 2 of the valuation hierarchy.

 

Long-Lived Assets Held-for-Sale – The Company recorded its long-lived assets associated with its property and equipment held-for-sale at fair value at December 31, 2021 of $1,000,000. These assets were sold during the three months ended September 30, 2022. The fair values of these assets are based on observable values for the assets through corroboration with market data and are designated as Level 3 inputs.

 

Other Derivative Instruments – The Company’s other derivative instruments consist of commodity positions. The fair values of the commodity positions are based on quoted prices on the commodity exchanges and are designated as Level 1 inputs.

  

The following table summarizes recurring and nonrecurring fair value measurements by level at September 30, 2022 (in thousands):

 

   Fair             
   Value   Level 1   Level 2   Level 3 
Assets:                
Derivative financial instruments  $7,384   $7,384   $
     —
   $
     —
 
Liabilities:                    
Derivative financial instruments  $(1,106)  $(1,106)  $
   $
 

 

The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2021 (in thousands):

 

                   Benefit Plan 
   Fair               Percentage 
   Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $15,839   $15,839   $
   $
      
Long-lived assets held-for-sale   1,000    
    
    1,000      
Defined benefit plan assets (1) (pooled separate accounts):                         
Large U.S. Equity(2)   5,612    
    5,612    
    28%
Small/Mid U.S. Equity(3)   3,684    
    3,684    
    18%
International Equity(4)   2,909    
    2,909    
    15%
Fixed Income(5)   7,782    
    7,782    
    39%
   $36,826   $15,839   $19,987   $1,000      
Liabilities:                         
Derivative financial instruments  $(13,582)  $(13,582)  $
   $
      

 

(1)Included in other assets in the consolidated balance sheets.

(2)This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(3)This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(4)This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(5)This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE

10. EARNINGS (LOSS) PER SHARE.

 

The following tables compute basic and diluted earnings (loss) per share (in thousands, except per share data):

 

   Three Months Ended September 30, 2022 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(28,038)          
Less: Preferred stock dividends   (319)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(28,357)   73,011   $(0.39)

 

   Three Months Ended September 30, 2021 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(3,132)          
Less: Preferred stock dividends   (319)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(3,451)   71,383   $(0.05)

 

   Nine Months Ended September 30, 2022 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(8,525)          
Less: Preferred stock dividends   (946)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(9,471)   71,815   $(0.13)

 

   Nine Months Ended September 30, 2021 
   Income
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net income  $9,936           
Less: Preferred stock dividends   (946)          
Less: Income allocated to participating securities   (120)          
Basic income per share:               
Income available to common stockholders  $8,870    71,002   $0.12 
Add: Dilutive instruments   
    1,258      
Diluted income per share:               
Income available to common stockholders  $8,870    72,260   $0.12 

 

There were an additional aggregate potentially dilutive weighted-average shares of 964,000 from convertible securities outstanding for the three and nine months ended September 30, 2022 and 2021. These securities were not considered in calculating diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021, as their effect would have been anti-dilutive. At December 31, 2021, the Company had outstanding unexercised warrants to purchase 8.9 million shares of its common stock at an exercise price of $9.76 per share. These warrants expired unexercised on April 28, 2022.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

11. SUBSEQUENT EVENTS.

 

New Term Loan Facility – On November 7, 2022, the Company closed on a senior secured term loan credit facility with certain funds managed by Orion Infrastructure Capital for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. The Company’s obligations under the term loan are secured by all of the Company’s tangible and intangible assets.

 

In connection with the term loan facility, the Company will issue to the lenders an aggregate of up to 1,602,564 shares of the Company’s common stock.

 

Kinergy Operating Line of Credit Extension – On November 7, 2022, the Company amended Kinergy’s operating line of credit to extend the maturity to 2027.

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Organization and Business

Organization and Business – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation (“Alto Op Co.”), Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.

 

On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022.

 

The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing.

 

The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties.

 

The Company focuses on four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. Products for the Health, Home & Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food & Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Essential Ingredients markets include dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Renewable Fuels includes fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.

 

As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility.

 

Basis of Presentation–Interim Financial Statements

Basis of PresentationInterim Financial Statements – The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Results for interim periods should not be considered indicative of results for a full year. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The accounting policies used in preparing these consolidated financial statements are the same as those described in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts – Trade accounts receivable are presented at face value, net of the allowance for doubtful accounts. The Company sells specialty alcohols to large consumer products companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and biodiesel customers generally without requiring collateral.

 

The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required.

 

Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.

 

Financial Instruments

Financial Instruments – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, derivative assets, accounts payable, accrued liabilities and derivative liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value because the interest rates on these instruments are variable.

 

Business Combinations

Business Combinations – Business acquisitions are accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations”. FASB ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).

 

Income from Cash Grant

Income from Cash Grant – The Company applied for and received $22,652,000 in cash from the USDA’s Biofuel Producer Program. The program was created as part of the CARES Act in 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The cash grant is not required to be repaid. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, Accounting for Government Grants and Disclosure of Government Assistance, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.

 

Share Repurchase Program

Share Repurchase Program – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50 million of its common stock with an initial purchase authorization of $10 million. Amounts in excess of the initial purchase authorization of $10 million will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the three and nine months ended September 30, 2022, the Company repurchased an aggregate of 259,000 shares for $1,002,000 in cash.

 

Estimates and Assumptions

Estimates and Assumptions – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for doubtful accounts, net realizable value of inventory, estimated lives of property and equipment, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisition of Eagle Alcohol (Tables)
9 Months Ended
Sep. 30, 2022
Acquisition of Eagle Alcohol [Abstract]  
Schedule of pro forma combined financial information assuming the acquisition occurred
  

Three Months Ended

September 30,

 
   2022   2021 
Revenues – pro forma  $336,877   $311,821 
Net loss available to common stockholders – pro forma  $(28,357)  $(3,424)
Diluted net loss per share – pro forma  $(0.38)  $(0.05)
Diluted shares   73,960    72,332 

 

   Nine Months Ended
September 30,
 
   2022   2021 
Revenues – pro forma  $1,007,711   $840,947 
Net income (loss) available to common stockholders – pro forma  $(9,538)  $8,474 
Diluted net income (loss) per share – pro forma  $(0.13)  $0.12 
Diluted shares   72,764    73,209 

  

Schedule of preliminary purchase price allocation
Cash and equivalents  $705 
Accounts receivable   5,517 
Inventories   1,388 
Other assets   29 
Total current assets   7,639 
      
Property and equipment   1,067 
Right of use assets   2,749 
Total tangible assets  $11,455 
      
Current liabilities  $6,262 
Right of use liability   2,749 
Total liabilities  $9,011 
      
Net tangible assets acquired  $2,444 
Customer relationships   6,556 
Tradename   420 
Goodwill   5,970 
Total Purchase Price  $15,390 

 

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segments (Tables)
9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Schedule of financial data for operating segments
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Net Sales                
Pekin Campus, recorded as gross:                    
Alcohol sales  $133,680   $114,587   $393,498   $341,967 
Essential ingredient sales   54,537    46,016    169,670    140,670 
Intersegment sales   332    293    857    919 
Total Pekin Campus sales   188,549    160,896    564,025    483,556 
Marketing and distribution:                    
Alcohol sales, gross  $55,262   $112,391   $172,746   $255,702 
Alcohol sales, net   308    505    975    1,489 
Intersegment sales   3,121    2,415    9,360    7,277 
Total marketing and distribution sales   58,691    115,311    183,081    264,468 
Other production, recorded as gross:                    
Alcohol sales  $64,492   $25,190   $191,483   $63,311 
Essential ingredient sales   24,439    6,867    66,748    19,261 
Intersegment sales   3    259    14    896 
Total Other production sales   88,934    32,316    258,245    83,468 
Corporate and other   4,159    
    12,064    
 
Intersegment eliminations   (3,456)   (2,967)   (10,231)   (9,092)
Net sales as reported  $336,877   $305,556   $1,007,184   $822,400 
Cost of goods sold:                
Pekin Campus  $207,939   $169,721   $572,512   $468,972 
Marketing and distribution   55,159    105,902    173,670    245,606 
Other production   91,663    35,613    261,514    87,055 
Corporate and other   2,925    
    8,995    
 
Intersegment eliminations   (970)   (2,281)   (3,285)   (4,904)
Cost of goods sold as reported  $356,716   $308,955   $1,013,406   $796,729 
Gross profit (loss):                    
Pekin Campus  $(19,390)  $(8,825)  $(8,487)  $14,584 
Marketing and distribution   3,532    9,409    9,411    18,862 
Other production   (2,729)   (3,297)   (3,269)   (3,587)
Corporate and other   1,234    
    3,069    
 
Intersegment eliminations   (2,486)   (686)   (6,946)   (4,188)
Gross profit (loss) as reported  $(19,839)  $(3,399)  $(6,222)  $25,671 
Income (loss) before provision for income taxes:                
Pekin Campus  $(22,664)  $(11,830)  $(6,252)  $8,907 
Marketing and distribution   1,622    7,517    3,444    12,929 
Other production   (4,958)   (4,856)   1,404    (12,467)
Corporate and other   (2,038)   6,037    (7,121)   567 
   $(28,038)  $(3,132)  $(8,525)  $9,936 
Depreciation and amortization of intangibles:                    
Pekin Campus  $4,758   $4,372   $14,381   $13,043 
Other production   1,273    1,468    4,095    4,433 
Corporate and other   229    11    646    44 
   $6,260   $5,851   $19,122   $17,520 
Interest expense, net of capitalized interest:                
Pekin Campus  $(48)  $176   $(81)  $767 
Marketing and distribution   487    295    1,060    721 
Other production   (74)   
    (128)   182 
Corporate and other   (25)   (42)   8    1,689 
   $340   $429   $859   $3,359 

 

Schedule of assets by operating segments
   September 30,
2022
   December 31,
2021
 
Total assets:        
Pekin Campus  $247,449   $266,197 
Marketing and distribution   111,900    130,302 
Other production   63,904    57,046 
Corporate and other   31,415    31,408 
   $454,668   $484,953 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories (Tables)
9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Schedule of inventories
   September 30,
2022
   December 31,
2021
 
Finished goods  $40,630   $35,509 
Work in progress   8,084    6,909 
Raw materials   11,321    10,837 
Other   1,053    1,118 
Total  $61,088   $54,373 
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivatives (Tables)
9 Months Ended
Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of derivatives not designated as hedging instruments
   As of September 30, 2022 
   Assets   Liabilities 
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
Cash collateral balance  Restricted cash  $3,955  
 
   
 
 
Commodity contracts  Derivative assets  $7,384   Derivative liabilities  $1,106 

   As of December 31, 2021 
   Assets   Liabilities 
Type of Instrument  Balance Sheet Location  Fair Value   Balance Sheet Location  Fair Value 
Cash collateral balance  Restricted cash  $11,513  
 
   
 
 
Commodity contracts  Derivative assets  $15,839   Derivative liabilities  $13,582 

 

Schedule of recognized gains for its derivatives
      Realized Losses 
      For the Three Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
Commodity contracts  Cost of goods sold  $(13,332)  $(2,894)
      $(13,332)  $(2,894)

 

      Realized Gains 
Type of Instrument  Statements of Operations Location  For the Nine Months Ended September 30, 
      2022   2021 
Commodity contracts  Cost of goods sold  $16,143   $21,449 
      $16,143   $21,449 

 

      Unrealized Gains 
      For the Three Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
            
Commodity contracts  Cost of goods sold  $11,560   $1,918 
      $11,560   $1,918 

 

      Unrealized Gains (Losses) 
      For the Nine Months
Ended September 30,
 
Type of Instrument  Statements of Operations Location  2022   2021 
            
Commodity contracts  Cost of goods sold  $4,021   $(3,014)
      $4,021   $(3,014)
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt (Tables)
9 Months Ended
Sep. 30, 2022
Debt [Abstract]  
Schedule of long-term borrowings
6.DEBT.

 

   September 30,
2022
   December 31,
2021
 
Kinergy line of credit  $45,949   $50,401 
Less unamortized debt financing costs   (61)   (40)
Less short-term portion   
    
 
Long-term debt  $45,888   $50,361 

 

XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of recurring and nonrecurring fair value measurements
   Fair             
   Value   Level 1   Level 2   Level 3 
Assets:                
Derivative financial instruments  $7,384   $7,384   $
     —
   $
     —
 
Liabilities:                    
Derivative financial instruments  $(1,106)  $(1,106)  $
   $
 

 

                   Benefit Plan 
   Fair               Percentage 
   Value   Level 1   Level 2   Level 3   Allocation 
Assets:                    
Derivative financial instruments  $15,839   $15,839   $
   $
      
Long-lived assets held-for-sale   1,000    
    
    1,000      
Defined benefit plan assets (1) (pooled separate accounts):                         
Large U.S. Equity(2)   5,612    
    5,612    
    28%
Small/Mid U.S. Equity(3)   3,684    
    3,684    
    18%
International Equity(4)   2,909    
    2,909    
    15%
Fixed Income(5)   7,782    
    7,782    
    39%
   $36,826   $15,839   $19,987   $1,000      
Liabilities:                         
Derivative financial instruments  $(13,582)  $(13,582)  $
   $
      

 

(1)Included in other assets in the consolidated balance sheets.

(2)This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(3)This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(4)This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

(5)This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.

XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of compute basic and diluted earnings per share
   Three Months Ended September 30, 2022 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(28,038)          
Less: Preferred stock dividends   (319)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(28,357)   73,011   $(0.39)

 

   Three Months Ended September 30, 2021 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(3,132)          
Less: Preferred stock dividends   (319)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(3,451)   71,383   $(0.05)

 

   Nine Months Ended September 30, 2022 
   Loss
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net loss  $(8,525)          
Less: Preferred stock dividends   (946)          
Basic and Diluted loss per share:               
Loss available to common stockholders  $(9,471)   71,815   $(0.13)

 

   Nine Months Ended September 30, 2021 
   Income
Numerator
   Shares
Denominator
   Per-Share
Amount
 
Net income  $9,936           
Less: Preferred stock dividends   (946)          
Less: Income allocated to participating securities   (120)          
Basic income per share:               
Income available to common stockholders  $8,870    71,002   $0.12 
Add: Dilutive instruments   
    1,258      
Diluted income per share:               
Income available to common stockholders  $8,870    72,260   $0.12 

 

XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization and Basis of Presentation (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 12, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Jan. 14, 2022
Organization and Basis of Presentation (Details) [Line Items]              
Production capacity per year       $ 350,000,000      
Annual payments of essential ingredients   $ 1,500,000   1,500,000      
Accounts receivable       54,972,000   $ 63,929,000  
Allowance for doubtful accounts   135,000   135,000   $ 378,000  
Bad Debt Expense   253,000 $ 3,000 187,000 $ 140,000    
Cash   22,652,000   22,652,000      
Loan       700,000,000      
Repurchase of common stock $ 50,000,000            
Excess amount of initial purchase 10,000,000            
Purchase additional amount $ 10,000,000            
Repurchased an aggregate shares in cash   $ 259,000   $ 1,002,000      
Ownership [Member]              
Organization and Basis of Presentation (Details) [Line Items]              
Equity interest owned             100.00%
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisition of Eagle Alcohol (Details) - USD ($)
3 Months Ended 9 Months Ended
Jan. 14, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Acquisition of Eagle Alcohol (Details) [Line Items]          
Purchased membership interests 100.00%        
Purchase price $ 14,000,000        
Net working capital 1,300,000        
Contingent consideration 14,000,000        
Combination cash 9,000,000        
Aggregate of common stock $ 5,000,000        
General and administrative expenses   $ 900,000   $ 2,600,000  
Net sales   4,200,000 $ 9,900,000 12,100,000 $ 27,500,000
Net income   0 1,000,000 $ 100,000 3,000,000
Estimated for useful life       12 years  
Amortization amount   $ 137,000 $ 10,000 $ 390,000 $ 30,000
Customer Relationships [Member]          
Acquisition of Eagle Alcohol (Details) [Line Items]          
Estimated for useful life       10 years  
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Schedule Of Pro Forma Combined Financial Information Assuming The Acquisition Occurred Abstract        
Revenues – pro forma $ 336,877 $ 311,821 $ 1,007,711 $ 840,947
Net income (loss) available to common stockholders – pro forma $ (28,357) $ (3,424) $ (9,538) $ 8,474
Diluted net income (loss) per share – pro forma (in Dollars per share) $ (0.38) $ (0.05) $ (0.13) $ 0.12
Diluted shares (in Shares) 73,960 72,332 72,764 73,209
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation - Acquisition of Eagle Alcohol [Member]
$ in Thousands
Sep. 30, 2022
USD ($)
Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation [Line Items]  
Cash and equivalents $ 705
Accounts receivable 5,517
Inventories 1,388
Other assets 29
Total current assets 7,639
Property and equipment 1,067
Right of use assets 2,749
Total tangible assets 11,455
Current liabilities 6,262
Right of use liability 2,749
Total liabilities 9,011
Net tangible assets acquired 2,444
Customer relationships 6,556
Tradename 420
Goodwill 5,970
Total Purchase Price $ 15,390
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segments (Details) - Schedule of financial data for operating segments - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Cost of goods sold:        
Cost of goods sold $ 356,716 $ 308,955 $ 1,013,406 $ 796,729
Gross profit (loss):        
Gross profit (19,839) (3,399) (6,222) 25,671
Pekin Campus Production [Member]        
Interest expense, net of capitalized interest:        
Interest expense, net of capitalized interest (48) 176 (81) 767
Marketing and Distribution [Member]        
Cost of goods sold:        
Cost of goods sold 55,159 105,902 173,670 245,606
Gross profit (loss):        
Gross profit 3,532 9,409 9,411 18,862
Income (loss) before provision for income taxes:        
Income before provision for income taxes 1,622 7,517 3,444 12,929
Interest expense, net of capitalized interest:        
Interest expense, net of capitalized interest 487 295 1,060 721
Other production [Member]        
Cost of goods sold:        
Cost of goods sold 91,663 35,613 261,514 87,055
Gross profit (loss):        
Gross profit (2,729) (3,297) (3,269) (3,587)
Income (loss) before provision for income taxes:        
Income before provision for income taxes (4,958) (4,856) 1,404 (12,467)
Depreciation and amortization of intangibles:        
Depreciation and amortization of intangibles 1,273 1,468 4,095 4,433
Interest expense, net of capitalized interest:        
Interest expense, net of capitalized interest (74) (128) 182
Corporate and other [Member]        
Pekin Campus, recorded as gross:        
Net sales 4,159 12,064
Gross profit (loss):        
Gross profit 1,234 3,069
Income (loss) before provision for income taxes:        
Income before provision for income taxes (2,038) 6,037 (7,121) 567
Depreciation and amortization of intangibles:        
Depreciation and amortization of intangibles 229 11 646 44
Interest expense, net of capitalized interest:        
Interest expense, net of capitalized interest (25) (42) 8 1,689
Intersegment Eliminations [Member]        
Pekin Campus, recorded as gross:        
Net sales (3,456) (2,967) (10,231) (9,092)
Cost of goods sold:        
Cost of goods sold (970) (2,281) (3,285) (4,904)
Gross profit (loss):        
Gross profit (2,486) (686) (6,946) (4,188)
Pekin Campus Production [Member]        
Cost of goods sold:        
Cost of goods sold 207,939 169,721 572,512 468,972
Gross profit (loss):        
Gross profit (19,390) (8,825) (8,487) 14,584
Income (loss) before provision for income taxes:        
Income before provision for income taxes (22,664) (11,830) (6,252) 8,907
Depreciation and amortization of intangibles:        
Depreciation and amortization of intangibles 4,758 4,372 14,381 13,043
Corporate and other [Member]        
Cost of goods sold:        
Cost of goods sold 2,925 8,995
Income (loss) before provision for income taxes [Member]        
Income (loss) before provision for income taxes:        
Income before provision for income taxes (28,038) (3,132) (8,525) 9,936
Depreciation and amortization of intangibles [Member]        
Depreciation and amortization of intangibles:        
Depreciation and amortization of intangibles 6,260 5,851 19,122 17,520
Total [Member]        
Interest expense, net of capitalized interest:        
Interest expense, net of capitalized interest 340 429 859 3,359
Alcohol sales [Member] | Pekin Campus Production [Member]        
Pekin Campus, recorded as gross:        
Net sales 133,680 114,587 393,498 341,967
Alcohol sales [Member] | Other production [Member]        
Pekin Campus, recorded as gross:        
Net sales 64,492 25,190 191,483 63,311
Essential Ingredient Sales [Member] | Pekin Campus Production [Member]        
Pekin Campus, recorded as gross:        
Net sales 54,537 46,016 169,670 140,670
Essential Ingredient Sales [Member] | Other production [Member]        
Pekin Campus, recorded as gross:        
Net sales 24,439 6,867 66,748 19,261
Intersegment Sales [Member] | Pekin Campus Production [Member]        
Pekin Campus, recorded as gross:        
Net sales 332 293 857 919
Intersegment Sales [Member] | Marketing and Distribution [Member]        
Pekin Campus, recorded as gross:        
Net sales 3,121 2,415 9,360 7,277
Intersegment Sales [Member] | Other production [Member]        
Pekin Campus, recorded as gross:        
Net sales 3 259 14 896
Total Pekin Campus Sales [Member] | Pekin Campus Production [Member]        
Pekin Campus, recorded as gross:        
Net sales 188,549 160,896 564,025 483,556
Alcohol sales, gross [Member] | Marketing and Distribution [Member]        
Pekin Campus, recorded as gross:        
Net sales 55,262 112,391 172,746 255,702
Alcohol sales, net [Member] | Marketing and Distribution [Member]        
Pekin Campus, recorded as gross:        
Net sales 308 505 975 1,489
Total Marketing and Distribution Sales [Member] | Marketing and Distribution [Member]        
Pekin Campus, recorded as gross:        
Net sales 58,691 115,311 183,081 264,468
Total Other production Sales [Member] | Other production [Member]        
Pekin Campus, recorded as gross:        
Net sales 88,934 32,316 258,245 83,468
Net sales as reported [Member]        
Pekin Campus, recorded as gross:        
Net sales $ 336,877 $ 305,556 $ 1,007,184 $ 822,400
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segments (Details) - Schedule of assets by operating segments - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Total assets:    
Total assets $ 454,668 $ 484,953 [1]
Pekin Campus [Member]    
Total assets:    
Total assets 247,449 266,197
Marketing and distribution [Member]    
Total assets:    
Total assets 111,900 130,302
Other production [Member]    
Total assets:    
Total assets 63,904 57,046
Corporate and other [Member]    
Total assets:    
Total assets $ 31,415 $ 31,408
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021.
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Inventory net $ 7,963,000 $ 0
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventories (Details) - Schedule of inventories - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Schedule Of Inventories Abstract    
Finished goods $ 40,630 $ 35,509
Work in progress 8,084 6,909
Raw materials 11,321 10,837
Other 1,053 1,118
Total $ 61,088 $ 54,373
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivatives (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]        
Recognized net gains $ 1,772,000 $ 976,000 $ 20,164,000 $ 18,435,000
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivatives (Details) - Schedule of derivatives not designated as hedging instruments - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Schedule Of Derivatives Not Designated As Hedging Instruments Abstract    
Type of Instrument Cash collateral balance Cash collateral balance Cash collateral balance
Assets, Balance Sheet Location Cash collateral balance Restricted cash Restricted cash
Assets, Fair Value Cash collateral balance $ 3,955 $ 11,513
Liabilities, Balance Sheet Location Cash collateral balance
Liabilities, Fair Value Cash collateral balance
Type of Instrument Commodity contracts Commodity contracts Commodity contracts
Assets, Balance Sheet Location Commodity contracts Derivative assets Derivative assets
Assets, Fair Value Commodity contracts $ 7,384 $ 15,839
Liabilities, Balance Sheet Location Commodity contracts Derivative liabilities Derivative liabilities
Liabilities, Fair Value Commodity contracts $ 1,106 $ 13,582
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Derivatives (Details) - Schedule of recognized gains for its derivatives - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Realized Losses [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Type of Instrument Commodity contracts      
Statements of Operations Location Cost of goods sold      
Realized Gains $ (13,332) $ (2,894)    
Total Realized Gains $ (13,332) (2,894)    
Realized Gains [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Type of Instrument     Commodity contracts  
Statements of Operations Location     Cost of goods sold  
Realized Gains     $ 16,143 $ 21,449
Total Realized Gains     $ 16,143 21,449
Unrealized Gains [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Type of Instrument Commodity contracts      
Statements of Operations Location Cost of goods sold      
Unrealized Gains (Losses) $ 11,560 1,918    
Total Unrealized Gains (Losses) $ 11,560 $ 1,918    
Unrealized Gains (Losses) [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Type of Instrument     Commodity contracts  
Statements of Operations Location     Cost of goods sold  
Unrealized Gains (Losses)     $ 4,021 (3,014)
Total Unrealized Gains (Losses)     $ 4,021 $ (3,014)
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt (Details)
$ in Millions
Sep. 30, 2022
USD ($)
Debt [Abstract]  
Unused borrowing $ 30.7
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt (Details) - Schedule of long-term borrowings - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Schedule Of Long Term Borrowings Abstract    
Kinergy line of credit $ 45,949 $ 50,401
Less unamortized debt financing costs (61) (40)
Less short-term portion
Long-term debt $ 45,888 $ 50,361
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Details)
9 Months Ended
Sep. 30, 2022
USD ($)
Commitments and Contingencies (Details) [Line Items]  
Indexed price purchase contracts gallons 92,771,000
Open fixed-price sales contracts valued $ 17,274,000
Future commitments for capital projects $ 46,796,000
Alcohol from Suppliers [Member] | Purchase Commitments [Member]  
Commitments and Contingencies (Details) [Line Items]  
Indexed price purchase contracts gallons 13,988,000
Fixed-price purchase contracts value $ 45,599,000
Corn from Suppliers [Member] | Purchase Commitments [Member]  
Commitments and Contingencies (Details) [Line Items]  
Fixed-price purchase contracts value $ 38,769,000
Natural Gas [Member] | Purchase Commitments [Member]  
Commitments and Contingencies (Details) [Line Items]  
Indexed price purchase contracts gallons 4,463,000
Fixed-price purchase contracts value $ 1,947,000
Alcohol Sales Contracts [Member]  
Commitments and Contingencies (Details) [Line Items]  
Open fixed-price sales contracts valued $ 101,427,000
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Pension and Retirement Benefit Plans (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Retirement Plan [Member]          
Pension and Retirement Benefit Plans (Details) [Line Items]          
Projected benefit obligation, amount         $ 23,800,000
Fair value of plan assets         20,000,000
Underfunded amount         3,800,000
Retirement plan’s net periodic benefit $ 8,000        
Expected return on plan assets 273,000 $ 238,000 $ 819,000 $ 714,000  
Interest cost 164,000 151,000 492,000 453,000  
Service cost 101,000 109,000 303,000 327,000  
Net periodic expense (income)   (22,000) 24,000 66,000  
Postretirement Plan [Member]          
Pension and Retirement Benefit Plans (Details) [Line Items]          
Projected benefit obligation, amount         $ 4,300,000
Interest cost 26,000 10,000 78,000 30,000  
Service cost 6,000 26,000 18,000 78,000  
Net periodic expense (income) $ 32,000 42,000 $ 96,000 126,000  
Amortization expense   $ 6,000   $ 18,000  
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Details)
Dec. 31, 2021
USD ($)
Fair Value Disclosures [Abstract]  
Property and equipment held-for-sale $ 1,000,000
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Assets:    
Assets   $ 36,826
Derivative Financial Instruments, Assets [Member]    
Assets:    
Assets $ 7,384 15,839
Derivative Financial Instruments, Liabilities [Member]    
Liabilities:    
Liabilities (1,106) (13,582)
Long-lived assets held-for-sale [Member]    
Assets:    
Assets   1,000
Large U.S. Equity [Member]    
Assets:    
Assets [1],[2]   $ 5,612
Benefit Plan Percentage Allocation [1],[2]   28.00%
Small/Mid U.S. Equity [Member]    
Assets:    
Assets [1],[3]   $ 3,684
Benefit Plan Percentage Allocation [1],[3]   18.00%
International Equity [Member]    
Assets:    
Assets [1],[4]   $ 2,909
Benefit Plan Percentage Allocation [1],[4]   15.00%
Fixed Income [Member]    
Assets:    
Assets [1],[5]   $ 7,782
Benefit Plan Percentage Allocation [1],[5]   39.00%
Level 1 [Member]    
Assets:    
Assets   $ 15,839
Level 1 [Member] | Derivative Financial Instruments, Assets [Member]    
Assets:    
Assets 7,384 15,839
Level 1 [Member] | Derivative Financial Instruments, Liabilities [Member]    
Liabilities:    
Liabilities (1,106) (13,582)
Level 1 [Member] | Long-lived assets held-for-sale [Member]    
Assets:    
Assets  
Level 1 [Member] | Large U.S. Equity [Member]    
Assets:    
Assets [1],[2]  
Level 1 [Member] | Small/Mid U.S. Equity [Member]    
Assets:    
Assets [1],[3]  
Level 1 [Member] | International Equity [Member]    
Assets:    
Assets [1],[4]  
Level 1 [Member] | Fixed Income [Member]    
Assets:    
Assets [1],[5]  
Level 2 [Member]    
Assets:    
Assets   19,987
Level 2 [Member] | Derivative Financial Instruments, Assets [Member]    
Assets:    
Assets
Level 2 [Member] | Derivative Financial Instruments, Liabilities [Member]    
Liabilities:    
Liabilities
Level 2 [Member] | Long-lived assets held-for-sale [Member]    
Assets:    
Assets  
Level 2 [Member] | Large U.S. Equity [Member]    
Assets:    
Assets [1],[2]   5,612
Level 2 [Member] | Small/Mid U.S. Equity [Member]    
Assets:    
Assets [1],[3]   3,684
Level 2 [Member] | International Equity [Member]    
Assets:    
Assets [1],[4]   2,909
Level 2 [Member] | Fixed Income [Member]    
Assets:    
Assets [1],[5]   7,782
Level 3 [Member]    
Assets:    
Assets   1,000
Level 3 [Member] | Derivative Financial Instruments, Assets [Member]    
Assets:    
Assets
Level 3 [Member] | Derivative Financial Instruments, Liabilities [Member]    
Liabilities:    
Liabilities
Level 3 [Member] | Long-lived assets held-for-sale [Member]    
Assets:    
Assets   1,000
Level 3 [Member] | Large U.S. Equity [Member]    
Assets:    
Assets [1],[2]  
Level 3 [Member] | Small/Mid U.S. Equity [Member]    
Assets:    
Assets [1],[3]  
Level 3 [Member] | International Equity [Member]    
Assets:    
Assets [1],[4]  
Level 3 [Member] | Fixed Income [Member]    
Assets:    
Assets [1],[5]  
[1] Included in other assets in the consolidated balance sheets.
[2] This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
[3] This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
[4] This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
[5] This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Details) - $ / shares
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Earnings Per Share [Abstract]          
Potentially dilutive shares from convertible securities outstanding   964,000 964,000 964,000 964,000
Outstanding unexercised warrants to purchase 8,900,000        
Common stock exercise price per share (in Dollars per share) $ 9.76        
Warrants expired Apr. 28, 2022        
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Schedule Of Compute Basic And Diluted Earnings Per Share Abstract        
Net income (loss) $ (28,038) $ (3,132) $ (8,525) $ 9,936
Less: Preferred stock dividends (319) (319) (946) (946)
Less: Income allocated to participating securities       (120)
Basic and Diluted loss per share:        
Income (loss) available to common stockholders $ (28,357) $ (3,451) $ (9,471) $ 8,870
Income (loss) available to common stockholders (in Shares) 73,011 71,383 71,815 71,002
Income (loss) available to common stockholders (in Dollars per share) $ (0.39) $ (0.05) $ (0.13) $ 0.12
Add: Dilutive instruments      
Add: Dilutive instruments (in Shares)       1,258
Diluted income per share:        
Diluted Income available to common stockholders       $ 8,870
Diluted Income available to common stockholders (in Shares)       72,260
Diluted Income available to common stockholders (in Dollars per share)       $ 0.12
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details) - Subsequent Event [Member]
Nov. 07, 2022
shares
Subsequent Events (Details) [Line Items]  
Description of subsequent events On November 7, 2022, the Company closed on a senior secured term loan credit facility with certain funds managed by Orion Infrastructure Capital for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. The Company’s obligations under the term loan are secured by all of the Company’s tangible and intangible assets.
Aggregate shares of common stock 1,602,564
XML 55 f10q0922_altoingred_htm.xml IDEA: XBRL DOCUMENT 0000778164 2022-01-01 2022-09-30 0000778164 2022-11-04 0000778164 2022-09-30 0000778164 2021-12-31 0000778164 us-gaap:SeriesAPreferredStockMember 2022-09-30 0000778164 us-gaap:SeriesAPreferredStockMember 2021-12-31 0000778164 us-gaap:SeriesBPreferredStockMember 2022-09-30 0000778164 us-gaap:SeriesBPreferredStockMember 2021-12-31 0000778164 us-gaap:NonvotingCommonStockMember 2022-09-30 0000778164 us-gaap:NonvotingCommonStockMember 2021-12-31 0000778164 2022-07-01 2022-09-30 0000778164 2021-07-01 2021-09-30 0000778164 2021-01-01 2021-09-30 0000778164 2020-12-31 0000778164 2021-09-30 0000778164 us-gaap:PreferredStockMember 2021-12-31 0000778164 us-gaap:CommonStockMember 2021-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000778164 us-gaap:RetainedEarningsMember 2021-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000778164 us-gaap:NoncontrollingInterestMember 2021-12-31 0000778164 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0000778164 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000778164 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0000778164 2022-01-01 2022-03-31 0000778164 us-gaap:PreferredStockMember 2022-03-31 0000778164 us-gaap:CommonStockMember 2022-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000778164 us-gaap:RetainedEarningsMember 2022-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2022-03-31 0000778164 2022-03-31 0000778164 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0000778164 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000778164 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0000778164 2022-04-01 2022-06-30 0000778164 us-gaap:PreferredStockMember 2022-06-30 0000778164 us-gaap:CommonStockMember 2022-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000778164 us-gaap:RetainedEarningsMember 2022-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-06-30 0000778164 2022-06-30 0000778164 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0000778164 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000778164 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0000778164 us-gaap:PreferredStockMember 2022-09-30 0000778164 us-gaap:CommonStockMember 2022-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000778164 us-gaap:RetainedEarningsMember 2022-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2022-09-30 0000778164 us-gaap:PreferredStockMember 2020-12-31 0000778164 us-gaap:CommonStockMember 2020-12-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000778164 us-gaap:RetainedEarningsMember 2020-12-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000778164 us-gaap:NoncontrollingInterestMember 2020-12-31 0000778164 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000778164 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000778164 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0000778164 2021-01-01 2021-03-31 0000778164 us-gaap:PreferredStockMember 2021-03-31 0000778164 us-gaap:CommonStockMember 2021-03-31 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000778164 us-gaap:RetainedEarningsMember 2021-03-31 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000778164 us-gaap:NoncontrollingInterestMember 2021-03-31 0000778164 2021-03-31 0000778164 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0000778164 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0000778164 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0000778164 2021-04-01 2021-06-30 0000778164 us-gaap:PreferredStockMember 2021-06-30 0000778164 us-gaap:CommonStockMember 2021-06-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000778164 us-gaap:RetainedEarningsMember 2021-06-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-06-30 0000778164 2021-06-30 0000778164 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0000778164 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0000778164 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-07-01 2021-09-30 0000778164 us-gaap:PreferredStockMember 2021-09-30 0000778164 us-gaap:CommonStockMember 2021-09-30 0000778164 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000778164 us-gaap:RetainedEarningsMember 2021-09-30 0000778164 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0000778164 us-gaap:NoncontrollingInterestMember 2021-09-30 0000778164 alto:OwnershipMember 2022-01-14 0000778164 2021-01-01 2021-12-31 0000778164 2022-09-02 2022-09-12 0000778164 2022-01-01 2022-01-14 0000778164 2022-01-14 0000778164 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-09-30 0000778164 alto:AcquisitionOfEagleAlcoholMember 2022-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:EthanolAlcoholSalesMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:EssentialIngredientSalesMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:IntersegmentSaleMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember alto:TotalPekinCampusSalesMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesGrossMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:AlcoholSalesNetMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:IntersegmentSaleMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember alto:TotalMarketingAndDistributionSalesMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EthanolAlcoholSalesMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:EssentialIngredientSalesMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:IntersegmentSaleMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember alto:TotalOtherProductionSalesMember 2021-01-01 2021-09-30 0000778164 us-gaap:CorporateAndOtherMember 2022-07-01 2022-09-30 0000778164 us-gaap:CorporateAndOtherMember 2021-07-01 2021-09-30 0000778164 us-gaap:CorporateAndOtherMember 2022-01-01 2022-09-30 0000778164 us-gaap:CorporateAndOtherMember 2021-01-01 2021-09-30 0000778164 alto:IntersegmentEliminationsMember 2022-07-01 2022-09-30 0000778164 alto:IntersegmentEliminationsMember 2021-07-01 2021-09-30 0000778164 alto:IntersegmentEliminationsMember 2022-01-01 2022-09-30 0000778164 alto:IntersegmentEliminationsMember 2021-01-01 2021-09-30 0000778164 alto:NetSalesMember 2022-07-01 2022-09-30 0000778164 alto:NetSalesMember 2021-07-01 2021-09-30 0000778164 alto:NetSalesMember 2022-01-01 2022-09-30 0000778164 alto:NetSalesMember 2021-01-01 2021-09-30 0000778164 alto:PekinCampusMember 2022-07-01 2022-09-30 0000778164 alto:PekinCampusMember 2021-07-01 2021-09-30 0000778164 alto:PekinCampusMember 2022-01-01 2022-09-30 0000778164 alto:PekinCampusMember 2021-01-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember 2022-07-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember 2021-07-01 2021-09-30 0000778164 alto:MarketingAndDistributionsMember 2022-01-01 2022-09-30 0000778164 alto:MarketingAndDistributionsMember 2021-01-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2022-07-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2021-07-01 2021-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2022-01-01 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2021-01-01 2021-09-30 0000778164 alto:CorporateActivitiesMember 2022-07-01 2022-09-30 0000778164 alto:CorporateActivitiesMember 2021-07-01 2021-09-30 0000778164 alto:CorporateActivitiesMember 2022-01-01 2022-09-30 0000778164 alto:CorporateActivitiesMember 2021-01-01 2021-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2022-07-01 2022-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2021-07-01 2021-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2022-01-01 2022-09-30 0000778164 alto:IncomelossBeforeProvisionForIncomeTaxesMember 2021-01-01 2021-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2022-07-01 2022-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2021-07-01 2021-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2022-01-01 2022-09-30 0000778164 alto:DepreciationAndAmortizationOfIntangiblesMember 2021-01-01 2021-09-30 0000778164 alto:ProductionMember 2022-07-01 2022-09-30 0000778164 alto:ProductionMember 2021-07-01 2021-09-30 0000778164 alto:ProductionMember 2022-01-01 2022-09-30 0000778164 alto:ProductionMember 2021-01-01 2021-09-30 0000778164 us-gaap:AssetsTotalMember 2022-07-01 2022-09-30 0000778164 us-gaap:AssetsTotalMember 2021-07-01 2021-09-30 0000778164 us-gaap:AssetsTotalMember 2022-01-01 2022-09-30 0000778164 us-gaap:AssetsTotalMember 2021-01-01 2021-09-30 0000778164 alto:PekinCampusMember 2022-09-30 0000778164 alto:PekinCampusMember 2021-12-31 0000778164 alto:MarketingAndDistributionsMember 2022-09-30 0000778164 alto:MarketingAndDistributionsMember 2021-12-31 0000778164 alto:OtherProductionIncomeTaxMember 2022-09-30 0000778164 alto:OtherProductionIncomeTaxMember 2021-12-31 0000778164 us-gaap:CorporateAndOtherMember 2022-09-30 0000778164 us-gaap:CorporateAndOtherMember 2021-12-31 0000778164 alto:RealizedLossesMember 2022-07-01 2022-09-30 0000778164 alto:RealizedLossesMember 2021-07-01 2021-09-30 0000778164 alto:RealizedGainsMember 2022-01-01 2022-09-30 0000778164 alto:RealizedGainsMember 2021-01-01 2021-09-30 0000778164 alto:UnrealizedGainsMember 2022-07-01 2022-09-30 0000778164 alto:UnrealizedGainsMember 2021-07-01 2021-09-30 0000778164 alto:UnrealizedGainsLossesMember 2022-01-01 2022-09-30 0000778164 alto:UnrealizedGainsLossesMember 2021-01-01 2021-09-30 0000778164 alto:AlcoholSalesContractsMember 2022-09-30 0000778164 alto:AlcoholFromItsSuppliersMember alto:EthanolPurchaseContractsMember 2022-01-01 2022-09-30 0000778164 alto:AlcoholFromItsSuppliersMember alto:EthanolPurchaseContractsMember 2022-09-30 0000778164 alto:CornFromSuppliersMember alto:EthanolPurchaseContractsMember 2022-09-30 0000778164 us-gaap:NaturalGasProductionMember alto:EthanolPurchaseContractsMember 2022-09-30 0000778164 us-gaap:NaturalGasProductionMember alto:EthanolPurchaseContractsMember 2022-01-01 2022-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2021-12-31 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2022-07-01 2022-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0000778164 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2021-12-31 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2022-07-01 2022-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2021-07-01 2021-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2022-01-01 2022-09-30 0000778164 us-gaap:DefinedBenefitPostretirementLifeInsuranceMember 2021-01-01 2021-09-30 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2022-09-30 0000778164 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2022-09-30 0000778164 us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsAssetsMember 2021-12-31 0000778164 alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:LonglivedAssetsHeldforsaleMember 2021-12-31 0000778164 alto:LargeUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:LargeUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:LargeUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:LargeUSEquityMember 2021-12-31 0000778164 alto:SmallMidUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:SmallMidUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:SmallMidUSEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:SmallMidUSEquityMember 2021-12-31 0000778164 alto:InternationalEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:InternationalEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:InternationalEquityMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:InternationalEquityMember 2021-12-31 0000778164 alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member alto:FixedIncomeMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member 2021-12-31 0000778164 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2021-12-31 0000778164 2021-12-01 2021-12-31 0000778164 us-gaap:SubsequentEventMember 2022-11-02 2022-11-07 0000778164 us-gaap:SubsequentEventMember 2022-11-07 shares iso4217:USD iso4217:USD shares pure 10-Q true 2022-09-30 2022 false 000-21467 ALTO INGREDIENTS, INC. DE 41-2170618 1300 South Second Street Pekin IL 61554 (916) 403-2123 Common Stock, $0.001 par value ALTO NASDAQ Yes Yes Accelerated Filer false false false 73956108 28458000 50612000 3955000 11513000 135000 378000 76455000 86888000 61088000 54373000 7384000 15839000 3125000 8966000 7176000 186306000 229526000 233475000 222550000 12895000 13413000 11641000 9234000 2678000 5970000 6788000 5145000 34887000 32877000 454668000 484953000 17493000 23251000 22172000 21307000 3646000 3909000 1106000 13582000 10096000 7553000 54513000 69602000 45888000 50361000 9201000 9382000 10068000 10394000 119670000 139739000 0.001 0.001 10000000 10000000 1684000 1684000 1581000 1581000 927000 927000 927000 927000 18075000 1000 1000 0.001 0.001 300000000 300000000 73956000 73956000 72778000 72778000 74000 73000 0.001 0.001 3553000 3553000 1000 1000 1000 1000 1036459000 1037205000 -284000 -284000 -701252000 -691781000 334998000 345214000 454668000 484953000 336877000 305556000 1007184000 822400000 356716000 308955000 1013406000 796729000 -19839000 -3399000 -6222000 25671000 7403000 5533000 24028000 19777000 3100000 -27242000 -8932000 -30250000 2794000 -340000 -429000 -859000 -3359000 22652000 -5973000 -9860000 -456000 256000 -68000 641000 -28038000 -3132000 -8525000 9936000 -28038000 -3132000 -8525000 9936000 319000 319000 946000 946000 120000 -28357000 -3451000 -9471000 8870000 -0.39 -0.05 -0.13 0.12 -0.39 -0.05 -0.13 0.12 73011 71383 71815 71002 73011 71383 71815 72260 -8525000 9936000 19122000 17520000 7963000 3100000 9860000 2546000 2283000 29000 732000 -187000 140000 -16137000 35072000 13290000 20192000 -7472000 8011000 3799000 3184000 2874000 -1467000 -10684000 8482000 1840000 -19511000 14766000 19500000 25233000 12240000 14685000 -25152000 7260000 -4452000 38198000 1002000 462000 37810000 946000 -6400000 850000 -29712000 -11401000 62125000 48187000 32413000 36786000 28458000 36029000 3955000 757000 32413000 36786000 961000 3194000 946000 927 1000 72778 73000 1037205000 -691781000 -284000 345214000 684 -9000 -9000 673000 673000 949 1000 1000 312000 312000 -2602000 -2602000 927 1000 74411 74000 1037869000 -694695000 -284000 342965000 -223 -2283000 -2283000 1106000 1106000 315000 315000 22115000 22115000 927 1000 74188 74000 1036692000 -672895000 -284000 363588000 27 2000 2000 -259 1002000 1002000 767000 767000 319000 319000 -28038000 -28038000 927 1000 73956 74000 1036459000 -701252000 -284000 334998000 927 1000 72487 72000 1036638000 -736598000 -3878000 296235000 550 1000 -186000 -185000 804000 804000 124 462000 462000 312000 312000 4678000 4678000 927 1000 73161 73000 1037718000 -732232000 -3878000 301682000 -350 -2589000 -2589000 851000 851000 315000 315000 8390000 8390000 927 1000 72811 73000 1035980000 -724157000 -3878000 308019000 -11 628000 628000 319000 319000 -3132000 -3132000 927 1000 72800 73000 1036608000 -727608000 -3878000 305196000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 1. <span style="font-variant: small-caps">ORGANIZATION </span>AND BASIS OF PRESENTATION.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><i><span style="text-decoration:underline">Organization and Business</span></i> – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation (“Alto Op Co.”), Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company focuses on four key markets: <i>Health, Home &amp; Beauty</i>; <i>Food &amp; Beverage</i>; <i>Essential Ingredients</i>; and <i>Renewable Fuels</i>. Products for the Health, Home &amp; Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food &amp; Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Essential Ingredients markets include dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Renewable Fuels includes fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Basis of Presentation</span></i><span style="text-decoration:underline">–<i>Interim Financial Statements</i></span> – The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Results for interim periods should not be considered indicative of results for a full year. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The accounting policies used in preparing these consolidated financial statements are the same as those described in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. All significant intercompany accounts and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Accounts Receivable and Allowance for Doubtful Accounts</span></i> – Trade accounts receivable are presented at face value, net of the allowance for doubtful accounts. The Company sells specialty alcohols to large consumer products companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and biodiesel customers generally without requiring collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Financial Instruments</span></i> – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, derivative assets, accounts payable, accrued liabilities and derivative liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value because the interest rates on these instruments are variable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Business Combinations</span></i> – Business acquisitions are accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations”. FASB ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Income from Cash Grant</span></i> – The Company applied for and received $22,652,000 in cash from the USDA’s Biofuel Producer Program. The program was created as part of the CARES Act in 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The cash grant is not required to be repaid. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, <i>Accounting for Government Grants and Disclosure of Government Assistance</i>, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Share Repurchase Program</span></i> – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50 million of its common stock with an initial purchase authorization of $10 million. Amounts in excess of the initial purchase authorization of $10 million will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the three and nine months ended September 30, 2022, the Company repurchased an aggregate of 259,000 shares for $1,002,000 in cash.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for doubtful accounts, net realizable value of inventory, estimated lives of property and equipment, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><i><span style="text-decoration:underline">Organization and Business</span></i> – The consolidated financial statements include, for all periods presented, the accounts of Alto Ingredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the “Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a California limited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation (“Alto Op Co.”), Alto Pekin, LLC, a Delaware limited liability company (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited liability company (“ICP”), and the Company’s production facilities in Oregon and Idaho.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">On May 14, 2021 and November 4, 2021, the Company completed the sale of its production facilities located in Madera and Stockton, California, respectively. The results of these facilities are included in the Company’s results reported for the three and nine months ended September 30, 2021. As discussed in Note 2, on January 14, 2022, the Company acquired 100% ownership of Eagle Alcohol Company LLC, a Missouri limited liability company (“Eagle Alcohol”), which is now a wholly-owned subsidiary of Alto Ingredients, Inc. The results of Eagle Alcohol since the date of the acquisition are included in the Company’s results reported for the three and nine months ended September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company is a leading producer and distributor of specialty alcohols and essential ingredients. The Company also produces, markets and distributes renewable fuel. The Company’s production facilities in Pekin, Illinois are located in the heart of the Corn Belt, benefit from low-cost and abundant feedstock and allow for access to many additional domestic markets. In addition, the Company’s ability to load barges, rail and trucks from these facilities allows for greater access to international markets. The Company’s two production facilities in Oregon and Idaho are located in close proximity to both feed and renewable fuel customers and thus enjoy unique advantages in efficiency, logistics and product pricing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company has a combined alcohol production capacity of 350 million gallons per year and produces, on an annualized basis, over 1.5 million tons of essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. In addition, the Company sells alcohols acquired from other producers, and markets and distributes fuel-grade ethanol produced by third parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company focuses on four key markets: <i>Health, Home &amp; Beauty</i>; <i>Food &amp; Beverage</i>; <i>Essential Ingredients</i>; and <i>Renewable Fuels</i>. Products for the Health, Home &amp; Beauty market include specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants and cleaners. Products for the Food &amp; Beverage markets include grain neutral spirits used in alcoholic beverages and vinegar as well as corn germ used for corn oils. Products for Essential Ingredients markets include dried yeast, corn gluten meal, corn gluten feed, corn germ, and distillers grains and liquid feed used in commercial animal feed and pet foods. Renewable Fuels includes fuel-grade ethanol and distillers corn oil used as a feedstock for renewable diesel and biodiesel fuels.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">As of September 30, 2022, all of the Company’s production facilities were operating. As market conditions change, the Company may increase, decrease or idle production at one or more operating facilities or resume operations at any then-idled facility.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> 1 350000000 1500000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Basis of Presentation</span></i><span style="text-decoration:underline">–<i>Interim Financial Statements</i></span> – The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Results for interim periods should not be considered indicative of results for a full year. These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The accounting policies used in preparing these consolidated financial statements are the same as those described in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results for interim periods have been included. All significant intercompany accounts and transactions have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Accounts Receivable and Allowance for Doubtful Accounts</span></i> – Trade accounts receivable are presented at face value, net of the allowance for doubtful accounts. The Company sells specialty alcohols to large consumer products companies, sells fuel-grade ethanol to gasoline refining and distribution companies, sells essential ingredients to animal feed customers, including distillers grains and other feed co-products to dairy operators and animal feedlots and corn oil to poultry and biodiesel customers generally without requiring collateral.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains an allowance for doubtful accounts for balances that appear to have specific collection issues. The collection process is based on the age of the invoice and requires attempted contacts with the customer at specified intervals. If, after a specified number of days, the Company has been unsuccessful in its collection efforts, a bad debt allowance is recorded for the balance in question. Delinquent accounts receivable are charged against the allowance for doubtful accounts once uncollectibility has been determined. The factors considered in reaching this determination are the apparent financial condition of the customer and the Company’s success in contacting and negotiating with the customer. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of ability to make payments, additional allowances may be required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Of the accounts receivable balance, approximately $54,972,000 and $63,929,000 at September 30, 2022 and December 31, 2021, respectively, were used as collateral under Kinergy’s operating line of credit. The allowance for doubtful accounts was $135,000 and $378,000 as of September 30, 2022 and December 31, 2021, respectively. The Company recorded a bad debt recovery of $253,000 and $3,000 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a bad debt recovery of $187,000 and bad debt expense of $140,000 for the nine months ended September 30, 2022 and 2021, respectively. The Company does not have any off-balance sheet credit exposure related to its customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 54972000 63929000 135000 378000 253000 3000 187000 140000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Financial Instruments</span></i> – The carrying values of cash and cash equivalents, restricted cash, accounts receivable, notes receivable, derivative assets, accounts payable, accrued liabilities and derivative liabilities are reasonable estimates of their fair values because of the short maturity of these items. The Company believes the carrying value of its long-term debt instruments are not considered materially different than fair value because the interest rates on these instruments are variable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Business Combinations</span></i> – Business acquisitions are accounted for in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations”. FASB ASC 805 requires the reporting entity to identify the acquirer, determine the acquisition date, recognize and measure the identifiable tangible and intangible assets acquired and liabilities assumed and recognize and measure goodwill or a gain from the purchase. Assets acquired and liabilities assumed are recorded at their fair values and the excess of the purchase price over the amounts assigned is recorded as goodwill. Adjustments to fair value assessments are recorded to goodwill over the measurement period (not longer than twelve months).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Income from Cash Grant</span></i> – The Company applied for and received $22,652,000 in cash from the USDA’s Biofuel Producer Program. The program was created as part of the CARES Act in 2020, which allocated $700,000,000 to support biofuel producers who experienced market losses due to the pandemic. The cash grant is not required to be repaid. Since these funds are provided to subsidize historical losses of the Company, and are not required to be repaid, the Company accounted for the proceeds by analogy to International Accounting Standards 20, <i>Accounting for Government Grants and Disclosure of Government Assistance</i>, and reported the amount as income from cash grant in the accompanying consolidated statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 22652000 700000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Share Repurchase Program</span></i> – On September 12, 2022, the Company announced a share repurchase program under which it may repurchase up to $50 million of its common stock with an initial purchase authorization of $10 million. Amounts in excess of the initial purchase authorization of $10 million will require additional board and preferred stockholder authorization. The share repurchase program does not have an expiration date, does not require the repurchase of any particular amount of shares, and may be implemented, modified, suspended or discontinued in whole or in part at any time and without further notice. As repurchases are made, the Company will retire the shares, resulting in a reduction of issued and outstanding shares. For the three and nine months ended September 30, 2022, the Company repurchased an aggregate of 259,000 shares for $1,002,000 in cash.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 50000000 10000000 10000000 259000 1002000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for doubtful accounts, net realizable value of inventory, estimated lives of property and equipment, long-lived asset impairments, fair value of warrants, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 2. ACQUISITION OF EAGLE ALCOHOL.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 14, 2022, the Company purchased 100% of the membership interests of Eagle Alcohol. The purchase price was $14.0 million in cash plus an estimated net working capital adjustment of $1.3 million in cash. The selling members of Eagle Alcohol are eligible to receive up to an additional $14.0 million of contingent consideration, payable through a combination of $9.0 million in cash over the next three years and an aggregate of $5.0 million in the Company’s common stock on the fourth and fifth year anniversaries of the closing date, subject to the satisfaction of certain conditions, including continued employment with the Company. With respect to these payments, the Company has recognized an estimated $0.9 million and $2.6 million for the three and nine months ended September 30, 2022, respectively, in selling, general and administrative expenses in the accompanying consolidated statements of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eagle Alcohol specializes in break bulk distribution of specialty alcohols. Eagle Alcohol purchases bulk alcohol from suppliers and then stores, denatures, packages, and resells alcohol products in smaller sizes, including tank trucks, totes, and drums, that garner a premium to bulk alcohols. Eagle Alcohol delivers products to customers in the beverage, food, and related-process industries via its own dedicated trucking fleet and common carrier. The acquisition has provided the Company further vertical integration and access to new markets in the specialty alcohol industry.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Eagle Alcohol’s unaudited results for the three months ended September 30, 2022 and 2021 generated $4.2 million and $9.9 million in net sales and $0.0 million and $1.0 million in net income, respectively. Eagle Alcohol’s unaudited results for the nine months ended September 30, 2022 and 2021 generated $12.1 million and $27.5 million in net sales and $0.1 million and $3.0 million in net income, respectively. The following table presents unaudited pro forma combined financial information assuming the acquisition occurred on January 1, 2021 (dollars in thousands except per share amounts): </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Revenues – pro forma</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">336,877</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">311,821</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net loss available to common stockholders – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(28,357</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,424</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Diluted net loss per share – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.38</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Diluted shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,960</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,332</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine Months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Revenues – pro forma</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,007,711</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">840,947</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net income (loss) available to common stockholders – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,538</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,474</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted net income (loss) per share – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.13</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Diluted shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,209</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following preliminary allocation of the estimated purchase price assumes, with the exception of property and equipment and intangibles, carrying values approximate fair value. Estimates of uncollectible accounts receivable are not considered material due to the short-term nature and customer collection history. The preliminary estimate of working capital is under review by management and is subject to change. Based upon these assumptions, the preliminary purchase price allocation is as follows (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash and equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">705</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,517</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,388</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total current assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,639</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Right of use assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,749</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Total tangible assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,455</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,262</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Right of use liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,749</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Total liabilities</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,011</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net tangible assets acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,444</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Tradename</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">420</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,970</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total Purchase Price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,390</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the value of the downstream integration that the operations of Eagle Alcohol will add to the Company. The Company expects the amortization of goodwill to be deductible for tax purposes. For the identifiable intangible assets, the Company has estimated 12 years for useful lives for customer relationships and 10 years for tradename. For the three months ended September 30, 2022, the Company recorded amortization expense of $137,000 and $10,000 for customer relationships and tradename, respectively. For the nine months ended September 30, 2022, the Company recorded amortization expense of $390,000 and $30,000 for customer relationships and tradename, respectively. Any changes to the initial estimates of the fair value of the acquired assets and assumed liabilities will be recorded as adjustments to those assets and liabilities and residual amounts will be allocated to goodwill if net assets acquired are less than the purchase price. The Company did not incur any material acquisition costs.</p> 1 14000000 1300000 14000000 9000000 5000000 900000 2600000 4200000 9900000 0 1000000 12100000 27500000 100000 3000000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">September 30,</p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Revenues – pro forma</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">336,877</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">311,821</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net loss available to common stockholders – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(28,357</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(3,424</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Diluted net loss per share – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.38</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.05</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Diluted shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,960</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,332</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine Months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Revenues – pro forma</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,007,711</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">840,947</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net income (loss) available to common stockholders – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,538</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,474</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Diluted net income (loss) per share – pro forma</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.13</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Diluted shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,764</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,209</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> 336877000 311821000 -28357000 -3424000 -0.38 -0.05 73960 72332 1007711000 840947000 -9538000 8474000 -0.13 0.12 72764 73209 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash and equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">705</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,517</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,388</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total current assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,639</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,067</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Right of use assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,749</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Total tangible assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,455</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6,262</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Right of use liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,749</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left">Total liabilities</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,011</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net tangible assets acquired</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,444</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Tradename</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">420</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,970</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total Purchase Price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,390</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 705000 5517000 1388000 29000 7639000 1067000 2749000 11455000 6262000 2749000 9011000 2444000 6556000 420000 5970000 15390000 P12Y P10Y 137000 10000 390000 30000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 3. SEGMENTS.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 6pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reports its financial and operating performance in three segments: (1) marketing and distribution, which includes marketing and merchant trading for Company-produced alcohols and essential ingredients on an aggregated basis and third-party fuel-grade ethanol sales (2) Pekin production, which includes the production and sale of alcohols and essential ingredients produced at the Company’s Pekin, Illinois campus (“Pekin Campus”), and (3) Other production, which includes the production and sale of renewable fuel and essential ingredients produced at all of the Company’s other production facilities on an aggregated basis (“Other production”), none of which are individually so significant as to be considered a reportable segment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables set forth certain financial data for the Company’s operating segments (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt">  </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine Months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Net Sales</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Pekin Campus, recorded as gross:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 52%; text-align: left">Alcohol sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">133,680</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">114,587</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">393,498</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">341,967</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Essential ingredient sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54,537</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">169,670</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">140,670</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intersegment sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">332</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">857</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">919</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.375in; text-align: left">Total Pekin Campus sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">188,549</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160,896</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">564,025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">483,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marketing and distribution:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Alcohol sales, gross</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">55,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">112,391</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">172,746</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">255,702</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Alcohol sales, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">505</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">975</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,489</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intersegment sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,121</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,415</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,277</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-align: left">Total marketing and distribution sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,691</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,311</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,468</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production, recorded as gross:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Alcohol sales</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">64,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,483</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">63,311</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Essential ingredient sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,439</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,867</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,748</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,261</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intersegment sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">259</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">896</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in; text-align: left">Total Other production sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,934</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">258,245</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,468</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Corporate and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,159</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,064</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Intersegment eliminations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,456</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,967</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,231</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,092</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Net sales as reported</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">336,877</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">305,556</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,007,184</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">822,400</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Cost of goods sold:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">207,939</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">169,721</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">572,512</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">468,972</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,159</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">173,670</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">245,606</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,613</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">261,514</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87,055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Corporate and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,925</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,995</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intersegment eliminations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(970</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,285</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,904</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Cost of goods sold as reported</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">356,716</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">308,955</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,013,406</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">796,729</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; width: 52%">Gross profit (loss):</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Pekin Campus</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(19,390</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,825</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,487</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,411</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,862</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,729</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,297</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,269</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,587</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Corporate and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,234</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Intersegment eliminations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,486</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(686</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,946</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,188</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Gross profit (loss) as reported</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(19,839</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,399</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,222</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">25,671</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Income (loss) before provision for income taxes:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(22,664</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(11,830</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,252</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,907</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,622</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,517</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,929</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,958</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,856</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,404</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,467</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,038</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,037</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">567</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(28,038</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,132</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(8,525</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,936</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; width: 52%">Depreciation and amortization of intangibles:</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Pekin Campus</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,372</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,381</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,043</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,273</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,095</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,433</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">229</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">646</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">44</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,260</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,851</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,122</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,520</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Interest expense, net of capitalized interest:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(48</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">176</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(81</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">767</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,060</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">721</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(74</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(128</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(25</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,689</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">340</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">429</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">859</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,359</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="margin: 0pt 0; font-size: 7pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the Company’s total assets by operating segment (in thousands): </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">September 30, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Total assets:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">247,449</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">266,197</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">111,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,302</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,046</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,415</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,408</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">454,668</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">484,953</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Nine Months Ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Net Sales</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Pekin Campus, recorded as gross:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 52%; text-align: left">Alcohol sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">133,680</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">114,587</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">393,498</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">341,967</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Essential ingredient sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54,537</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,016</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">169,670</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">140,670</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intersegment sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">332</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">293</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">857</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">919</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.375in; text-align: left">Total Pekin Campus sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">188,549</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160,896</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">564,025</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">483,556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marketing and distribution:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Alcohol sales, gross</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">55,262</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">112,391</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">172,746</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">255,702</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Alcohol sales, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">308</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">505</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">975</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,489</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intersegment sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,121</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,415</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,360</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,277</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-align: left">Total marketing and distribution sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,691</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,311</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">183,081</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">264,468</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production, recorded as gross:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Alcohol sales</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">64,492</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,190</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">191,483</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">63,311</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Essential ingredient sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,439</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,867</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,748</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">19,261</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Intersegment sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">259</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">896</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in; text-align: left">Total Other production sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">88,934</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">32,316</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">258,245</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">83,468</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Corporate and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,159</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,064</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Intersegment eliminations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,456</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,967</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,231</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,092</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Net sales as reported</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">336,877</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">305,556</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,007,184</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">822,400</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Cost of goods sold:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">207,939</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">169,721</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">572,512</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">468,972</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,159</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105,902</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">173,670</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">245,606</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">91,663</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,613</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">261,514</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">87,055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Corporate and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,925</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,995</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intersegment eliminations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(970</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,285</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,904</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Cost of goods sold as reported</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">356,716</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">308,955</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,013,406</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">796,729</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; width: 52%">Gross profit (loss):</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Pekin Campus</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(19,390</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,825</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,487</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,584</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,532</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,409</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,411</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,862</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,729</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,297</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,269</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,587</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Corporate and other</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,234</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">—</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Intersegment eliminations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,486</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(686</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,946</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,188</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Gross profit (loss) as reported</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(19,839</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,399</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,222</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">25,671</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Income (loss) before provision for income taxes:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(22,664</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(11,830</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,252</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,907</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,622</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,517</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,444</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,929</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,958</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,856</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,404</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(12,467</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,038</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,037</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,121</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">567</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(28,038</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,132</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(8,525</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">9,936</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; font-style: italic; text-decoration: underline; text-align: left; width: 52%">Depreciation and amortization of intangibles:</td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 1%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 9%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Pekin Campus</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,758</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4,372</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,381</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,043</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,273</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,468</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,095</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,433</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">229</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">646</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">44</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">6,260</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,851</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,122</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,520</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Interest expense, net of capitalized interest:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 52%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(48</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">176</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(81</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">767</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">487</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">295</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,060</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">721</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(74</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(128</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(25</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,689</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">340</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">429</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">859</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,359</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="margin: 0pt 0; font-size: 7pt; text-align: justify"> </p> 133680000 114587000 393498000 341967000 54537000 46016000 169670000 140670000 332000 293000 857000 919000 188549000 160896000 564025000 483556000 55262000 112391000 172746000 255702000 308000 505000 975000 1489000 3121000 2415000 9360000 7277000 58691000 115311000 183081000 264468000 64492000 25190000 191483000 63311000 24439000 6867000 66748000 19261000 3000 259000 14000 896000 88934000 32316000 258245000 83468000 4159000 12064000 -3456000 -2967000 -10231000 -9092000 336877000 305556000 1007184000 822400000 207939000 169721000 572512000 468972000 55159000 105902000 173670000 245606000 91663000 35613000 261514000 87055000 2925000 8995000 -970000 -2281000 -3285000 -4904000 356716000 308955000 1013406000 796729000 -19390000 -8825000 -8487000 14584000 3532000 9409000 9411000 18862000 -2729000 -3297000 -3269000 -3587000 1234000 3069000 -2486000 -686000 -6946000 -4188000 -19839000 -3399000 -6222000 25671000 -22664000 -11830000 -6252000 8907000 1622000 7517000 3444000 12929000 -4958000 -4856000 1404000 -12467000 -2038000 6037000 -7121000 567000 -28038000 -3132000 -8525000 9936000 4758000 4372000 14381000 13043000 1273000 1468000 4095000 4433000 229000 11000 646000 44000 6260000 5851000 19122000 17520000 -48000 176000 -81000 767000 487000 295000 1060000 721000 -74000 -128000 182000 -25000 -42000 8000 1689000 340000 429000 859000 3359000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">September 30, <br/> 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; font-style: italic; text-align: left"><span style="text-decoration:underline">Total assets:</span></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: right"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Pekin Campus</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">247,449</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">266,197</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Marketing and distribution</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">111,900</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,302</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other production</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,904</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,046</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Corporate and other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,415</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,408</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">454,668</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">484,953</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 247449000 266197000 111900000 130302000 63904000 57046000 31415000 31408000 454668000 484953000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">4. INVENTORIES.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories consisted primarily of bulk ethanol, specialty alcohols, corn, essential ingredients and unleaded fuel, and are valued at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventory is net of a valuation adjustment of $7,963,000 and $0 as of September 30, 2022 and December 31, 2021, respectively. Inventory balances consisted of the following (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">40,630</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">35,509</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,084</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,909</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,321</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,837</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,053</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,118</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">61,088</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">54,373</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 7963000 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">40,630</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">35,509</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Work in progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,084</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,909</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Raw materials</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,321</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,837</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,053</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,118</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">61,088</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">54,373</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 40630000 35509000 8084000 6909000 11321000 10837000 1053000 1118000 61088000 54373000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 5. DERIVATIVES.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The business and activities of the Company expose it to a variety of market risks, including risks related to changes in commodity prices. The Company monitors and manages these financial exposures as an integral part of its risk management program. This program recognizes the unpredictability of financial markets and seeks to reduce the potentially adverse effects that market volatility could have on operating results.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Commodity Risk</span></i><span style="text-decoration:underline"> – <i>Cash Flow Hedges</i></span> – The Company uses derivative instruments to protect cash flows from fluctuations caused by volatility in commodity prices for periods of up to twelve months in order to protect gross profit margins from potentially adverse effects of market and price volatility on alcohol sales and purchase commitments where the prices are set at a future date and/or if the contracts specify a floating or index-based price. In addition, the Company hedges anticipated sales of alcohol to minimize its exposure to the potentially adverse effects of price volatility. These derivatives may be designated and documented as cash flow hedges and effectiveness is evaluated by assessing the probability of the anticipated transactions and regressing commodity futures prices against the Company’s purchase and sales prices. Ineffectiveness, which is defined as the degree to which the derivative does not offset the underlying exposure, is recognized immediately in cost of goods sold. For the three and nine months ended September 30, 2022 and 2021, the Company did not designate any of its derivatives as cash flow hedges.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Commodity Risk – Non-Designated Hedges</span></i> – The Company uses derivative instruments to lock in prices for certain amounts of corn and alcohols by entering into exchange-traded forward contracts or options for those commodities. These derivatives are not designated for hedge accounting treatment. The changes in fair value of these contracts are recorded on the balance sheet and recognized immediately in cost of goods sold. The Company recognized net losses of $1,772,000 and $976,000 as the change in the fair value of these contracts for the three months ended September 30, 2022 and 2021, respectively. The Company recognized net gains of $20,164,000 and $18,435,000 as the change in the fair value of these contracts for the nine months ended September 30, 2022 and 2021, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Non Designated Derivative Instruments</span></i> – The classification and amounts of the Company’s derivatives not designated as hedging instruments, and related cash collateral balances, are as follows (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">As of September 30, 2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Type of Instrument</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Cash collateral balance</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%; text-align: left">Restricted cash</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,955</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%; text-align: left"><div style="-sec-ix-hidden: hidden-fact-184"> </div></td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185"> </div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,384</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,106</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">As of December 31, 2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Type of Instrument</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Cash collateral balance</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%; text-align: left">Restricted cash</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">11,513</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%"><div style="-sec-ix-hidden: hidden-fact-186"> </div></td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187"> </div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,839</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,582</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The above amounts represent the gross balances of the contracts; however, the Company does have a right of offset with each of its derivative brokers, but its intent is to close out positions individually, therefore, they are reported at gross.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The classification and amounts of the Company’s recognized gains (losses) for its derivatives not designated as hedging instruments are as follows (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Realized Losses</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Three Months<br/> Ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Type of Instrument</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">Statements of Operations Location</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(13,332</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(2,894</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(13,332</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,894</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Realized Gains</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Type of Instrument</td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">Statements of Operations Location</td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Nine Months Ended September 30,</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">16,143</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">21,449</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">16,143</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">21,449</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Unrealized Gains</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Three Months<br/> Ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Type of Instrument</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Statements of Operations Location</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">11,560</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,918</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,560</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,918</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Unrealized Gains (Losses)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Nine Months<br/> Ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; border-bottom: Black 1.5pt solid">Type of Instrument</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; border-bottom: Black 1.5pt solid">Statements of Operations Location</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">4,021</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(3,014</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,021</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,014</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> 1772000 976000 20164000 18435000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">As of September 30, 2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Type of Instrument</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Cash collateral balance</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%; text-align: left">Restricted cash</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,955</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%; text-align: left"><div style="-sec-ix-hidden: hidden-fact-184"> </div></td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185"> </div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,384</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,106</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">As of December 31, 2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="4" style="border-bottom: Black 1.5pt solid; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Type of Instrument</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Balance Sheet Location</td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Cash collateral balance</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%; text-align: left">Restricted cash</td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">11,513</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 20%"><div style="-sec-ix-hidden: hidden-fact-186"> </div></td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187"> </div></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,839</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; padding-bottom: 1.5pt">Derivative liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,582</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> Cash collateral balance Restricted cash 3955000 Commodity contracts Derivative assets 7384000 Derivative liabilities 1106000 Cash collateral balance Restricted cash 11513000 Commodity contracts Derivative assets 15839000 Derivative liabilities 13582000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Realized Losses</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Three Months<br/> Ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Type of Instrument</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">Statements of Operations Location</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(13,332</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(2,894</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(13,332</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,894</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Realized Gains</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Type of Instrument</td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">Statements of Operations Location</td><td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Nine Months Ended September 30,</td><td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">16,143</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">21,449</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">16,143</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">21,449</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Unrealized Gains</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Three Months<br/> Ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Type of Instrument</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid">Statements of Operations Location</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">11,560</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">1,918</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: right; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">11,560</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,918</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Unrealized Gains (Losses)</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">For the Nine Months<br/> Ended September 30,</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; border-bottom: Black 1.5pt solid">Type of Instrument</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: left; border-bottom: Black 1.5pt solid">Statements of Operations Location</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Commodity contracts</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 40%; text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">4,021</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(3,014</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,021</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,014</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> Commodity contracts Cost of goods sold -13332000 -2894000 -13332000 -2894000 Commodity contracts Cost of goods sold 16143000 21449000 16143000 21449000 Commodity contracts Cost of goods sold 11560000 1918000 11560000 1918000 Commodity contracts Cost of goods sold 4021000 -3014000 4021000 -3014000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.25in">6.</td><td>DEBT.</td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term borrowings are summarized as follows (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Kinergy line of credit</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">50,401</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Less unamortized debt financing costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(61</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Less short-term portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left">Long-term debt</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">45,888</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">50,361</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2022, Kinergy had $30.7 million in unused borrowing availability under its line of credit. The Company believes it was in compliance with its covenants under the line of credit as of September 30, 2022.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.25in">6.</td><td>DEBT.</td></tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">September 30,<br/> 2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">December 31,<br/> 2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Kinergy line of credit</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,949</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">50,401</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Less unamortized debt financing costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(61</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Less short-term portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-align: left">Long-term debt</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">45,888</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">50,361</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 45949000 50401000 61000 40000 45888000 50361000 30700000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 7. COMMITMENTS AND CONTINGENCIES.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Sales Commitments</span></i> – At September 30, 2022, the Company had entered into sales contracts with its major customers to sell certain quantities of alcohol and essential ingredients. The Company had open alcohol indexed-price contracts for 92,771,000 gallons as of September 30, 2022 and open fixed-price alcohol sales contracts totaling $101,427,000 as of September 30, 2022. The Company had open fixed-price sales contracts for essential ingredients totaling $17,274,000 as of September 30, 2022. These sales contracts are scheduled to be completed throughout 2022 and 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Purchase Commitments</span></i> – At September 30, 2022, the Company had indexed-price purchase contracts to purchase 13,988,000 gallons of alcohol and fixed-price purchase contracts to purchase $45,599,000 of alcohol from its suppliers. The Company had fixed-price purchase contracts to purchase $38,769,000 of corn from its suppliers as of September 30, 2022. The Company had fixed-price purchase contracts for natural gas totaling $1,947,000 and indexed-price purchase contracts for natural gas totaling 4,463,000 MMBTU. The Company also had future commitments for certain capital projects totaling $46,796,000. These purchase commitments are scheduled to be satisfied throughout 2022 and 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Litigation – General</span> –</i> The Company is subject to various claims and contingencies in the ordinary course of its business, including those related to litigation, business transactions, employee-related matters, environmental regulations, and others. When the Company is aware of a claim or potential claim, it assesses the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, the Company will record a liability for the loss. If the loss is not probable or the amount of the loss cannot be reasonably estimated, the Company discloses the claim if the likelihood of a potential loss is reasonably possible and the amount involved could be material. While there can be no assurances, the Company does not expect that any of its pending legal proceedings will have a material impact on the Company’s financial condition or results of operations.</p> 92771000 101427000 17274000 13988000 45599000 38769000 1947000 4463000 46796000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 8. PENSION AND RETIREMENT BENEFIT PLANS.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company sponsors a defined benefit pension plan (the “Retirement Plan”) and a healthcare and life insurance plan (the “Postretirement Plan”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Retirement Plan is noncontributory, and covers only “grandfathered” unionized employees at the Company’s Pekin, Illinois facility who fulfill minimum age and service requirements. Benefits are based on a prescribed formula based upon the employee’s years of service. The Retirement Plan, which is part of a collective bargaining agreement, covers only union employees hired prior to November 1, 2010.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company uses a December 31 measurement date for its Retirement Plan. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations. As of December 31, 2021, the Retirement Plan’s accumulated projected benefit obligation was $23.8 million, with a fair value of plan assets of $20.0 million. The underfunded amount of $3.8 million is recorded on the Company’s consolidated balance sheet in other liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">For the three months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $8,000, comprised of $273,000 of expected return on plan assets, partially offset by $164,000 in interest cost and $101,000 in service cost. For the three months ended September 30, 2021, the Retirement Plan’s net periodic expense was $22,000, comprised of $151,000 in interest cost and $109,000 in service cost, partially offset by $238,000 of expected return on plan assets. For the nine months ended September 30, 2022, the Retirement Plan’s net periodic benefit was $24,000, comprised of $819,000 of expected return on plan assets, partially offset by $492,000 in interest cost and $303,000 in service cost. For the nine months ended September 30, 2021, the Retirement Plan’s net periodic expense was $66,000, comprised of $453,000 in interest cost and $327,000 in service cost, partially offset by $714,000 of expected return on plan assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Postretirement Plan provides postretirement medical benefits and life insurance to certain “grandfathered” unionized employees. Employees hired after December 31, 2000 are not eligible to participate in the Postretirement Plan. The Postretirement Plan is contributory, with contributions required at the same rate as active employees. Benefit eligibility under the plan declines at age 65 from a defined benefit to a defined dollar cap based upon years of service. As of December 31, 2021, the Postretirement Plan’s accumulated projected benefit obligation was $4.3 million and is recorded on the Company’s consolidated balance sheet in other liabilities. The Company’s funding policy is to make the minimum annual contribution required by applicable regulations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">For the three months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $32,000, comprised of $6,000 of interest cost and $26,000 of service cost. For the three months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $42,000, comprised of $10,000 of interest cost, $26,000 of service cost and $6,000 of amortization expense.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">For the nine months ended September 30, 2022, the Postretirement Plan’s net periodic expense was $96,000, comprised of $18,000 of interest cost and $78,000 of service cost. For the nine months ended September 30, 2021, the Postretirement Plan’s net periodic expense was $126,000, comprised of $30,000 of interest cost, $78,000 of service cost and $18,000 of amortization expense.</p> 23800000 20000000 3800000 8000 273000 164000 101000 -22000 151000 109000 238000 24000 819000 492000 303000 66000 453000 327000 714000 4300000 32000 6000 26000 42000 10000 26000 6000 96000 18000 78000 126000 30000 78000 18000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9. FAIR VALUE MEASUREMENTS.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair va<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lue hierarchy prioritizes the inputs used in valuation techniques into three levels, as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Observable inputs – unadjusted quoted prices in active markets for identical assets and liabilities;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs – includes amounts derived from valuation models where one or more significant inputs are unobservable. For fair value measurements using significant unobservable inputs, a description of the inputs and the information used to develop the inputs is required along with a reconciliation of Level 3 values from the prior reporting period.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Pooled separate accounts</span></i> – Pooled separate accounts invest primarily in domestic and international stocks, commercial paper or single mu</span>tual funds. The net asset value is used as a practical expedient to determine fair value for these accounts. Each pooled separate account provides for redemptions by the Retirement Plan at reported net asset values per share, with little to no advance notice requirement, therefore these funds are classified within Level 2 of the valuation hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Long-Lived Assets Held-for-Sale</span></i> – The Company recorded its long-lived assets associated with its property and equipment held-for-sale at fair value at December 31, 2021 of $1,000,000. These assets were sold during the three months ended September 30, 2022. The fair values of these assets are based on observable values for the assets through corroboration with market data and are designated as Level 3 inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Other Derivative Instruments</span></i> – The Company’s other derivative instruments consist of commodity positions. The fair values of the commodity positions are based on quoted prices on the commodity exchanges and are designated as Level 1 inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes recurring and nonrecurring fair value measurements by level at September 30, 2022 (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center">Fair</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Value</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 0"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 0">Assets:</td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; padding-left: 0.125in; width: 52%; text-align: left">Derivative financial instruments</td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">7,384</td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">7,384</td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">     —</div></td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">     —</div></td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 0">Liabilities:</td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Derivative financial instruments</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,106</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,106</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes recurring and nonrecurring fair value measurements by level at December 31, 2021 (in thousands):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Benefit Plan</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Fair</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Percentage</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Value</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Allocation</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td>Assets:</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Derivative financial instruments</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,839</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,839</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Long-lived assets held-for-sale</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Defined benefit plan assets (1) (pooled separate accounts):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Large U.S. Equity(2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Small/Mid U.S. Equity(3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,684</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,684</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td>International Equity(4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Fixed Income(5)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,782</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,782</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">36,826</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,839</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,987</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Derivative financial instruments</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(13,582</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(13,582</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Included in other assets in the consolidated balance sheets.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0in"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td></tr></table> 1000000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center">Fair</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Value</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 0"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 0">Assets:</td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td><td style="padding-bottom: 0"> </td> <td colspan="2" style="padding-bottom: 0; text-align: center"> </td><td style="padding-bottom: 0"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; padding-left: 0.125in; width: 52%; text-align: left">Derivative financial instruments</td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">7,384</td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">7,384</td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">     —</div></td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 4pt; width: 1%"> </td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">     —</div></td><td style="padding-bottom: 4pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 0">Liabilities:</td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0"> </td> <td style="padding-bottom: 0; text-align: left"> </td><td style="padding-bottom: 0; text-align: right"> </td><td style="padding-bottom: 0; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Derivative financial instruments</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,106</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,106</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Benefit Plan</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Fair</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Percentage</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Value</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Level 1</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Level 2</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Level 3</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Allocation</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td>Assets:</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Derivative financial instruments</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,839</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,839</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">—</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Long-lived assets held-for-sale</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Defined benefit plan assets (1) (pooled separate accounts):</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Large U.S. Equity(2)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,612</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Small/Mid U.S. Equity(3)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,684</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,684</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td>International Equity(4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,909</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">—</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Fixed Income(5)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,782</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,782</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">—</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">39</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">36,826</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">15,839</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">19,987</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Derivative financial instruments</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(13,582</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(13,582</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">—</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Included in other assets in the consolidated balance sheets.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td> </tr></table><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0in"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund.</td></tr></table> 7384000 7384000 -1106000 -1106000 15839000 15839000 1000000 1000000 5612000 5612000 0.28 3684000 3684000 0.18 2909000 2909000 0.15 7782000 7782000 0.39 36826000 15839000 19987000 1000000 -13582000 -13582000 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 10. EARNINGS (LOSS) PER SHARE.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables compute basic and diluted earnings (loss) per share (in thousands, except per share data):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Loss<br/> Numerator</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares<br/> Denominator</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Per-Share<br/> Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(28,038</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(319</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Basic and Diluted loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Loss available to common stockholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(28,357</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">73,011</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.39</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended September 30, 2021</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Loss<br/> Numerator</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares<br/> Denominator</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Per-Share<br/> Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Net loss</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,132</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(319</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Basic and Diluted loss per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,451</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">71,383</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.05</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended September 30, 2022</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Loss<br/> Numerator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares<br/> Denominator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Per-Share<br/> Amount</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Net loss</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(8,525</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(946</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Basic and Diluted loss per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,471</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">71,815</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.13</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended September 30, 2021</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Income<br/> Numerator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares<br/> Denominator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Per-Share<br/> Amount</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Net income</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,936</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(946</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Less: Income allocated to participating securities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(120</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif">Basic income per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt">Income available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right">8,870</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right">71,002</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.12</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Add: Dilutive instruments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">—</div></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,258</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Diluted income per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Income available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,870</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">72,260</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.12</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were an additional aggregate potentially dilutive weighted-average shares of 964,000 from convertible securities outstanding for the three and nine months ended September 30, 2022 and 2021. These securities were not considered in calculating diluted net income (loss) per share for the three and nine months ended September 30, 2022 and 2021, as their effect would have been anti-dilutive. At December 31, 2021, the Company had outstanding unexercised warrants to purchase 8.9 million shares of its common stock at an exercise price of $9.76 per share. These warrants expired unexercised on April 28, 2022.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended September 30, 2022</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Loss<br/> Numerator</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares<br/> Denominator</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Per-Share<br/> Amount</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: justify">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(28,038</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(319</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Basic and Diluted loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt">Loss available to common stockholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(28,357</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">73,011</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(0.39</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Three Months Ended September 30, 2021</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Loss<br/> Numerator</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares<br/> Denominator</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Per-Share<br/> Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Net loss</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,132</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(319</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Basic and Diluted loss per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(3,451</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">71,383</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.05</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended September 30, 2022</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Loss<br/> Numerator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares<br/> Denominator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Per-Share<br/> Amount</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Net loss</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">(8,525</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Less: Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(946</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Basic and Diluted loss per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Loss available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,471</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">71,815</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.13</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Nine Months Ended September 30, 2021</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Income<br/> Numerator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares<br/> Denominator</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Per-Share<br/> Amount</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: justify">Net income</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif"> </td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 9%; font: 10pt Times New Roman, Times, Serif; text-align: right">9,936</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 1%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 9%; font-size: 10pt; text-align: right"> </td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Less: Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(946</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Less: Income allocated to participating securities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(120</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: bold 10pt Times New Roman, Times, Serif">Basic income per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 4pt">Income available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right">8,870</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: right">71,002</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.12</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Add: Dilutive instruments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">—</div></td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,258</td><td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif">Diluted income per share:</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Income available to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,870</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">72,260</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.12</td><td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> -28038000 -319000 -28357000 73011 -0.39 -3132000 -319000 -3451000 71383 -0.05 -8525000 -946000 -9471000 71815 -0.13 9936000 -946000 -120000 8870000 71002 0.12 1258 8870000 72260 0.12 964000 964000 964000 964000 8900000 9.76 2022-04-28 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> 11. SUBSEQUENT EVENTS.</p><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"><i><span style="text-decoration:underline">New Term Loan Facility</span></i> – On November 7, 2022, the Company closed on a senior secured term loan credit facility with certain funds managed by Orion Infrastructure Capital for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. The Company’s obligations under the term loan are secured by all of the Company’s tangible and intangible assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE">In connection with the term loan facility, the Company will issue to the lenders an aggregate of up to 1,602,564 shares of the Company’s common stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: #FEFEFE"><i><span style="text-decoration:underline">Kinergy Operating Line of Credit Extension</span></i> – On November 7, 2022, the Company amended Kinergy’s operating line of credit to extend the maturity to 2027.</p> On November 7, 2022, the Company closed on a senior secured term loan credit facility with certain funds managed by Orion Infrastructure Capital for up to $125 million. The term loan allows for periodic draws in an aggregate amount of up to $100 million, with an additional $25 million available upon the attainment of certain performance conditions. As of November 7, 2022, no amounts had been drawn. The six-year term loan has a fixed annual interest rate of 10% and will be issued at an original issue discount of 1.5%. The term loan does not require scheduled principal amortization payments but includes customary prepayment obligations as well as semi-annual sweeps of a portion of excess cash flow commencing for the six-month period ending December 31, 2023. The Company’s obligations under the term loan are secured by all of the Company’s tangible and intangible assets. 1602564 false --12-31 Q3 0000778164 Amounts derived from the audited consolidated financial statements for the year ended December 31, 2021. This category includes investments in funds comprised of equity securities of large U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. Included in other assets in the consolidated balance sheets. This category includes investments in funds comprised of equity securities of small- and medium-sized U.S. companies. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. This category includes investments in funds comprised of U.S. and foreign investment-grade fixed income securities, high-yield fixed income securities that are rated below investment-grade, U.S. treasury securities, mortgage-backed securities, and other asset-backed securities. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. This category includes investments in funds comprised of equity securities of foreign companies including emerging markets. The funds are valued using the net asset value method in which an average of the market prices for the underlying investments is used to value the fund. EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 280 269 1 true 53 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://altoingredients.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://altoingredients.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://altoingredients.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://altoingredients.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders??? Equity (Unaudited) Sheet http://altoingredients.com/role/ShareholdersEquityType2or3 Consolidated Statements of Stockholders??? Equity (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Organization and Basis of Presentation Sheet http://altoingredients.com/role/OrganizationandBasisofPresentation Organization and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Acquisition of Eagle Alcohol Sheet http://altoingredients.com/role/AcquisitionofEagleAlcohol Acquisition of Eagle Alcohol Notes 8 false false R9.htm 008 - Disclosure - Segments Sheet http://altoingredients.com/role/Segments Segments Notes 9 false false R10.htm 009 - Disclosure - Inventories Sheet http://altoingredients.com/role/Inventories Inventories Notes 10 false false R11.htm 010 - Disclosure - Derivatives Sheet http://altoingredients.com/role/Derivatives Derivatives Notes 11 false false R12.htm 011 - Disclosure - Debt Sheet http://altoingredients.com/role/Debt Debt Notes 12 false false R13.htm 012 - Disclosure - Commitments and Contingencies Sheet http://altoingredients.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Pension and Retirement Benefit Plans Sheet http://altoingredients.com/role/PensionandRetirementBenefitPlans Pension and Retirement Benefit Plans Notes 14 false false R15.htm 014 - Disclosure - Fair Value Measurements Sheet http://altoingredients.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 015 - Disclosure - Earnings (Loss) Per Share Sheet http://altoingredients.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 16 false false R17.htm 016 - Disclosure - Subsequent Events Sheet http://altoingredients.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 017 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://altoingredients.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 18 false false R19.htm 018 - Disclosure - Acquisition of Eagle Alcohol (Tables) Sheet http://altoingredients.com/role/AcquisitionofEagleAlcoholTables Acquisition of Eagle Alcohol (Tables) Tables http://altoingredients.com/role/AcquisitionofEagleAlcohol 19 false false R20.htm 019 - Disclosure - Segments (Tables) Sheet http://altoingredients.com/role/SegmentsTables Segments (Tables) Tables http://altoingredients.com/role/Segments 20 false false R21.htm 020 - Disclosure - Inventories (Tables) Sheet http://altoingredients.com/role/InventoriesTables Inventories (Tables) Tables http://altoingredients.com/role/Inventories 21 false false R22.htm 021 - Disclosure - Derivatives (Tables) Sheet http://altoingredients.com/role/DerivativesTables Derivatives (Tables) Tables http://altoingredients.com/role/Derivatives 22 false false R23.htm 022 - Disclosure - Debt (Tables) Sheet http://altoingredients.com/role/DebtTables Debt (Tables) Tables http://altoingredients.com/role/Debt 23 false false R24.htm 023 - Disclosure - Fair Value Measurements (Tables) Sheet http://altoingredients.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://altoingredients.com/role/FairValueMeasurements 24 false false R25.htm 024 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://altoingredients.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://altoingredients.com/role/EarningsLossPerShare 25 false false R26.htm 025 - Disclosure - Organization and Basis of Presentation (Details) Sheet http://altoingredients.com/role/OrganizationandBasisofPresentationDetails Organization and Basis of Presentation (Details) Details http://altoingredients.com/role/OrganizationandBasisofPresentation 26 false false R27.htm 026 - Disclosure - Acquisition of Eagle Alcohol (Details) Sheet http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails Acquisition of Eagle Alcohol (Details) Details http://altoingredients.com/role/AcquisitionofEagleAlcoholTables 27 false false R28.htm 027 - Disclosure - Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred Sheet http://altoingredients.com/role/ScheduleofproformacombinedfinancialinformationassumingtheacquisitionoccurredTable Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred Details http://altoingredients.com/role/AcquisitionofEagleAlcoholTables 28 false false R29.htm 028 - Disclosure - Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation Sheet http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation Details http://altoingredients.com/role/AcquisitionofEagleAlcoholTables 29 false false R30.htm 029 - Disclosure - Segments (Details) - Schedule of financial data for operating segments Sheet http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable Segments (Details) - Schedule of financial data for operating segments Details http://altoingredients.com/role/SegmentsTables 30 false false R31.htm 030 - Disclosure - Segments (Details) - Schedule of assets by operating segments Sheet http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable Segments (Details) - Schedule of assets by operating segments Details http://altoingredients.com/role/SegmentsTables 31 false false R32.htm 031 - Disclosure - Inventories (Details) Sheet http://altoingredients.com/role/InventoriesDetails Inventories (Details) Details http://altoingredients.com/role/InventoriesTables 32 false false R33.htm 032 - Disclosure - Inventories (Details) - Schedule of inventories Sheet http://altoingredients.com/role/ScheduleofinventoriesTable Inventories (Details) - Schedule of inventories Details http://altoingredients.com/role/InventoriesTables 33 false false R34.htm 033 - Disclosure - Derivatives (Details) Sheet http://altoingredients.com/role/DerivativesDetails Derivatives (Details) Details http://altoingredients.com/role/DerivativesTables 34 false false R35.htm 034 - Disclosure - Derivatives (Details) - Schedule of derivatives not designated as hedging instruments Sheet http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable Derivatives (Details) - Schedule of derivatives not designated as hedging instruments Details http://altoingredients.com/role/DerivativesTables 35 false false R36.htm 035 - Disclosure - Derivatives (Details) - Schedule of recognized gains for its derivatives Sheet http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable Derivatives (Details) - Schedule of recognized gains for its derivatives Details http://altoingredients.com/role/DerivativesTables 36 false false R37.htm 036 - Disclosure - Debt (Details) Sheet http://altoingredients.com/role/DebtDetails Debt (Details) Details http://altoingredients.com/role/DebtTables 37 false false R38.htm 037 - Disclosure - Debt (Details) - Schedule of long-term borrowings Sheet http://altoingredients.com/role/ScheduleoflongtermborrowingsTable Debt (Details) - Schedule of long-term borrowings Details http://altoingredients.com/role/DebtTables 38 false false R39.htm 038 - Disclosure - Commitments and Contingencies (Details) Sheet http://altoingredients.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://altoingredients.com/role/CommitmentsandContingencies 39 false false R40.htm 039 - Disclosure - Pension and Retirement Benefit Plans (Details) Sheet http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails Pension and Retirement Benefit Plans (Details) Details http://altoingredients.com/role/PensionandRetirementBenefitPlans 40 false false R41.htm 040 - Disclosure - Fair Value Measurements (Details) Sheet http://altoingredients.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://altoingredients.com/role/FairValueMeasurementsTables 41 false false R42.htm 041 - Disclosure - Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements Sheet http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements Details http://altoingredients.com/role/FairValueMeasurementsTables 42 false false R43.htm 042 - Disclosure - Earnings (Loss) Per Share (Details) Sheet http://altoingredients.com/role/EarningsLossPerShareDetails Earnings (Loss) Per Share (Details) Details http://altoingredients.com/role/EarningsLossPerShareTables 43 false false R44.htm 043 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share Sheet http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share Details http://altoingredients.com/role/EarningsLossPerShareTables 44 false false R45.htm 044 - Disclosure - Subsequent Events (Details) Sheet http://altoingredients.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://altoingredients.com/role/SubsequentEvents 45 false false All Reports Book All Reports f10q0922_altoingred.htm alto-20220930.xsd alto-20220930_cal.xml alto-20220930_def.xml alto-20220930_lab.xml alto-20220930_pre.xml f10q0922ex31-1_altoingred.htm f10q0922ex31-2_altoingred.htm f10q0922ex32-1_altoingred.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 61 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0922_altoingred.htm": { "axisCustom": 0, "axisStandard": 16, "contextCount": 280, "dts": { "calculationLink": { "local": [ "alto-20220930_cal.xml" ] }, "definitionLink": { "local": [ "alto-20220930_def.xml" ] }, "inline": { "local": [ "f10q0922_altoingred.htm" ] }, "labelLink": { "local": [ "alto-20220930_lab.xml" ] }, "presentationLink": { "local": [ "alto-20220930_pre.xml" ] }, "schema": { "local": [ "alto-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 425, "entityCount": 1, "hidden": { "http://altoingredients.com/20220930": 7, "http://fasb.org/us-gaap/2022": 202, "http://xbrl.sec.gov/dei/2022": 4, "total": 213 }, "keyCustom": 37, "keyStandard": 232, "memberCustom": 32, "memberStandard": 21, "nsprefix": "alto", "nsuri": "http://altoingredients.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://altoingredients.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Inventories", "role": "http://altoingredients.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Derivatives", "role": "http://altoingredients.com/role/Derivatives", "shortName": "Derivatives", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Debt", "role": "http://altoingredients.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Commitments and Contingencies", "role": "http://altoingredients.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Pension and Retirement Benefit Plans", "role": "http://altoingredients.com/role/PensionandRetirementBenefitPlans", "shortName": "Pension and Retirement Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Fair Value Measurements", "role": "http://altoingredients.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Earnings (Loss) Per Share", "role": "http://altoingredients.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Subsequent Events", "role": "http://altoingredients.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://altoingredients.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Acquisition of Eagle Alcohol (Tables)", "role": "http://altoingredients.com/role/AcquisitionofEagleAlcoholTables", "shortName": "Acquisition of Eagle Alcohol (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Consolidated Balance Sheets", "role": "http://altoingredients.com/role/ConsolidatedBalanceSheet", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Segments (Tables)", "role": "http://altoingredients.com/role/SegmentsTables", "shortName": "Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Inventories (Tables)", "role": "http://altoingredients.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Derivatives (Tables)", "role": "http://altoingredients.com/role/DerivativesTables", "shortName": "Derivatives (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Debt (Tables)", "role": "http://altoingredients.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Fair Value Measurements (Tables)", "role": "http://altoingredients.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Earnings (Loss) Per Share (Tables)", "role": "http://altoingredients.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProductionRelatedImpairmentsOrCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Organization and Basis of Presentation (Details)", "role": "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails", "shortName": "Organization and Basis of Presentation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProductionRelatedImpairmentsOrCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c110", "decimals": "2", "first": true, "lang": null, "name": "alto:PurchasedMembershipInterests", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Acquisition of Eagle Alcohol (Details)", "role": "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails", "shortName": "Acquisition of Eagle Alcohol (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c110", "decimals": "2", "first": true, "lang": null, "name": "alto:PurchasedMembershipInterests", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred", "role": "http://altoingredients.com/role/ScheduleofproformacombinedfinancialinformationassumingtheacquisitionoccurredTable", "shortName": "Acquisition of Eagle Alcohol (Details) - Schedule of pro forma combined financial information assuming the acquisition occurred", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c113", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation", "role": "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable", "shortName": "Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c113", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "role": "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Segments (Details) - Schedule of financial data for operating segments", "role": "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable", "shortName": "Segments (Details) - Schedule of financial data for operating segments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c198", "decimals": "-3", "lang": null, "name": "alto:InterestExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Segments (Details) - Schedule of assets by operating segments", "role": "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "shortName": "Segments (Details) - Schedule of assets by operating segments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c206", "decimals": "-3", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryPartsAndComponentsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Inventories (Details)", "role": "http://altoingredients.com/role/InventoriesDetails", "shortName": "Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryPartsAndComponentsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Inventories (Details) - Schedule of inventories", "role": "http://altoingredients.com/role/ScheduleofinventoriesTable", "shortName": "Inventories (Details) - Schedule of inventories", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Derivatives (Details)", "role": "http://altoingredients.com/role/DerivativesDetails", "shortName": "Derivatives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "alto:TypeOfInstrumentCashCollateralBalance", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Derivatives (Details) - Schedule of derivatives not designated as hedging instruments", "role": "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable", "shortName": "Derivatives (Details) - Schedule of derivatives not designated as hedging instruments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "alto:TypeOfInstrumentCashCollateralBalance", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c214", "decimals": null, "first": true, "lang": "en-US", "name": "alto:TypeOfInstrumentRealizedGains", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Derivatives (Details) - Schedule of recognized gains for its derivatives", "role": "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable", "shortName": "Derivatives (Details) - Schedule of recognized gains for its derivatives", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c214", "decimals": null, "first": true, "lang": "en-US", "name": "alto:TypeOfInstrumentRealizedGains", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Debt (Details)", "role": "http://altoingredients.com/role/DebtDetails", "shortName": "Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnamortizedLossReacquiredDebtNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Debt (Details) - Schedule of long-term borrowings", "role": "http://altoingredients.com/role/ScheduleoflongtermborrowingsTable", "shortName": "Debt (Details) - Schedule of long-term borrowings", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c2", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnamortizedLossReacquiredDebtNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "alto:IndexedpricePurchaseContracts", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Commitments and Contingencies (Details)", "role": "http://altoingredients.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "alto:IndexedpricePurchaseContracts", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Statements of Operations (Unaudited)", "role": "http://altoingredients.com/role/ConsolidatedIncomeStatement", "shortName": "Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c228", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Pension and Retirement Benefit Plans (Details)", "role": "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails", "shortName": "Pension and Retirement Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c228", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Fair Value Measurements (Details)", "role": "http://altoingredients.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements", "role": "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable", "shortName": "Fair Value Measurements (Details) - Schedule of recurring and nonrecurring fair value measurements", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Earnings (Loss) Per Share (Details)", "role": "http://altoingredients.com/role/EarningsLossPerShareDetails", "shortName": "Earnings (Loss) Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share", "role": "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable", "shortName": "Earnings (Loss) Per Share (Details) - Schedule of compute basic and diluted earnings per share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c10", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c278", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Subsequent Events (Details)", "role": "http://altoingredients.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c278", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "role": "http://altoingredients.com/role/ConsolidatedCashFlow", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": "-3", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c61", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Statements of Stockholders\u2019 Equity (Unaudited)", "role": "http://altoingredients.com/role/ShareholdersEquityType2or3", "shortName": "Consolidated Statements of Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c68", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Organization and Basis of Presentation", "role": "http://altoingredients.com/role/OrganizationandBasisofPresentation", "shortName": "Organization and Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Acquisition of Eagle Alcohol", "role": "http://altoingredients.com/role/AcquisitionofEagleAlcohol", "shortName": "Acquisition of Eagle Alcohol", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Segments", "role": "http://altoingredients.com/role/Segments", "shortName": "Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_altoingred.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 53, "tag": { "alto_AcquisitionOfEagleAlcoholMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition Of Eagle Alcohol Member", "terseLabel": "Acquisition of Eagle Alcohol [Member]" } } }, "localname": "AcquisitionOfEagleAlcoholMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "domainItemType" }, "alto_AcquisitionofEagleAlcoholDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Eagle Alcohol (Details) [Line Items]" } } }, "localname": "AcquisitionofEagleAlcoholDetailsLineItems", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "stringItemType" }, "alto_AcquisitionofEagleAlcoholDetailsScheduleofpreliminarypurchasepriceallocationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation [Line Items]" } } }, "localname": "AcquisitionofEagleAlcoholDetailsScheduleofpreliminarypurchasepriceallocationLineItems", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "stringItemType" }, "alto_AcquisitionofEagleAlcoholDetailsScheduleofpreliminarypurchasepriceallocationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Eagle Alcohol (Details) - Schedule of preliminary purchase price allocation [Table]" } } }, "localname": "AcquisitionofEagleAlcoholDetailsScheduleofpreliminarypurchasepriceallocationTable", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "stringItemType" }, "alto_AcquisitionofEagleAlcoholDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Eagle Alcohol (Details) [Table]" } } }, "localname": "AcquisitionofEagleAlcoholDetailsTable", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "stringItemType" }, "alto_AlcoholFromItsSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alcohol From Its Suppliers Member", "terseLabel": "Alcohol from Suppliers [Member]" } } }, "localname": "AlcoholFromItsSuppliersMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "alto_AlcoholSalesContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alcohol Sales Contracts Member", "terseLabel": "Alcohol Sales Contracts [Member]" } } }, "localname": "AlcoholSalesContractsMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "alto_AlcoholSalesGrossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alcohol Sales Gross Member", "terseLabel": "Alcohol sales, gross [Member]" } } }, "localname": "AlcoholSalesGrossMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_AlcoholSalesNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alcohol Sales Net Member", "terseLabel": "Alcohol sales, net [Member]" } } }, "localname": "AlcoholSalesNetMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_AltoIngredientsIncStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Alto Ingredients Inc Stockholders Equity Abstract", "terseLabel": "Alto Ingredients, Inc. Stockholders\u2019 Equity:" } } }, "localname": "AltoIngredientsIncStockholdersEquityAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "alto_AssetsAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Abstract0", "terseLabel": "Assets:" } } }, "localname": "AssetsAbstract0", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "stringItemType" }, "alto_AssetsBalanceSheetLocationDerivativesAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, Balance Sheet Location.", "label": "Assets Balance Sheet Location Derivatives Assets", "terseLabel": "Assets, Balance Sheet Location Commodity contracts" } } }, "localname": "AssetsBalanceSheetLocationDerivativesAssets", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "stringItemType" }, "alto_AssetsBalanceSheetLocationRestrictedcashs": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets, balance sheet location cash collateral balance.", "label": "Assets Balance Sheet Location Restrictedcashs", "terseLabel": "Assets, Balance Sheet Location Cash collateral balance" } } }, "localname": "AssetsBalanceSheetLocationRestrictedcashs", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "stringItemType" }, "alto_AssetsFairValueRestrictedcash": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.", "label": "Assets Fair Value Restrictedcash", "terseLabel": "Assets, Fair Value Cash collateral balance" } } }, "localname": "AssetsFairValueRestrictedcash", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "monetaryItemType" }, "alto_BadDebtExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of bad debt expense.", "label": "Bad Debt Expense", "terseLabel": "Bad Debt Expense" } } }, "localname": "BadDebtExpense", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "alto_BasicAndDilutedLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic And Diluted Loss Per Share Abstract", "terseLabel": "Basic and Diluted loss per share:" } } }, "localname": "BasicAndDilutedLossPerShareAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "stringItemType" }, "alto_CashAndCashEquivalents": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "alto_TotalCashCashEquivalentsAndRestrictedCash", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalents.", "label": "Cash And Cash Equivalents", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalents", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "alto_CommitmentsandContingenciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "localname": "CommitmentsandContingenciesDetailsLineItems", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "alto_CommitmentsandContingenciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "localname": "CommitmentsandContingenciesDetailsTable", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "alto_CommonStockValueOne": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value One", "terseLabel": "Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValueOne", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "alto_CornFromSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Corn From Suppliers Member", "terseLabel": "Corn from Suppliers [Member]" } } }, "localname": "CornFromSuppliersMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "alto_CorporateActivitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate Assets [Member]", "label": "Corporate Activities Member", "terseLabel": "Corporate and other [Member]" } } }, "localname": "CorporateActivitiesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_CostOfGoodsSoldAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost Of Goods Sold Abstract", "terseLabel": "Cost of goods sold:" } } }, "localname": "CostOfGoodsSoldAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_CurrentPortionOperatingLeases": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current portion operating leases.", "label": "Current Portion Operating Leases", "terseLabel": "Current portion \u2013 operating leases" } } }, "localname": "CurrentPortionOperatingLeases", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "alto_DepreciationAndAmortizationOfIntangiblesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Depreciation And Amortization Of Intangibles Abstract", "terseLabel": "Depreciation and amortization of intangibles:" } } }, "localname": "DepreciationAndAmortizationOfIntangiblesAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_DepreciationAndAmortizationOfIntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Depreciation And Amortization Of Intangibles Member", "terseLabel": "Depreciation and amortization of intangibles [Member]" } } }, "localname": "DepreciationAndAmortizationOfIntangiblesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_DilutedIncomeAvailableToCommonStockholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diluted Income available to common stockholders shares.", "label": "Diluted Income Available To Common Stockholders", "terseLabel": "Diluted Income available to common stockholders (in Shares)" } } }, "localname": "DilutedIncomeAvailableToCommonStockholders", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "sharesItemType" }, "alto_DilutedIncomeAvailableToCommonStockholdersPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diluted Income available to common stockholders s per share.", "label": "Diluted Income Available To Common Stockholders Per Share", "terseLabel": "Diluted Income available to common stockholders (in Dollars per share)" } } }, "localname": "DilutedIncomeAvailableToCommonStockholdersPerShare", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "perShareItemType" }, "alto_DilutedIncomePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Diluted Income Per Share Abstract", "terseLabel": "Diluted income per share:" } } }, "localname": "DilutedIncomePerShareAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "stringItemType" }, "alto_DilutiveInstruments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive securities shares.", "label": "Dilutive Instruments", "terseLabel": "Add: Dilutive instruments (in Shares)" } } }, "localname": "DilutiveInstruments", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "sharesItemType" }, "alto_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_EssentialIngredientSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Essential Ingredient Sales Member", "terseLabel": "Essential Ingredient Sales [Member]" } } }, "localname": "EssentialIngredientSalesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_EthanolAlcoholSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ethanol Alcohol Sales Member", "terseLabel": "Alcohol Sales [Member]", "verboseLabel": "Alcohol sales [Member]" } } }, "localname": "EthanolAlcoholSalesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_EthanolPurchaseContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ethanol Purchase Contracts [Member]", "label": "Ethanol Purchase Contracts Member", "terseLabel": "Purchase Commitments [Member]" } } }, "localname": "EthanolPurchaseContractsMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "alto_ExcessAmountOfInitialPurchase": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Authorization excess amount of initial purchase.", "label": "Excess Amount Of Initial Purchase", "terseLabel": "Excess amount of initial purchase" } } }, "localname": "ExcessAmountOfInitialPurchase", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "alto_FixedIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fixed Income Member", "terseLabel": "Fixed Income [Member]" } } }, "localname": "FixedIncomeMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "alto_GrossProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gross Profit Loss Abstract", "terseLabel": "Gross profit (loss):" } } }, "localname": "GrossProfitLossAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_IncomeAllocatedToParticipatingSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income allocated to participating securities.", "label": "Income Allocated To Participating Securities", "terseLabel": "Less: Income allocated to participating securities" } } }, "localname": "IncomeAllocatedToParticipatingSecurities", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "alto_IncomeFromLoanForgiveness": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income from loan forgiveness", "label": "Income From Loan Forgiveness", "negatedLabel": "Income from loan forgiveness" } } }, "localname": "IncomeFromLoanForgiveness", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "alto_IncomeLossBeforeProvisionForIncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Loss Before Provision For Income Taxes Abstract", "terseLabel": "Income (loss) before provision for income taxes:" } } }, "localname": "IncomeLossBeforeProvisionForIncomeTaxesAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_IncomelossAvailableToCommonStockholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Incomeloss Available To Common Stockholders", "terseLabel": "Income (loss) available to common stockholders" } } }, "localname": "IncomelossAvailableToCommonStockholders", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "alto_IncomelossAvailableToCommonStockholdersInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Incomeloss Available To Common Stockholders In Shares", "terseLabel": "Income (loss) available to common stockholders (in Shares)" } } }, "localname": "IncomelossAvailableToCommonStockholdersInShares", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "sharesItemType" }, "alto_IncomelossBeforeBenefitForIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income (loss) before benefit for income taxes.", "label": "Incomeloss Before Benefit For Income Taxes", "terseLabel": "Income before provision for income taxes" } } }, "localname": "IncomelossBeforeBenefitForIncomeTaxes", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "alto_IncomelossBeforeProvisionForIncomeTaxesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incomeloss Before Provision For Income Taxes Member", "terseLabel": "Income (loss) before provision for income taxes [Member]" } } }, "localname": "IncomelossBeforeProvisionForIncomeTaxesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_IncreaseDecreaseInOtherAssets": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) classified as other.", "label": "Increase Decrease In Other Assets", "terseLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherAssets", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "alto_IndexedpricePurchaseContracts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indexed-price purchase contracts", "label": "Indexedprice Purchase Contracts", "terseLabel": "Indexed price purchase contracts gallons" } } }, "localname": "IndexedpricePurchaseContracts", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "integerItemType" }, "alto_InterestExpenseNetOfCapitalizedInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Expense Net Of Capitalized Interest Abstract", "terseLabel": "Interest expense, net of capitalized interest:" } } }, "localname": "InterestExpenseNetOfCapitalizedInterestAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_InterestExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expenses.", "label": "Interest Expenses", "terseLabel": "Interest expense, net of capitalized interest" } } }, "localname": "InterestExpenses", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "alto_InternationalEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "International Equity Member", "terseLabel": "International Equity [Member]" } } }, "localname": "InternationalEquityMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "alto_IntersegmentEliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intersegment Eliminations Member", "terseLabel": "Intersegment Eliminations [Member]" } } }, "localname": "IntersegmentEliminationsMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_IntersegmentSaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intersegment Sale Member", "terseLabel": "Intersegment Sales [Member]" } } }, "localname": "IntersegmentSaleMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_LargeUSEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Large USEquity Member", "terseLabel": "Large U.S. Equity [Member]" } } }, "localname": "LargeUSEquityMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "alto_LiabilitiesBalanceSheetLocation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liabilities, Balance Sheet Location.", "label": "Liabilities Balance Sheet Location", "terseLabel": "Liabilities, Balance Sheet Location Cash collateral balance" } } }, "localname": "LiabilitiesBalanceSheetLocation", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "stringItemType" }, "alto_LiabilitiesBalanceSheetLocationDerivativeLiabilities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liabilities, Balance Sheet Location.", "label": "Liabilities Balance Sheet Location Derivative Liabilities", "terseLabel": "Liabilities, Balance Sheet Location Commodity contracts" } } }, "localname": "LiabilitiesBalanceSheetLocationDerivativeLiabilities", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "stringItemType" }, "alto_LoanAdvance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loan.", "label": "Loan Advance", "terseLabel": "Loan" } } }, "localname": "LoanAdvance", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "alto_LonglivedAssetsHeldforsaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Longlived Assets Heldforsale Member", "terseLabel": "Long-lived assets held-for-sale [Member]" } } }, "localname": "LonglivedAssetsHeldforsaleMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "alto_MarketingAndDistributionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Marketing And Distributions Member", "terseLabel": "Marketing and Distribution [Member]", "verboseLabel": "Marketing and distribution [Member]" } } }, "localname": "MarketingAndDistributionsMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_NetSalesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Sales Abstract", "terseLabel": "Net Sales" } } }, "localname": "NetSalesAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_NetSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Sales Member", "terseLabel": "Net sales as reported [Member]" } } }, "localname": "NetSalesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_NetWorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of net working capital.", "label": "Net Working Capital", "terseLabel": "Net working capital" } } }, "localname": "NetWorkingCapital", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "alto_OrganizationandBasisofPresentationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Basis of Presentation (Details) [Line Items]" } } }, "localname": "OrganizationandBasisofPresentationDetailsLineItems", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "alto_OrganizationandBasisofPresentationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Basis of Presentation (Details) [Table]" } } }, "localname": "OrganizationandBasisofPresentationDetailsTable", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "alto_OtherProductionIncomeTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Production Income Tax Member", "terseLabel": "Other production [Member]" } } }, "localname": "OtherProductionIncomeTaxMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_OwnershipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ownership [Member]", "label": "Ownership Member", "terseLabel": "Ownership [Member]" } } }, "localname": "OwnershipMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "alto_PekinCampusMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pekin Campus Member", "terseLabel": "Pekin Campus Production [Member]", "verboseLabel": "Pekin Campus [Member]" } } }, "localname": "PekinCampusMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_PekinCampusRecordedAsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pekin Campus Recorded As Gross Abstract", "terseLabel": "Pekin Campus, recorded as gross:" } } }, "localname": "PekinCampusRecordedAsGrossAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_PensionandRetirementBenefitPlansDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pension and Retirement Benefit Plans (Details) [Line Items]" } } }, "localname": "PensionandRetirementBenefitPlansDetailsLineItems", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "alto_PensionandRetirementBenefitPlansDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pension and Retirement Benefit Plans (Details) [Table]" } } }, "localname": "PensionandRetirementBenefitPlansDetailsTable", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "alto_ProductionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Production Member", "terseLabel": "Pekin Campus Production [Member]" } } }, "localname": "ProductionMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_PurchaseAdditionalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase additional amount.", "label": "Purchase Additional Amount", "terseLabel": "Purchase additional amount" } } }, "localname": "PurchaseAdditionalAmount", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "alto_PurchasedMembershipInterests": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased membership interests.", "label": "Purchased Membership Interests", "terseLabel": "Purchased membership interests" } } }, "localname": "PurchasedMembershipInterests", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "percentItemType" }, "alto_RealizedGainsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Realized Gains Member", "terseLabel": "Realized Gains [Member]" } } }, "localname": "RealizedGainsMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "domainItemType" }, "alto_RealizedLossesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Realized Losses Member", "terseLabel": "Realized Losses [Member]" } } }, "localname": "RealizedLossesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "domainItemType" }, "alto_ReconciliationOfTotalCashCashEquivalentsAndRestrictedCashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation Of Total Cash Cash Equivalents And Restricted Cash Abstract", "terseLabel": "Reconciliation of total cash, cash equivalents and restricted cash:" } } }, "localname": "ReconciliationOfTotalCashCashEquivalentsAndRestrictedCashAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "alto_RepurchaseOfCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of repurchase of common stock.", "label": "Repurchase Of Common Stock", "terseLabel": "Repurchase of common stock" } } }, "localname": "RepurchaseOfCommonStock", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "alto_RepurchasedAnAggregateSharesInCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repurchased an aggregate shares in cash.", "label": "Repurchased An Aggregate Shares In Cash", "terseLabel": "Repurchased an aggregate shares in cash" } } }, "localname": "RepurchasedAnAggregateSharesInCash", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "alto_ScheduleOfAssetsByOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Assets By Operating Segments Abstract" } } }, "localname": "ScheduleOfAssetsByOperatingSegmentsAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfComputeBasicAndDilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Compute Basic And Diluted Earnings Per Share Abstract" } } }, "localname": "ScheduleOfComputeBasicAndDilutedEarningsPerShareAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfDerivativesNotDesignatedAsHedgingInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Derivatives Not Designated As Hedging Instruments Abstract" } } }, "localname": "ScheduleOfDerivativesNotDesignatedAsHedgingInstrumentsAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfFinancialDataForOperatingSegmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Financial Data For Operating Segments Abstract" } } }, "localname": "ScheduleOfFinancialDataForOperatingSegmentsAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfInventoriesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Inventories Abstract" } } }, "localname": "ScheduleOfInventoriesAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfLongTermBorrowingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Long Term Borrowings Abstract" } } }, "localname": "ScheduleOfLongTermBorrowingsAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfPreliminaryPurchasePriceAllocationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Preliminary Purchase Price Allocation Abstract" } } }, "localname": "ScheduleOfPreliminaryPurchasePriceAllocationAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfProFormaCombinedFinancialInformationAssumingTheAcquisitionOccurredAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Pro Forma Combined Financial Information Assuming The Acquisition Occurred Abstract" } } }, "localname": "ScheduleOfProFormaCombinedFinancialInformationAssumingTheAcquisitionOccurredAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfRecognizedGainsForItsDerivativesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Recognized Gains For Its Derivatives Abstract" } } }, "localname": "ScheduleOfRecognizedGainsForItsDerivativesAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ScheduleOfRecurringAndNonrecurringFairValueMeasurementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Recurring And Nonrecurring Fair Value Measurements Abstract" } } }, "localname": "ScheduleOfRecurringAndNonrecurringFairValueMeasurementsAbstract", "nsuri": "http://altoingredients.com/20220930", "xbrltype": "stringItemType" }, "alto_ShareRepurchaseProgramPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Repurchase Program [Policy Text Block]", "label": "Share Repurchase Program Policy Text Block", "terseLabel": "Share Repurchase Program" } } }, "localname": "ShareRepurchaseProgramPolicyTextBlock", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "alto_SharesBasedCompensation": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation", "label": "Shares Based Compensation", "terseLabel": "Non-cash compensation" } } }, "localname": "SharesBasedCompensation", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "alto_SmallMidUSEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Small Mid USEquity Member", "terseLabel": "Small/Mid U.S. Equity [Member]" } } }, "localname": "SmallMidUSEquityMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "alto_StatementsOfOperationsLocationRealizedGains": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statements of Operations Location.", "label": "Statements Of Operations Location Realized Gains", "terseLabel": "Statements of Operations Location" } } }, "localname": "StatementsOfOperationsLocationRealizedGains", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "alto_StatementsOfOperationsLocationUnrealizedLosses": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statements of Operations Location.", "label": "Statements Of Operations Location Unrealized Losses", "terseLabel": "Statements of Operations Location" } } }, "localname": "StatementsOfOperationsLocationUnrealizedLosses", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "alto_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "alto_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "alto_TotalAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Assets Abstract", "terseLabel": "Total assets:" } } }, "localname": "TotalAssetsAbstract", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "alto_TotalCashCashEquivalentsAndRestrictedCash": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total cash, cash equivalents and restricted cash.", "label": "Total Cash Cash Equivalents And Restricted Cash", "totalLabel": "Total cash, cash equivalents and restricted cash" } } }, "localname": "TotalCashCashEquivalentsAndRestrictedCash", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "alto_TotalMarketingAndDistributionSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total marketing and distribution sales [Member]", "label": "Total Marketing And Distribution Sales Member", "terseLabel": "Total Marketing and Distribution Sales [Member]" } } }, "localname": "TotalMarketingAndDistributionSalesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_TotalOtherProductionSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Other production sales [Member]", "label": "Total Other Production Sales Member", "terseLabel": "Total Other production Sales [Member]" } } }, "localname": "TotalOtherProductionSalesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_TotalPekinCampusSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Pekin Campus sales [Member]", "label": "Total Pekin Campus Sales Member", "terseLabel": "Total Pekin Campus Sales [Member]" } } }, "localname": "TotalPekinCampusSalesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "alto_TypeOfInstrumentCashCollateralBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of Instrument Cash collateral balance.", "label": "Type Of Instrument Cash Collateral Balance", "terseLabel": "Type of Instrument Cash collateral balance" } } }, "localname": "TypeOfInstrumentCashCollateralBalance", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "stringItemType" }, "alto_TypeOfInstrumentCommoditysContracts1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of Instrument.", "label": "Type Of Instrument Commoditys Contracts1", "terseLabel": "Type of Instrument Commodity contracts" } } }, "localname": "TypeOfInstrumentCommoditysContracts1", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "stringItemType" }, "alto_TypeOfInstrumentRealizedGains": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of derivative instrument, such as a swap, forward, and option. Excludes the underlying risk of the instrument.", "label": "Type Of Instrument Realized Gains", "terseLabel": "Type of Instrument" } } }, "localname": "TypeOfInstrumentRealizedGains", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "alto_TypeOfInstrumentUnrealizedLosses": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of derivative instrument, such as a swap, forward, and option. Excludes the underlying risk of the instrument.", "label": "Type Of Instrument Unrealized Losses", "terseLabel": "Type of Instrument" } } }, "localname": "TypeOfInstrumentUnrealizedLosses", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "alto_UnrealizedGainsLossesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unrealized Gains Losses Member", "terseLabel": "Unrealized Gains (Losses) [Member]" } } }, "localname": "UnrealizedGainsLossesMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "domainItemType" }, "alto_UnrealizedGainsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unrealized Gains Member", "terseLabel": "Unrealized Gains [Member]" } } }, "localname": "UnrealizedGainsMember", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "domainItemType" }, "alto_ValueOfRestrictedCash": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "alto_TotalCashCashEquivalentsAndRestrictedCash", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Value Of Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "ValueOfRestrictedCash", "nsuri": "http://altoingredients.com/20220930", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r547" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r544" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://altoingredients.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r92", "r246", "r250", "r255", "r396", "r397", "r401", "r402", "r457", "r543" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r176", "r243", "r244", "r284", "r285", "r496", "r529", "r530" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r176", "r243", "r244", "r284", "r285", "r496", "r529", "r530" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.", "label": "Accounts and Other Receivables, Net, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsAndOtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r10", "r41" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable \u2013 trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r7", "r24", "r181", "r182" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableSale": { "auth_ref": [ "r200" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease from sale of accounts receivable.", "label": "Accounts Receivable, Sale", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableSale", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r27", "r52", "r53", "r54", "r520", "r535", "r536" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r51", "r54", "r57", "r58", "r59", "r94", "r95", "r96", "r400", "r453", "r531", "r532" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accum. Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r25", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r94", "r95", "r96", "r374", "r375", "r376", "r422" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r31", "r187", "r199" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Net of allowance for doubtful accounts (in Dollars)" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r67", "r81", "r266", "r446" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of deferred financing fees" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r81", "r225", "r230" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization amount" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Potentially dilutive shares from convertible securities outstanding" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r81", "r233" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "negatedLabel": "Asset impairments", "terseLabel": "Asset impairments" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow", "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r16", "r90", "r158", "r165", "r172", "r197", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r396", "r401", "r437", "r458", "r460", "r501", "r516" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r40", "r90", "r197", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r396", "r401", "r437", "r458", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": { "auth_ref": [ "r232", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.", "label": "Assets Held-for-sale, Not Part of Disposal Group, Current", "terseLabel": "Accounts receivable, net (net of allowance for doubtful accounts of $135 and $378, respectively)" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date.", "label": "Assets, Total [Member]", "terseLabel": "Total [Member]" } } }, "localname": "AssetsTotalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation\u2013Interim Financial Statements" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r93" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Organization and Business" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r383", "r384" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net income (loss)" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r383", "r384" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenues \u2013 pro forma" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofproformacombinedfinancialinformationassumingtheacquisitionoccurredTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r390", "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r388", "r392" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "ACQUISITION OF EAGLE ALCOHOL" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcohol" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r385", "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r385", "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Net tangible assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r385", "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "terseLabel": "Total Purchase Price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Eagle Alcohol [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r12", "r460", "r538", "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r12", "r83" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r77", "r83", "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r77", "r438" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": { "auth_ref": [ "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.", "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge", "terseLabel": "Recognized net gains" } } }, "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/DerivativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r21", "r22", "r23", "r89", "r90", "r111", "r112", "r117", "r120", "r124", "r134", "r135", "r136", "r197", "r246", "r250", "r251", "r252", "r255", "r256", "r274", "r275", "r276", "r277", "r279", "r437", "r549" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Common stock exercise price per share (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/EarningsLossPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r47", "r508", "r526" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r240", "r241", "r242", "r245", "r542" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockHeldBySubsidiary": { "auth_ref": [ "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of entity shares held by subsidiary, which are purchased for the purpose of granting the shares to senior employees as part of an employee stock option plan approved by the Entity's Board of Directors. Presented as a reduction of shareholders' equity at their cost to the subsidiary.", "label": "Common Stock Held by Subsidiary", "terseLabel": "Aggregate of common stock" } } }, "localname": "CommonStockHeldBySubsidiary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r94", "r95", "r422" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r23", "r279" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r23", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; 300,000 shares authorized; 73,956 and 72,778 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r141", "r142", "r179", "r435", "r436", "r541" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r141", "r142", "r179", "r435", "r436", "r537", "r541" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_CorporateAndOtherMember": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.", "label": "Corporate and Other [Member]", "terseLabel": "Corporate and other [Member]" } } }, "localname": "CorporateAndOtherMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r65", "r496" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r88", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r265", "r267", "r268", "r270", "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r18" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Debt Instrument, Annual Principal Payment", "terseLabel": "Annual payments of essential ingredients" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount", "terseLabel": "Unused borrowing" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/DebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan, Accumulated Benefit Obligation", "terseLabel": "Projected benefit obligation, amount" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r289", "r328", "r351", "r357", "r358" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "terseLabel": "Amortization expense" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r289", "r327", "r350", "r357", "r358" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r288", "r311", "r357" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "terseLabel": "Underfunded amount" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r289", "r294", "r326", "r349", "r357", "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan, Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r324", "r347", "r357", "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "terseLabel": "Net periodic expense (income)" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "auth_ref": [ "r345", "r346", "r357" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r312", "r357" ], "lang": { "en-us": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage", "terseLabel": "Benefit Plan Percentage Allocation" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r290", "r331", "r354" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "terseLabel": "Retirement plan\u2019s net periodic benefit" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r292", "r325", "r348", "r357", "r358" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan, Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPostretirementLifeInsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide postretirement life insurance benefits to retiree or beneficiary. Includes, but is not limited to, defined benefit and defined contribution plans.", "label": "Postretirement Life Insurance [Member]", "terseLabel": "Postretirement Plan [Member]" } } }, "localname": "DefinedBenefitPostretirementLifeInsuranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r81", "r234" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and amortization of intangibles" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r81", "r234" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization of intangibles" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Current", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFinancialInstrumentsAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).", "label": "Derivative Financial Instruments, Assets [Member]", "terseLabel": "Derivative Financial Instruments, Assets [Member]" } } }, "localname": "DerivativeFinancialInstrumentsAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFinancialInstrumentsLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This item represents derivative instrument obligations meeting the definition of a liability which are reported as of the balance sheet date. Derivative instrument obligations are generally measured at fair value, and adjustments to the carrying amount of hedged items reflect changes in their fair value (that is, losses) that are attributable to the risk being hedged and that arise while the hedge is in effect.", "label": "Derivative Financial Instruments, Liabilities [Member]", "terseLabel": "Derivative Financial Instruments, Liabilities [Member]" } } }, "localname": "DerivativeFinancialInstrumentsLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r421", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "DERIVATIVES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/Derivatives" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r408", "r409", "r413", "r415", "r416", "r418", "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value", "terseLabel": "Assets, Fair Value Commodity contracts" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DilutiveSecurities": { "auth_ref": [ "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.", "label": "Dilutive Securities, Effect on Basic Earnings Per Share", "terseLabel": "Add: Dilutive instruments" } } }, "localname": "DilutiveSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Diluted net income (loss) per share \u2013 pro forma (in Dollars per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofproformacombinedfinancialinformationassumingtheacquisitionoccurredTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r281", "r514" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Preferred stock dividends" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r61", "r99", "r100", "r101", "r102", "r103", "r107", "r111", "r120", "r123", "r124", "r130", "r131", "r423", "r424", "r509", "r527" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net income (loss) per share, basic (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r61", "r99", "r100", "r101", "r102", "r103", "r111", "r120", "r123", "r124", "r130", "r131", "r423", "r424", "r509", "r527" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net income (loss) per share, diluted (in Dollars per share)", "verboseLabel": "Income (loss) available to common stockholders (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement", "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r126", "r128", "r129", "r132" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "EARNINGS (LOSS) PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r57", "r58", "r59", "r94", "r95", "r96", "r98", "r104", "r106", "r133", "r198", "r279", "r281", "r374", "r375", "r376", "r378", "r379", "r422", "r439", "r440", "r441", "r442", "r443", "r444", "r453", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity interest owned" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r426", "r427", "r432" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r426", "r427", "r428", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Schedule of recurring and nonrecurring fair value measurements" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r264", "r271", "r272", "r313", "r315", "r316", "r317", "r318", "r319", "r320", "r357", "r427", "r467", "r468", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueHedgeLiabilitiesAtFairValue": { "auth_ref": [ "r410" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.", "label": "Fair Value Hedge Liabilities", "terseLabel": "Liabilities, Fair Value Cash collateral balance" } } }, "localname": "FairValueHedgeLiabilitiesAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r264", "r313", "r315", "r320", "r357", "r427", "r467" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r264", "r271", "r272", "r313", "r315", "r320", "r357", "r427", "r468" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r264", "r271", "r272", "r313", "r315", "r316", "r317", "r318", "r319", "r320", "r357", "r427", "r469" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r264", "r271", "r272", "r313", "r315", "r316", "r317", "r318", "r319", "r320", "r357", "r467", "r468", "r469" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r433", "r434" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "auth_ref": [ "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Right of use liability" } } }, "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r191", "r192", "r193", "r194", "r195", "r201", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r269", "r278", "r421", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r549", "r550", "r551", "r552", "r553", "r554", "r555" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Liabilities, Fair Value Commodity contracts" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofderivativesnotdesignatedashedginginstrumentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedCustomerRelationshipsGross": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date to an asset acquired in a business combination representing a favorable existing relationship with customers having a finite beneficial life.", "label": "Finite-Lived Customer Relationships, Gross", "terseLabel": "Customer relationships" } } }, "localname": "FiniteLivedCustomerRelationshipsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r226", "r227", "r229", "r231", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r226", "r228" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedTradeNamesGross": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a reasonably expected period of economic benefit.", "label": "Finite-Lived Trade Names, Gross", "terseLabel": "Tradename" } } }, "localname": "FiniteLivedTradeNamesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet": { "auth_ref": [ "r407", "r417" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain and losses (whether realized or unrealized) on all derivative instruments held for trading purposes whether or not settled physically.", "label": "Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net", "terseLabel": "Realized Gains", "verboseLabel": "Total Realized Gains" } } }, "localname": "GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfInvestments": { "auth_ref": [ "r81" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.", "label": "Gain (Loss) on Sale of Investments", "negatedLabel": "Income from loan forgiveness" } } }, "localname": "GainLossOnSaleOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r14", "r214", "r215", "r222", "r224", "r460", "r499" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r63", "r90", "r158", "r164", "r168", "r171", "r174", "r197", "r246", "r247", "r248", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r437" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross profit", "totalLabel": "Gross profit (loss)" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuarantyAssets": { "auth_ref": [ "r507" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the contractual right to receive fees, as compensation in exchange for providing a guarantee to a third party, over life of the guarantee.", "label": "Guaranty Assets", "terseLabel": "Total tangible assets" } } }, "localname": "GuarantyAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r91", "r105", "r106", "r156", "r377", "r380", "r381", "r528" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r80" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r80" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAssetsHeldForSale": { "auth_ref": [ "r80" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in book value of long-lived assets that the reporting entity plans to sell within one year (or one business cycle).", "label": "Increase (Decrease) in Assets Held-for-sale", "negatedLabel": "Assets held-for-sale" } } }, "localname": "IncreaseDecreaseInAssetsHeldForSale", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInMortgageLoansHeldForSale": { "auth_ref": [ "r80" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the value of mortgage loans that are held with the intention to sell or be securitized in the near future.", "label": "Increase (Decrease) in Mortgage Loans Held-for-sale", "negatedLabel": "Liabilities held-for-sale" } } }, "localname": "IncreaseDecreaseInMortgageLoansHeldForSale", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Liabilities [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of business acquisition:" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r80" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss": { "auth_ref": [ "r511" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income or expense, including any amortization and accretion (as applicable) of discounts and premiums, including consideration of the provisions for loan, lease, credit, and other related losses.", "label": "Interest Income (Expense), after Provision for Loan Loss", "totalLabel": "Income (loss) before provision for income taxes" } } }, "localname": "InterestIncomeExpenseAfterProvisionForLoanLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r510" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "terseLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "terseLabel": "Income from cash grant" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r75", "r78", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntermediateLifePlantsUsefulLife": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Useful life of intermediate-life plants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Intermediate-life Plants, Useful Life", "terseLabel": "Estimated for useful life" } } }, "localname": "IntermediateLifePlantsUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "durationItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r32" ], "calculation": { "http://altoingredients.com/role/ScheduleofinventoriesTable": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r38" ], "calculation": { "http://altoingredients.com/role/ScheduleofinventoriesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Total" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReservePeriodCharge": { "auth_ref": [ "r211" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.", "label": "Inventory, LIFO Reserve, Period Charge", "terseLabel": "Inventory valuation" } } }, "localname": "InventoryLIFOReservePeriodCharge", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r38", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPartsAndComponentsNetOfReserves": { "auth_ref": [ "r35", "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date for elements of machinery or equipment held for the purpose of replacing similar parts in the course of repair or maintenance.", "label": "Inventory, Parts and Components, Net of Reserves", "terseLabel": "Inventory net" } } }, "localname": "InventoryPartsAndComponentsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/InventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r34" ], "calculation": { "http://altoingredients.com/role/ScheduleofinventoriesTable": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Raw Materials, Gross", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r33" ], "calculation": { "http://altoingredients.com/role/ScheduleofinventoriesTable": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory, Work in Process, Gross", "terseLabel": "Work in progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r42", "r90", "r166", "r197", "r246", "r247", "r248", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r397", "r401", "r402", "r437", "r458", "r459" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r30", "r90", "r197", "r437", "r460", "r505", "r522" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r9", "r44", "r90", "r197", "r246", "r247", "r248", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r397", "r401", "r402", "r437", "r458", "r459", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r426" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansAndLeasesReceivableGainLossOnSalesNet": { "auth_ref": [ "r477" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reflects the net positive or negative amount derived from subtracting from net proceeds of sale and the carrying amounts, net of allocated reserves, of financial assets transferred to third parties in transactions that qualify for sales treatment.", "label": "Loans and Leases Receivable, Gain (Loss) on Sales, Net", "terseLabel": "Net sales" } } }, "localname": "LoansAndLeasesReceivableGainLossOnSalesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r18" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, net of current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.", "label": "Long-Term Purchase Commitment, Amount", "terseLabel": "Future commitments for capital projects" } } }, "localname": "LongTermPurchaseCommitmentAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NaturalGasProductionMember": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Process of obtaining and processing of flammable gas occurring naturally underground.", "label": "Natural Gas, Production [Member]", "terseLabel": "Natural Gas [Member]" } } }, "localname": "NaturalGasProductionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r77" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r77" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r77", "r79", "r82" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r99", "r100", "r101", "r102", "r107", "r108", "r119", "r124", "r158", "r164", "r168", "r171", "r174" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income (loss) available to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r110", "r113", "r114", "r115", "r116", "r119", "r124" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Diluted Income available to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Net income (loss) available to common stockholders \u2013 pro forma" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofproformacombinedfinancialinformationassumingtheacquisitionoccurredTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r94", "r95", "r96", "r281", "r393" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non- Controlling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_NonvotingCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock securities that do not empower a holder to vote on corporate resolutions or the election of directors.", "label": "Nonvoting Common Stock [Member]", "terseLabel": "Non-Voting Common Stock" } } }, "localname": "NonvotingCommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_NotesAndLoansReceivableNetCurrent": { "auth_ref": [ "r181", "r182", "r506" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.", "label": "Financing Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Notes receivable, current" } } }, "localname": "NotesAndLoansReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r158", "r164", "r168", "r171", "r174" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r448" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating leases, net of current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r449", "r451" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "negatedLabel": "Operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r447" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right of use operating lease assets, net", "verboseLabel": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r4", "r406" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND BASIS OF PRESENTATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r15", "r500", "r515" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "terseLabel": "Other assets", "totalLabel": "Total other assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]", "terseLabel": "Other Assets:" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r39", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "verboseLabel": "Total current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r15" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Intangible assets, net" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventory": { "auth_ref": [ "r35" ], "calculation": { "http://altoingredients.com/role/ScheduleofinventoriesTable": { "order": 4.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of other inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Other Inventory, Gross", "terseLabel": "Other" } } }, "localname": "OtherInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r43", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities", "verboseLabel": "Current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet", "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r18", "r503", "r518" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-Term Debt", "terseLabel": "Long-term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoflongtermborrowingsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r68" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_InterestIncomeExpenseAfterProvisionForLoanLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expense classified as other.", "label": "Other Selling, General and Administrative Expense", "terseLabel": "General and administrative expenses" } } }, "localname": "OtherSellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilities": { "auth_ref": [ "r17", "r19", "r502", "r517" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate carrying amount, as of the balance sheets date, of obligations not otherwise itemized or categorized in the footnotes to the financial statements.", "label": "Other Sundry Liabilities", "terseLabel": "Total liabilities" } } }, "localname": "OtherSundryLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r73" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Stock repurchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r73" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Preferred stock dividends paid" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r70" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Purchase of Eagle Alcohol, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r71" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Additions to property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r312", "r314", "r320", "r337", "r339", "r340", "r341", "r342", "r343", "r357", "r359", "r360", "r361", "r371" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "PENSION AND RETIREMENT BENEFIT PLANS" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r286", "r288", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r341", "r344", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r361", "r362", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Retirement Plan [Member]" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockAccretionOfRedemptionDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of accretion of the preferred stock redemption discount during the period.", "label": "Preferred Stock, Accretion of Redemption Discount", "terseLabel": "Accrued preferred stock dividends" } } }, "localname": "PreferredStockAccretionOfRedemptionDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsAndOtherAdjustments": { "auth_ref": [ "r108", "r125" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate value of preferred stock dividends and other adjustments necessary to derive net income apportioned to common stockholders.", "label": "Preferred Stock Dividends and Other Adjustments", "negatedLabel": "Preferred stock dividends" } } }, "localname": "PreferredStockDividendsAndOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r89", "r276" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred Stock, Liquidation Preference, Value", "terseLabel": "Preferred stock, liquidation preference (in Dollars)" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r22", "r274" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r22", "r274" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r22", "r460" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of September 30, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of September 30, 2022 and December 31, 2021; liquidation preference of $18,075 as of September 30, 2022" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).", "label": "Proceeds from (Repayments of) Lines of Credit", "terseLabel": "Net proceeds from (payments on) Kinergy\u2019s line of credit" } } }, "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfSecuredDebt": { "auth_ref": [], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt wholly or partially secured by collateral. Excludes tax exempt secured debt.", "label": "Proceeds from (Repayments of) Secured Debt", "terseLabel": "Proceeds from principal payments on notes receivable" } } }, "localname": "ProceedsFromRepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfBuildings": { "auth_ref": [ "r69" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from sale of buildings.", "label": "Proceeds from Sale of Buildings", "terseLabel": "Proceeds from asset sales" } } }, "localname": "ProceedsFromSaleOfBuildings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r72", "r373" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock option exercises" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductionRelatedImpairmentsOrCharges": { "auth_ref": [ "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nonrecurring impairment charges related to the write-off of production-related equipment and inventory. This tag is used when an Entity charges this cost to cost of goods sold.", "label": "Production Related Impairments or Charges", "terseLabel": "Production capacity per year" } } }, "localname": "ProductionRelatedImpairmentsOrCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/OrganizationandBasisofPresentationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r55", "r56", "r59", "r76", "r90", "r97", "r105", "r106", "r158", "r164", "r168", "r171", "r174", "r197", "r246", "r247", "r248", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r395", "r398", "r399", "r404", "r405", "r424", "r437", "r512" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow", "http://altoingredients.com/role/ConsolidatedIncomeStatement", "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r13", "r235" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment held-for-sale" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r236", "r460", "r513", "r524" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r62", "r202" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt expense (benefit)" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis": { "auth_ref": [ "r20", "r504", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by arrangement, in which the entity has agreed to expend funds to procure goods or services from one or more suppliers.", "label": "Purchase Commitment, Excluding Long-Term Commitment [Axis]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain": { "auth_ref": [ "r20", "r504", "r519" ], "lang": { "en-us": { "role": { "documentation": "This item is intended to be populated, by the entity, with Members identifying each purchase commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.", "label": "Purchase Commitment, Excluding Long-Term Commitment [Domain]" } } }, "localname": "PurchaseCommitmentExcludingLongtermCommitmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": { "auth_ref": [ "r20", "r504", "r519" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.", "label": "Purchase Commitment, Remaining Minimum Amount Committed", "terseLabel": "Fixed-price purchase contracts value" } } }, "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r460", "r523", "r540" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables, Net, Current", "terseLabel": "Notes receivable, noncurrent" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": { "auth_ref": [ "r165", "r168" ], "lang": { "en-us": { "role": { "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.", "label": "Reconciliation of Assets from Segment to Consolidated [Table]" } } }, "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "auth_ref": [ "r165", "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.", "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Schedule of assets by operating segments" } } }, "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r338", "r454", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofpreliminarypurchasepriceallocationTable" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r74" ], "calculation": { "http://altoingredients.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Principal payments on borrowings" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r12", "r85" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r281", "r460", "r521", "r534", "r536" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r94", "r95", "r96", "r98", "r104", "r106", "r198", "r374", "r375", "r376", "r378", "r379", "r422", "r531", "r533" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r286", "r287", "r288", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r341", "r344", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/PensionandRetirementBenefitPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r149", "r150", "r163", "r169", "r170", "r176", "r177", "r179", "r283", "r284", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r86", "r87" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Income from Cash Grant" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r60", "r90", "r149", "r150", "r163", "r169", "r170", "r176", "r177", "r179", "r197", "r246", "r247", "r248", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r437", "r512" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of long-term borrowings" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r409", "r413", "r416" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Schedule of recognized gains for its derivatives" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of pro forma combined financial information assuming the acquisition occurred" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": { "auth_ref": [ "r112", "r124", "r131" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]", "terseLabel": "Schedule of compute basic and diluted earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r11", "r35", "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r412", "r414" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Schedule of derivatives not designated as hedging instruments" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/DerivativesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of preliminary purchase price allocation" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r158", "r161", "r167", "r223" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r158", "r161", "r167", "r223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of financial data for operating segments" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r146", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r163", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r174", "r179", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r238", "r239", "r529" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingAssetReconcilingItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting, Asset Reconciling Item [Line Items]" } } }, "localname": "SegmentReportingAssetReconcilingItemLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r146", "r147", "r148", "r158", "r162", "r168", "r172", "r173", "r174", "r175", "r176", "r178", "r179", "r180" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENTS" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/Segments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_SelfInsuranceReserveNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid after one year (or the normal operating cycle, if longer).", "label": "Self Insurance Reserve, Noncurrent", "terseLabel": "Combination cash" } } }, "localname": "SelfInsuranceReserveNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r66" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r21", "r22", "r279" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r21", "r22", "r279" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r80" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Aggregate shares of common stock" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balances (in Shares)", "periodStartLabel": "Balances (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r450", "r452" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-Term Lease, Cost", "negatedLabel": "Less short-term portion" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoflongtermborrowingsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted": { "auth_ref": [ "r47", "r508", "r525" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The floor amount as of the balance sheet date that the entity must expend to satisfy the terms of disclosed arrangements (excluding long-term commitments) in which the entity must commit resources to supply goods or services to one or more customers.", "label": "Supply Commitment, Remaining Minimum Amount Committed", "terseLabel": "Open fixed-price sales contracts valued" } } }, "localname": "SignificantSupplyCommitmentRemainingMinimumAmountCommitted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r146", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r163", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r174", "r179", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r237", "r238", "r239", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofassetsbyoperatingsegmentsTable", "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r21", "r22", "r23", "r89", "r90", "r111", "r112", "r117", "r120", "r124", "r134", "r135", "r136", "r197", "r246", "r250", "r251", "r252", "r255", "r256", "r274", "r275", "r276", "r277", "r279", "r437", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r49", "r57", "r58", "r59", "r94", "r95", "r96", "r98", "r104", "r106", "r133", "r198", "r279", "r281", "r374", "r375", "r376", "r378", "r379", "r422", "r439", "r440", "r441", "r442", "r443", "r444", "r453", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r94", "r95", "r96", "r133", "r496" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r22", "r23", "r281" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Shares issued for Eagle Alcohol acquisition (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r22", "r23", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Outstanding unexercised warrants to purchase" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/EarningsLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r22", "r23", "r279", "r281" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuances of common stock (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r22", "r23", "r279", "r281" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Restricted stock issued to employees and directors, net of cancellations and tax (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r49", "r279", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Shares issued for Eagle Alcohol acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r22", "r23", "r279", "r281" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuances of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r22", "r23", "r281", "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Restricted stock issued to employees and directors, net of cancellations and tax" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "terseLabel": "Less: Preferred stock dividends" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofcomputebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r22", "r23", "r279", "r281" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Stock repurchases (in Shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r22", "r23", "r279", "r281" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Stock repurchases" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r23", "r28", "r29", "r90", "r189", "r197", "r437", "r460" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balances", "periodStartLabel": "Balances" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r58", "r90", "r94", "r95", "r96", "r98", "r104", "r197", "r198", "r281", "r374", "r375", "r376", "r378", "r379", "r393", "r394", "r403", "r422", "r437", "r439", "r440", "r444", "r453", "r532", "r533" ], "calculation": { "http://altoingredients.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoffinancialdataforoperatingsegmentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event, Description", "terseLabel": "Description of subsequent events" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r445", "r462" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r445", "r462" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r461", "r463" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_SupplyCommitmentArrangementMember": { "auth_ref": [ "r20", "r504", "r519" ], "lang": { "en-us": { "role": { "documentation": "This item is intended to be populated, by the entity, with Members identifying each supply commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.", "label": "Supply Commitment Arrangement [Domain]" } } }, "localname": "SupplyCommitmentArrangementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplyCommitmentAxis": { "auth_ref": [ "r20", "r504", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by arrangements in which the entity has committed resources to supply goods or services to a customer.", "label": "Supply Commitment [Axis]" } } }, "localname": "SupplyCommitmentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Net income" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r183", "r184", "r185", "r186", "r188", "r190" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r191", "r192", "r193", "r194", "r195", "r269", "r278", "r421", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r549", "r550", "r551", "r552", "r553", "r554", "r555" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecurringandnonrecurringfairvaluemeasurementsTable" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockReissuedAtLowerThanRepurchasePrice": { "auth_ref": [ "r23", "r279", "r281", "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "In cases when treasury stock is reissued at a price lower than the cost to repurchase, the excess difference between the selling price and cost to repurchase is charged against retained earnings (assuming that all APIC arising from treasury stock transactions has first been exhausted).", "label": "Treasury Stock Reissued at Lower than Repurchase Price", "terseLabel": "Purchase price" } } }, "localname": "TreasuryStockReissuedAtLowerThanRepurchasePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AcquisitionofEagleAlcoholDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedLabel": "Less unamortized debt financing costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoflongtermborrowingsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnamortizedLossReacquiredDebtNoncurrent": { "auth_ref": [ "r15" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unamortized Loss on Reacquired Debt is the loss incurred upon reacquisition or refinancing of debt, is treated as a deferred charge and amortized over the life of the new debt issued.", "label": "Unamortized Loss Reacquired Debt, Noncurrent", "terseLabel": "Kinergy line of credit" } } }, "localname": "UnamortizedLossReacquiredDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleoflongtermborrowingsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "auth_ref": [ "r118", "r121", "r122" ], "calculation": { "http://altoingredients.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic", "negatedLabel": "Income allocated to participating securities" } } }, "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Unrealized Gains (Losses)", "verboseLabel": "Total Unrealized Gains (Losses)" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofrecognizedgainsforitsderivativesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r137", "r138", "r139", "r140", "r143", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants and Rights Outstanding, Maturity Date", "terseLabel": "Warrants expired" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/EarningsLossPerShareDetails" ], "xbrltype": "dateItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r110", "r124" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares outstanding, diluted (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r107", "r124" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares outstanding, basic (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.", "label": "Weighted Average Number of Shares, Restricted Stock", "terseLabel": "Diluted shares (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesRestrictedStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://altoingredients.com/role/ScheduleofproformacombinedfinancialinformationassumingtheacquisitionoccurredTable" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "65", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2793-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2814-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.L)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126982154&loc=d3e400-110220" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r245": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r273": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=64906022&loc=d3e23086-112654" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r371": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r392": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r406": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41322-113958" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r425": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r463": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107425-111719" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "905", "URI": "https://asc.fasb.org/extlink&oid=6471048&loc=d3e5272-110052" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(17))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(7))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.12)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r544": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r545": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r546": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r547": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r548": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r549": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r550": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r551": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r552": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r553": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r554": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r555": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r556": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" } }, "version": "2.1" } ZIP 62 0001213900-22-070278-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-070278-xbrl.zip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

&UUC&7#U:_NX):M$SSD@BA[^^T#14%T=+2RV.[I=&??6PG MM'-T@"V.;8"I=ESW==AWL;B%4&T8Y.IC :8^ TP[S59GH9',0,BWRHK*H9W4 MZBR$+_76D'RIZZCVGI?MMB MP)SC'3"G#LPYW %S?D:OZHG TUOJ4*T .=UJ6P6D2T&GYU'\6VT,+C4 IWQV M642YB_T?U,7^6K%L

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end